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ABSTRACT 
 
 Consumption of whole grains has been linked to reduced risk of colon cancer. 
This study determined estrogenic activity of sorghum phenolic extracts of different 
phenolic profiles and identified possible estrogenic compounds in sorghum in vitro, as 
well as evaluated the potential of estrogenic sorghum phenolic extracts to prevent colon 
carcinogenesis in vivo. The thermal stability of sorghum 3-deoxyanthocyanins was also 
studied, to determine their suitability as functional food colorants. 
White and TX430 (black) sorghum extracts showed estrogenic activity in cell 
models predominantly expressing estrogen receptor-α (ERα) or ERβ at 5 and 10 µg/mL, 
respectively. The same treatments led to induction of apoptosis in cells expressing ERβ. 
The red TX2911 sorghum did not possess these activities. Compositional analysis 
revealed differences in flavones and flavanones. Flavones with estrogen-like properties, 
i.e. luteolin and apigenin, were detected in White and TX430 (black) sorghum extracts, 
but not in red TX2911 extract. Naringenin, a flavanone known to antagonize ERα 
signalling, was only detected in the red TX2911 extract. Additional experiments with 
sorghum extracts of distinct flavones/flavanone ratio, as well as with pure apigenin and 
naringenin, suggested that flavones are the more potent ERβ agonists in sorghum. On the 
other hand, 3-deoxyanthocyanins were probably not estrogenic. 
Estrogenic white and black sorghum phenolic extracts (fed at 1% level in the 
diet) reduced the number of azoxymethane induced colon premalignant lesion (aberrant 
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crypt foci) by 39.3% and 14.7%, respectively, in ovariectomized mice. Further studies 
are needed to elucidate the protective mechanisms induced by these sorghum extracts. 
Sorghum 3-deoxyanthocyanins retained good color stability after 30 minutes of 
heat treatment at 121 °C under pressure: More than 80% of color retained in pH 1 and 2 
HCl and citric acid solutions, and 39-84% retained from pHs 3-7. Formic acid negatively 
affected the color stability at pH 1 and pH 2 due to its reducing capacity. Methoxylation 
decreased the thermal stability of 3-deoxyanthocyanins. The heat stability of 3-
deoxyanthocyanins indicates good potential for food use. 
Overall, the inherent estrogenic activity of specific sorghum phenolic extracts is 
a likely mechanism for colon cancer prevention. Further studies are needed to assess 
physiologically relevant dietary level of sorghum phenolics for prevention of colon 
cancer, and effect of food processing on the activity and bioavailability of the 
chemopreventive components. 
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CHAPTER I 
 INTRODUCTION 
 
 Colon cancer is one of the most common types of cancers in the United States 
and around the world. It accounts for around 9% of all cancer incidences and is the most 
prevalent diagnosed malignancy in the digestive tract (1, 2). Many factors have been 
associated with lower colon cancer risk, for example, consumption of whole grains (3), 
fruits and vegetables (4, 5), consumption of soybeans and related products (6), use of 
hormone replacement therapy (7), etc. The female hormone estrogen is considered 
protective against colon cancer because observational studies find lower incidence of 
colon cancer in females compared with males (8, 9), in premenopausal women compared 
with post-menopausal women (10), and in post-menopausal women who used hormone 
or estrogen replacement therapies (7).  A plausible mechanism is estrogen-induced 
protective activities mediated through estrogen receptor-β (ERβ), the predominant 
estrogen receptor in the colon; e.g., via apoptosis in damaged colonocytes (11) and 
activation of tumor suppressor gene p53 (12). However, the utilization of estrogen 
replacement therapy as a chemopreventive strategy remains controversial because 
elevated levels of estrogen is associated with higher risk of female reproductive system 
cancers, especially breast cancer (7, 13).  
Phytoestrogens are a group of plant derived polyphenolic compounds which have 
similar physiological function as estrogen (17β-estradiol). They have shown benefits in 
colon cancer prevention but were not associated with the risk of traditional hormone 
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replacement therapy (14). Phytoestrogens are widely distributed in the plant kingdom 
but only a few major ones are present in human diet, which include isoflavones from 
legumes and lignans from whole grains (15). 
 Sorghum is an important cereal grain in many arid and semi-arid areas around the 
world (16). Consumption of sorghum was related to reduced incidence of esophageal 
cancer (17). Bran of black and tannin sorghum in the diet reduced the formation of 
premalignant lesions in the colon of rats treated with carcinogen (18). Our previous 
studies showed that phenolic extracts of sorghum inhibited the growth of human 
esophageal (OE33) and colon (HT-29) adenocarcinoma cell growth in vitro, with IC50s 
(concentrations to inhibit 50% cell growth) ranging from 49.7-883 µg/mL (19). 
Compared with phenolic extracts from nuts (20) and grapes (21), sorghum extracts 
required lower concentrations to inhibit HT-29 cell growth. The mechanisms of 
chemoprevention and the active components are still unknown. 
Sorghum grains of different genotypes are good sources of different groups of 
phenolic compounds (22). Sorghum grains with a pigmented testa under the pericarp 
accumulate high amounts of condensed tannins (proanthocyanidins) (23). Based on 
pericarp color, non-tannin containing sorghum grains can be divided into 3 main 
categories: White grains with the least amount of phenolics, red (including the black) 
grains with the highest amount of 3-deoxyanthocyanins, and lemon-yellow grains with 
high amounts of flavanones (e.g. naringenin) (24, 25). Sorghum secondary plant color 
(i.e. tan, red or purple) also influences the phenolic compositions of sorghum grains: Tan 
plants accumulate higher amounts of flavones (e.g. apigenin) than red/purple plants; 
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while red/purple plants accumulate higher amounts of 3-deoxyanthocyanins (24, 25). All 
sorghum grains contain phenolic acids (26).  
Among the phenolic compounds present in sorghum, 3-deoxyanthocyanins are a 
unique group, as sorghum is the only edible source of these pigments. Compared to 
anthocyanins, 3-deoxyanthocyanins do not possess the C-3 substitution in the C-ring, 
and are more stable to pH changes (27, 28) and the bleaching effects of common food 
additives (29). These properties suggest 3-deoxyanthocyanins are suitable for food 
colorants. However, the effect of thermal processing on stability of 3-deoxyanthocyanins 
are still unknown. In addition to their color stability advantages, the 3-
deoxyanthocyanins are more potent against human colon cancer cell growth in vitro than 
anthocyanins (30). In our previous in vitro study, black sorghum grain extract (highest in 
3-deoxyanthocyanins) was the strongest cancer cell growth inhibitor among all non-
tannin sorghums. The 3-deoxyanthocyanins are also capable of inducing quinone 
oxidoreductase (a phase II) activity in murine hepatoma cells. This indicates 3-
deoxyanthocyanins possess chemopreventive potential that anthocyanins may not have. 
However, the chemopreventive mechanisms of 3-deoxyanthocyanins are unknown.  
 Many cellular signaling pathways have been suggested as mechanisms for 
protection against colon cancer development. Besides antioxidant and anti-inflammatory 
capacity, estrogenic activity and associated activation of ERβ is recognized as a 
chemopreventive pathway that is important in the early stages of colon carcinogenesis. 
Among sorghum polyphenols, flavones and flavanones are recognized as estrogenic 
(31). The 3-deoxyanthocyanins may also possess estrogenic activity based on their 
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structural similarity to estrogenic flavonoids (lack of C-ring substitution). This 
hypothesis needs to be investigated to determine the potential of 3-deoxyanthocyanins to 
activate ERβ, which is relevant to gastrointestinal tract cancer prevention. 
The overall goal of this study is to evaluate estrogenicity as a potential 
chemopreventive mechanism of sorghum phenolics. This would lead to targeted 
utilization of specific sorghum varieties or compounds for cancer prevention, especially 
cancers of the gastrointestinal tract. The hypothesis is that sorghum phenolics possess 
estrogenic activity hence are capable of inducing apoptosis and other protective activities 
in the colon. Condensed tannins were not included in this study because their large 
molecular weight and spatial configuration likely excludes them from binding to 
estrogen receptors. The thermal stability of 3-deoxyanthocyanins, the most unique 
flavonoids in sorghum, was also studied since this property reflects the potential to use 
them as functional/chemopreventive food colorants.  
The objectives of this study were: 
1. To determine the estrogenic activity of sorghum grain phenolic extracts by in 
vitro methods; 
2. To identify possible estrogenic compounds in sorghum grain phenolic 
extracts; 
3. To determine the ability of estrogenic sorghum grain phenolic extracts to 
prevent azoxymethane induced colon carcinogenesis in ovariectomized mice; 
4. To determine thermal stability of sorghum 3-deoxyanthocyanins. 
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CHAPTER II 
 LITERATURE REVIEW 
 
Prevalence of Colon Cancer  
Colon cancer is the third most prevalent type of cancer in the US, with 102,480 
new cases and 50,830 deaths expected in 2013 (1). Colon cancer is also a common type 
of cancer worldwide, ranked as third most diagnosed cancer in males (663,600 new 
cases) and second in females (570,100 new cases), as well as the most commonly 
diagnosed malignancy in the digestive tract (2). In 2008, over 1.2 million new cases and 
608,700 deaths were estimated to have occurred around the world. The incidence of 
colon cancer in developed countries, i.e. Australia and New Zealand, Europe, and North 
America, is among the highest in the world; the incidence in Africa and Southeastern 
Asia is the lowest. In the past decade, the incidence of colon cancer in developed 
countries has been stabilizing or decreasing, mostly due to early detection and removal 
of precancerous lesions through annual colon cancer screening (32, 33). On the other 
hand, the incidence in some areas where colon cancer used to be low, such as several 
countries in Eastern Asia and Eastern Europe, have increased (33, 34). Adopting to 
Western diet is believed to be a major contributor to such trend (33, 34).  
 
Colon Carcinogenesis 
Colonic carcinogenesis involves multi-step pathologic changes which turn 
normal colonic epithelial cells into invasive carcinoma (Figure 1) (35, 36). The process 
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can be roughly divided into three main stages, initiation, promotion and progression. The 
complete process can take decades and is related to mutations of multiple genes 
regulating cellular functions. Colon cancer may be sporadic, hereditary or as a result of 
inflammatory bowel disease (IBD) (37). 
 
 
 
Figure 1. A simplified illustration of colon carcinogenesis with major pathological 
events and gene mutations. Figure was adapted with changes from Jänne, P.A. & Mayer, 
R.J. (35) with information from Kinzler, K.W. & Vogelstein, B. (36). 
 
 
 
The initiation step starts with damage to DNA and results in loss of tightly 
maintained balance between apoptosis and proliferation/differentiation of normal colonic 
epithelium (colonocytes) (37). Colonic crypts are U-shape units of colonic mucosa. Stem 
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cells are located at the bottom of the crypts and divide slowly. Daughter cells are 
gradually pushed up along the sides of the crypts and differentiated into cells with 
various morphologies and functions.  Cells moved to luminal surface of crypts become 
epithelial cells. The ones reaching the uppermost part undergo apoptosis and are slough 
off without further differentiation or replication (38, 39). During normal crypt 
development, one cryptic cell with genetic or epigenetic changes (mutated/damaged 
DNA) can develop resistance to apoptosis signal upon arrival at the uppermost part of 
the crypt and keep proliferating (Figure 1). The APC (adenomatous polyposis coli) gene 
mutation and associated overexpression of mutant β-catenin are commonly found in this 
initiation stage, causing increased proliferation and decreased apoptosis (40). Mutated 
APC gene could lead to mutation of k-ras, one of the oncogenes (41). The mutated forms 
of k-ras stimulate cell proliferation, transformation and differentiation (42), then as a 
result build up more resistance to apoptosis (38, 40). 
The crypt with pre-cancerous properties is called aberrant crypt foci (ACF) and 
has been widely used as a biomarker of colon carcinogenesis in chemoprevention studies 
(38, 43-45). These ACFs are characterized by crypts with altered luminal openings, 
thickened epithelia and being larger than the adjacent normal crypts (46). Figure 2 shows 
examples of ACFs in animals and humans (38).  
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Figure 2. Images of colonic aberrant crypt foci (ACF) found in mouse (a and b), rat (c 
and d) and human (e and f). Methylene blue staining is capable of identifying ACF (a, c 
and e). Adapted from Tanaka et al. (38). 
 
 
The promotion stage of colonic carcinogenesis mostly results in development of 
adenoma (well-demarcated lumps of epithelial tumor cells) from the hyperproliferative 
colon epithelium (Figure 1). Though most of them remain benign, a small fraction of 
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these lesions may evolve into malignancy (38, 47). The promotion stage transforms 
small adenomas to large adenomas and finally infiltrating carcinomas (Figure 1). The 
genetic events in these two stages include mutations of oncogenes (such as k-ras) and 
mutator genes (DNA mismatch repair genes, such as MLH1 and MSH2), inactivation of 
tumor suppressor genes (such as APC, p53 and DCC (deleted in colorectal carcinoma)) 
and disturbances of DNA methylation and microsatellite stability (38, 48).  
Discovery of ACFs, removal of small benign adenomas and other pre-malignant 
lesions are effective in early detection of colon cancer reducing the probability of onset 
of the diseases. However, the required annual endoscopic screening and associated 
medical technique are not ubiquitously accessible and/or affordable. The estimated mean 
charge per discharge inpatient of colon cancer increased from $25,289 in 1998 to 
$51,569 in 2007; while the mean cost for each inpatient rose from $12,124 to $16,688 (a 
37.6% increase) in that decade (49). The cost of cancer is also increasing on public 
health expenditures side. It is predicted that by 2020, the average colorectal cancer-
related medical care cost will increase by 42.3%, to approximately $14.02 billion, in the 
US (50). On the other hand, prospective studies suggest as much as 70% of current colon 
cancer burden could be prevented by moderate modifications in dietary pattern (reduce 
red meat and increase poultry/fish consumption; adequate consumption of fruits, 
vegetables, whole grains and fiber) and lifestyle (avoid smoking and heavy alcohol use, 
maintain a healthy weight, and moderate level of physical activity) (51, 52). Hence the 
ultimate goal of “fighting” colon cancer should be primary prevention, which is of 
importance in improving the quality of lives and reducing health care expenditure.  
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Chemoprevention entails protective actions, including retarding, blocking or 
even reversing carcinogenesis (53). Practically, this strategy uses natural or synthetic 
chemical substances to reduce the risk of developing cancer, or to reduce the chance that 
cancer will recur. In colon cancer prevention, restoring the balance between apoptosis 
and proliferation, as well as reducing the formation of ACFs are used as major strategies 
(38, 54). 
 
Diet and Risk of Colon Cancer  
 
Dietary Factors Related to Increased Colon Cancer Risk 
The majority of, though not all, evidence from epidemiological and observational 
studies suggest that diets high in saturated fat (55), red (56) and processed meats, highly 
refined grains/starches and added sugar (57) are related to higher risk of colorectal 
cancer. 
Dietary saturated fat, red and processed meats cause increased concentration of 
bile acids in the bowel content, which can interfere with the balance between 
proliferative and apoptotic cells (56). In addition, the metabolites of bile acids, e.g. 
secondary bile acid deoxycholic acid, are capable of destroying cytoplasmic membrane 
in epithelial cells of the colon, which indirectly results in increased cell proliferation and 
higher sensitivity to mutagenic factors (58). 
Consuming diets high in saturated fat, red and processed meats, refined grains 
and added sugar stimulate the secretion of insulin thus result in increased level of free 
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IGF-1 (insulin-like growth factor-1), which may lead to increased cell proliferation and 
reduced apoptosis (59, 60). 
 
Dietary Factors Related to Decreased Colon Cancer Risk  
 Some dietary components have been suggested to lower the risk for colon cancer, 
e.g. a balanced diet with low amount of saturated fat and high amount of whole grains 
(3), fruits and vegetables (4, 5), as well as dietary fiber (61); habit of drinking tea (62, 
63); frequent consumption of soybeans and soy food products (64); regular consumption 
of fish rich in n-3 polyunsaturated fatty acids (65, 66), etc. The underlined mechanisms 
for the protective effects can be roughly divided into five main categories (67, 68):  
1) Interaction with and/or scavenging of carcinogenic substances exposed to 
colon epithelium, by compounds such as antioxidants and complex carbohydrates;  
2) Breaking the unbalanced proliferation/apoptosis in malignant cells by 
induction of apoptosis and/or arrest of cell cycles, by compounds such as genistein, one 
of the isoflavones in soybeans (69) and many other polyphenols, n-3 polyunsaturated 
fatty acids, butyrate produced from dietary fiber, among others.;  
3) Activation of cellular detoxifying/damage repairing/defensive mechanism, e.g. 
transcription factor Nrf2 (nuclear factor (erythroid-derived 2)-like 2) and associated 
transcriptional control element ARE (antioxidant response element); 
4) Reduction of inflammation and suppression of related genes/molecular 
pathways, e.g. NF-κB ; and,  
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5) Suppression of oncogenes and restoration/maintaining of suppressed tumor 
suppressor genes.  
It is noteworthy that many chemopreventive dietary components function 
through more than one of these mechanisms, which all work together to protect against 
colon tumor initiation and progression. 
 
Sorghum in Cancer Prevention 
Sorghum (Sorghum bicolor) is the fifth most important cereal crop in the world 
in terms of production (23). The agronomic advantages of sorghum (mainly drought and 
heat tolerance) make it suitable to grow in most arid and semi-arid areas around the 
world. Sorghum grain is a staple food and important cereal in many parts of Africa, 
Asia, and the Middle East (16). Sorghum in these areas is mainly consumed in the forms 
of couscous, porridge, baked goods (bread, flat bread, cookie, and steam bread), and 
fermented drinks. Sorghum is an important alternative grain to use in gluten-free diets 
(70). Besides grains, leaf sheaths of some red plant sorghum are used as food colorants 
in traditional African cooking (71). Sorghum is fairly resistant to pests and diseases, 
which is partly linked to its unique profile of phytochemicals (72). 
In Africa and parts of Asia, regular consumption of sorghum and millets was 
associated with lower esophageal cancer incidences compared to areas where wheat and 
corn were the major cereals consumed (73, 74). In addition the amount of sorghum and 
millets consumed correlated with decreased incidence of esophageal cancer (17). On the 
other hand, increased incidence of esophageal cancer among South African blacks was 
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suggested to be due to substitution of sorghum with corn as a staple diet (75). These 
observations provided evidence that sorghum may have chemopreventive properties that 
other grains do not possess. 
Black and tannin sorghum bran (6% in diet) decreased the number of 
azoxymethane induced premalignant lesions in the colons of rats compared with control 
diet (6% cellulose) (18). The sorghum brans lowered proliferation and induced apoptosis 
in colonocytes, which was possibly due to their ability to induce murine endogenous 
antioxidant enzyme activities (superoxide dismutase, catalase, and glutathione 
peroxidase) (18).  
Hwanggeumchal (which means “golden” in color and “sticky” in texture) 
sorghum extracts reduced the growth of human breast tumor xenografts in mice and 
blocked metastasis to the lungs (76). The mechanism was linked to cycline D1 induced 
G1 cell cycle arrest and suppressed tumor growth by down regulation of Jak2/STAT 
pathways (76). Moreover this sorghum extract possessed higher capacity to decrease 
expression of oncogenic proteins than extracts from other grains, i.e. wheat and millet 
(76). However, the composition of the sorghum extract was not provided. A 
procyanidin-rich sorghum extract inhibited tumor growth in C57BL/6J mice bearing 
Lewis lung cancer by suppressing vascular endothelial growth factor (VEGF); in 
addition the sorghum extract improved the activity of antioxidant enzymes (superoxide 
dismutase and glutathione peroxidase) after D-galactose induced oxidative stress (77). 
These studies show that sorghum phenolics can suppress tumor progression in mouse 
models; however, the active components have not been identified.   
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We previously demonstrated that aqueous acetone extracts from sorghum grains 
of various phenolic profiles inhibited human esophageal (OE33) and colon 
adenocarcinoma (HT-29) cell growth in vitro, with IC50s of 49.7-883 μg/mL. The 
antiproliferative capacity was correlated with their antioxidant efficacy, with tannin 
sorghum extracts as the most potent inhibitors followed by black sorghum rich in 3-
deoxyanthocyanin pigments (19). In addition, we showed that specific non-tannin 
sorghum extracts induced the activity of quinone reductase (a phase II protective 
enzyme) in murine liver cells (Hepa1c1c7), with black sorghum as the most potent 
inducer. Further research with pure 3-deoxyanthocyanidins revealed a structure-activity 
relationship: O-methyl substitution on the A-ring increased the antiproliferative and QR 
inducing capacity of 3-deoxyanthocyanidins (78). This evidence indicated that phenolic 
composition of sorghum affects their chemopreventive potential (19). 
 
Phenolic Composition of Sorghum Grains 
The composition of phenolic compounds in sorghum grains is influenced by 
genotypes (24, 25). Genetic factors control the presence of pigmented testa in sorghum 
grains, pericarp color of the grains, thickness of pericarp, and secondary plant color of 
sorghum (79). Sorghum grains with a pigmented testa under the pericarp accumulate 
high amounts of condensed tannins (proanthocyanidins), which are high-molecular 
weight polymerized flavan-3-ol and/or flavan-3,4-diol units (Figure 3) (80). Based on 
pericarp color, non-tannin containing sorghum grains can be divided into 3 main 
categories: white grains, with the least amount of phenolics, red (including the black) 
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grains, with the highest amount of 3-deoxyanthocyanins (Table 1), as well as lemon-
yellow grains, with the highest amounts of flavanones (Table 1) (24, 25). Sorghum 
secondary plant colors (i.e. tan, red and purple) also influence the phenolic composition 
of sorghum grains (Table 1). Sorghum grains with tan secondary plant color contain 
higher amounts of flavones than red/purple plants, while grains with red/purple plant 
color have higher 3-deoxyanthocyanins than the tan plants. On the other hand, the levels 
of flavanones are not affected by secondary plant color (24, 25). All sorghum grains 
contain phenolic acids, mainly hydroxycinnamic acids and their derivatives (81, 82).  
 
 
Table 1. Levels (µg/g of ground sorghum grains, fresh weight) of flavonoids in different 
types of sorghum grains (24, 25). 
Criteria Grain types Compounds Amount (µg/g) 
Pericarp color 
White Flavones 19.4-65.0 
Flavanones Not detected 
3-Deoxyanthocyanins 0.6-1.5 
Red (including Black) Flavones 3.5-386 
Flavanones 8.1-241 
3-Deoxyanthocyanins 0.4-680 
Lemon-yellow Flavones 20.5-362 
Flavanones 134-1780 
3-Deoxyanthocyanins 0.6-108 
Secondary 
plant color 
Tan Flavones 19.0-386 
Flavanones 0-1428 
3-Deoxyanthocyanins 0-1 
Red/Purple Flavones 0-67.0 
Flavanones 0-1780 
3-Deoxyanthocyanins 8.0-680 
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Figure 3. Skeletal structure of major sorghum phenolics: 3-deoxyanthocyanins, flavones, 
flavanones, phenolic acid esters of glycerol and condensed tannins. 
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Sorghum grains have higher contents of polyphenols and antioxidant capacity 
than other major cereal grains, such as wheat, barley, millet and rye (83). Sorghum also 
contains phenolic compounds not commonly found in other cereal grains (Table 2). For 
example, flavanones (eriodictyol, naringenin and glycosides) are mainly present in citrus 
fruits (e.g. grapefruits, lemons, limes and oranges) (84) and flavones (derivatives of 
luteolin and apigenin) are mainly found in herbs and spices (e.g. parsley, dried oregano, 
and celery seeds) (84). The flavanol derivatives in sorghum are mostly of the condensed 
type (proanthocyanidins with degree of polymerization >10); barley and red finger 
millets are the other cereal grains with these compounds (85). Additionally, the 
extractable phenolic acids found in sorghum are mostly esters of glycerol (Figure 3) 
(82), which are different from the most commonly reported simple phenolic acids in 
grains. The pigments of black pericarp sorghums, 3-deoxyanthocyanins (Figure 3), are 
unique compared to anthocyanins, and sorghum is the only known edible source of such 
pigments. The 3-deoxyanthocyanins lack a substitution at the C-3 position of the C-ring, 
which makes them more stable as colorants (29, 86), and more cytotoxic than their 
anthocyanin analogs (30). 
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Table 2. Contents of major phenolic compounds in sorghum grains compared with other 
sources. 
Compounds Resources Amount (µg/g) References 
Phenolic acids Sorghum 385-746 (87) 
Barley 450-1346 (88) 
Millets (Finger, Foxtail and Pearl 
millets) 
612-3907 
(89) 
Corn (Maize)  601 (88) 
Oat 472 (88) 
Rice 197-376 (88) 
Rye 1362-1366 (88) 
Wheat 1342 (88) 
Condensed 
tannins 
Sorghum 7880-21970 (90, 91) 
Barley 740 (90) 
Anthocyanins Red/Black pericarp Sorghum* 0.4-680 (25) 
Blue barley 4 (92) 
Pigmented corn 93-965 (92) 
Black rice 2283 (92) 
Blue/Purple wheat 13-153 (92) 
Flavones Sorghum 3.5-386 (24, 25) 
Wheat Not quantified (93, 94) 
Millets (Kodo, Finger, Foxtail, 
Proso, Pearl, and Little millets) 
1.9-123.51 
(95) 
Oats Not quantified (96) 
Parsley, dried 17746-135062 (84) 
Oregano, dried 9168-11465 (84) 
Celery seeds 8951 (84) 
Flavanones Sorghum 134-1380 (24, 25) 
Citrus fruits (grapefruits, oranges, 
and lemons) 
153.9-925.1 
(84) 
*Sorghum contains 3-deoxyanthocyanins (apigeninidin, luteolinidin and their 
derivatives) 
 
 
As discussed earlier, observational studies, animal, and cell culture studies 
suggest directly or indirectly that phenolics present in sorghum grains contribute to 
chemoprevention. Possible mechanisms involved include antioxidant activity which is 
exerted by all phenolics, antiproliferation (induction of apoptosis or cell cycle arrest), 
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and anti-inflammation activity by specific polyphenols in sorghum. Many cellular 
signaling pathways have been associated with the chemopreventive benefits of phenolic 
compounds, such as activation of Nrf2 and suppression of NF-κB (68). Besides these, 
inherent estrogenic activity of the phenolic compounds may be a distinct 
chemopreventive mechanism, because of the potentially protective role of estrogen in 
gastrointestinal tract cancers. Among sorghum polyphenols, flavones and flavanones 
have been recognized as estrogenic (31). Based on structural similarities, 3-
deoxyanthocyanins may possess estrogenic activity as well. Hence investigating 
estrogenic mechanism may provide valuable information on the role of sorghum 
polyphenols in cancer prevention. 
 
 Estrogen and Colon Cancer Prevention  
 
Estrogen Signaling and Estrogen Receptors 
The female steroid hormone, estrogen, is essential for the development and 
functions of female reproductive system and related mammary glands. Estrogen also 
plays an important role in other endocrine responsive systems, such as brain, bone, 
cardiovascular system and adipose tissue (97). Estrogen is believed to participate in the 
development and progression of various diseases, for example, cancer (breast, ovarian, 
colorectal, prostate), osteoporosis, cardiovascular diseases, and cognition diseases (98). 
The function of estrogen is mainly mediated through estrogen receptor (ER). 
 20 
 
 
The estrogen receptor is a ligand-binding inducible transcription factor which 
after activation regulates the expression of target genes (97). Two ER subtypes have 
been discovered in humans and rodents: ERα and ERβ. The two ERs are ubiquitously 
expressed in many tissues but have distinct tissue distribution patterns and physiological 
functions. ERα is the major ER in reproductive systems, i.e. endometrium, breast, 
ovarian stroma, and hypothalamic tissue; while ERβ is the major ER in all other non-
reproductive system related tissues, e.g. kidney, brain, bone, heart, lungs, intestinal 
mucosa, and endothelial cells (98). 
The genomic (classical) action of estrogen is through ligand binding. Estrogen 
binds to the ligand binding domain of ER, then induces the ligand-specific 
conformational changes of the protein (so called “activation” of ER) (99). The ligand 
bound receptor (estrogen-ER) then dimerizes and binds to specific DNA-binding 
domain, estrogen responsive element (ERE), located within the promoter region of target 
genes. The estrogen-ER binding to ERE results in recruitment of coregulatory proteins 
(coactivators or corepressors) to the promoter, increase or decrease in mRNA levels and 
associated protein production, and finally, a physiological response (98).  
The two ERs lead to different signaling pathways. Cell growth for ERα and 
apoptosis for ERβ (100). ERα is the main ER mediating the essential function of 
estrogen in the development of female reproductive systems. On the other hand, ERβ is 
believed to be a target of disease prevention/protection in tissues where it is 
predominantly expressed, such as the colon (101).  
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Mechanism of Estrogen and ERβ in Colon Cancer Prevention 
Observational studies have found lower incidence of colon cancer in females 
compared with males (8, 9), and also in premenopausal women compared with post-
menopausal women (10). Long term administration of oral contraceptives has been 
associated with reduced colon cancer incidence in women (102). Multiple observational 
studies showed approximately 30% reduction in relative risk for colon cancer in 
postmenopausal women who received hormone or estrogen replacement therapy 
compared with those who did not (103-105). These evidence suggest that estrogen plays 
a protective role in the development of colon cancer. 
The role of ERβ in colon cancer prevention was discovered by the observed 
changes in expression pattern during colon cancer development. ERβ is the prevalent ER 
in normal colon mucosa and it is capable of modulating colonic physiological functions 
(106). However, its expression is progressively reduced during colon cancer 
development (107-109). In addition, the proliferative activity in colon adenomatous 
tissue was inversely correlated with the expression of ERβ  (109). The major form of 
estrogen, 17β-estradiol (E2), reduced non-malignant colonocytes growth in vitro and 
colonic tumor formation in vivo by ERβ mediated apoptosis (11) and p53 activation (12). 
All these evidence suggest that ERβ is important in the early stage of colon 
carcinogenesis and could be a target in chemoprevention. However, the utilization of 
estrogen as a colon cancer chemopreventive agent remains controversial because 
elevated levels of estrogen are also associated with increased risk of breast cancer (103-
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105). Selective ERβ agonists could thus be good alternatives for colon cancer 
chemoprevention. 
 
Phytoestrogens and Colon Cancer Prevention 
 
Characteristics of Phytoestrogens 
Due to the ligand binding activation mechanism of ER, estrogens are not the only 
group of compounds which can bind to ER. Other compounds capable of binding to ER 
are called selective estrogen receptor modulators (SERMs), to which phytoestrogens 
belong. Phytoestrogens are a group of plant derived polyphenolic compounds which can 
modulate the activation of estrogen receptors, i.e. possess similar function as E2 (110, 
111). Steroid-like plant hormones are not considered as phytoestrogens because of their 
similar structure to the hormones in animals (15). Estrogenic compounds have been 
documented in more than 300 plant species, but only a few of these are found in the diets 
of human and animals. Among phytoestrogens, isoflavones from soybeans and lignans 
from flaxseed as well as whole grains are the two most common groups (15). The major 
groups of phytoestrogens and their origins are summarized in Table 3.  
Phytoestrogens are more selective than estradiol in binding to ERβ and produce 
different estrogenic potencies after binding to ERs (14, 112). Genistein, for example, has 
a selective affinity to ERβ that is 7- to 48-fold higher than affinity to ERα (113-115). 
Genistein also produces different relative estrogenic potency compared to estradiol. 
When bound to ERα, genistein produces less than 1% of the activity of estradiol; 
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however, when bound to ERβ, it can produce up to 30-fold higher activity, depending on 
the assay system (113-115). The selective binding and higher potency of phytoestrogens 
towards ERβ make them good candidates for preventing cancers involving ERβ, such as 
colon cancer, esophageal cancer and other gastrointestinal tract cancers. 
 
Table 3. Major phytoestrogens and their origin (15, 116). 
Group name Skeleton structure Major compounds Origins 
Isoflavones 
O
O  
Genistein, daidzein, 
glycitein and their 
glycosides 
Soybeans and other 
beans (117) 
BiochaninA Chickpeas (118) 
Formononetin 
glycosides 
Alfalfa sprouts (119) 
Coumestans 
O
O
O
 
Coumestrol 
Clover, alfalfa 
sprouts (119), 
soybeans (117) 
Lignans 
 
Dimeric 
phenylpropanoids 
(mostly 8-8’ linked): 
secoisolariciresinol 
and matairesinol 
Flaxseeds, bran of 
most whole grains, 
and some 
fruits/vegetables 
(120) 
Prenylflavonoids O
OH
HO
OH O  
Prenylnaringenin 
(especially 8-prenyl-) 
Hops and beer (121, 
122) 
Others 
(weak/limited 
evidence) 
O
O  
Flavones Spices (123) 
OH
HO
OH  
Resveratrol 
Grapes and wine 
(124, 125) 
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Phytoestrogens in Colon Cancer Prevention 
Multiple epidemiological studies have suggested that frequent consumption of 
soy foods (e.g. ≥ 4 times/week) reduced the risk of colon cancer, by 10-53% (6). 
Interestingly, the meta-analysis of relevant studies showed an approximate 21% 
reduction of colon cancer risk in women but not in men who consume soy foods (6). On 
the other hand, studies with consumption of soy or phytoestrogens indicate no elevated 
breast cancer risk (14). 
A case-control study conducted at Toronto found higher intake of dietary lignans 
from typical Western diet (> 0.255 mg/day) was associated with a significant 27% 
reduction in colorectal cancer risk, compared with lowest dietary lignans consumption 
(0-0.158 mg/day); the same study also observed a similar reduction in colorectal cancer 
risk in people who consumed higher amounts of dietary isoflavones (>1.097 vs. 0-0.289 
mg/day) (126).  
A recent case-cohort study in Danish men and women examined the plasma 
concentrations of enterolactone, the microbial metabolites of lignans, and observed that 
with each doubling in enterolactone concentration, the relative risk for colon cancer in 
women decreased by 24%; no protective effect was found in men (127). 
Many studies have looked at the mechanism by which phytoestrogens contribute 
to colon cancer prevention. Genistein is the most extensively studied phytoestrogen and 
has been shown to possess antiproliferative capacity (cell cycle arrest, apoptotic activity 
and tyrosine kinase inhibitor activity), and capacity to reduce the number of colonic 
ACFs and tumor numbers in animals treated with carcinogens (128). Enterolactone has 
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also been demonstrated to have antiproliferation, apoptotic and phase II enzyme 
(NADPH: quinone reductase) inducing capacity in various human colon cancer cells 
(129). Purified lignans from whole grains (flaxseed and rye) reduced the formation of 
ACFs and colonic polyps in mice studies (129).  
Some studies have linked the colon cancer prevention capacity of phytoestrogens 
with activities mediated by ERβ, the predominant ER in the colon. For example, dietary 
soy isoflavones supplementation (genistein level 250 mg/kg diet) reduced tumor 
incidence in wild type and ERα-knockout ovariectomized mice, suggesting protection 
was ERα independent (130).  Soy isoflavones decreased azoxymethane induced colon 
tumor size and burden in rats and inhibited human colon cancer cells (DLD-1) growth by 
elevating expression of ERβ (131). Further research by this group confirmed the 
antiproliferative effect was due to a G2/M cell cycle arrest mediated by ERβ (69). Diet 
enriched with cumestrol (ERβ agonist with a 200-fold higher affinity than E2) was 
capable of reducing polyp numbers and increasing enterocyte migration in 
ovariectomized APC+/- mice (132). All these studies indicate that the protective effect of 
phytoestrogens against colon cancer development is likely linked to ERβ. Hence the 
activities mediated through ERβ should be considered in studies targeting estrogenic 
phenolic compounds in colon cancer prevention. 
 
Methods Used to Determine Estrogenic Activity 
Many methods, both in vitro and in vivo, have been utilized to determine 
estrogenic activities of various compounds. The major methods include:  
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1) Rat/mouse uterotrophic assays. These assays evaluate the effect of 
administered compounds in supporting female animal reproductive system development. 
The outcomes measured are weights of uteri, vagina, cervix, and records of vaginal 
openings, etc. (133-135). This assay determines the activities associated with ERα.  
2) ER dependent responses in cell lines. These assays employ immortalized and 
proliferative cells which express or are transfected with ER expression vector and 
determine the typical cellular effect after activation of ER, such as increased/decreased 
cell proliferation, and expression of related genes/proteins (135-137).  
3) Induction of transcriptioanal activity by estrogen response element (ERE) 
reporter. In these assays, ERE is constructed in conjunction with a reporter gene, such as 
luciferase and green fluorescent protein genes, then transfected into cell lines or yeasts 
expressing ER (as is or via transgenic approaches). The quantities of signals produced 
during the assay then reflect the transcriptional activity after administration of test 
compounds. A housekeeping gene (such as β-galactosidase) is always co-transfected to 
normalize the results (138, 139).  
4) ER binding affinity assay in vitro. This assay measures the binding or 
competitive binding of target compounds to ER. Estradiol (E2) is used as the binding 
competitor. The binding affinity is always expressed as molar concentration of 50% 
competition and this concentration is typically compared with that of E2 (133, 137).   
Most of the time, the activities determined in each of these assays are specific to 
one subtype of ER. Multiple assays from each category are used complementarily for 
one target compound due to the complexity of cell physiology. Stable and strong ER 
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antagonists, such as ICI 182, 780, have high binding affinity to ER but do not activate 
estrogen induced transcriptional activities (140). Parallel administration of ER 
antagonists eliminates the binding of estrogenic compounds to ER, which is also used to 
confirm ER mediated activities. 
  
Models Used to Study Chemopreventive Potential of Estrogenic Compounds 
against Colon Cancer  
 
In vitro Cell Culture Models  
Many cell models derived from human colon adenocarcinoma have been used to 
study the chemopreventive potential of various compounds. Among the common cell 
lines are HT-29, Caco-2, LoVo, and HCT116. These models represent a wide range of 
disease progression stages and genetic make-up; hence are valuable tools to test 
hypotheses regarding colon cancer. However, all these cells are models of tumor 
progression. Information derived from cell culture models on how phytoestrogens affect 
the initiation and promotion stages of colon cancer is scarce, partly because of the 
difficulties in establishing cell lines from normal colonic epithelium.  
The recently developed young adult mouse colonocytes (YAMCs) cell line 
provides a suitable model for studying the effect of dietary compounds in prevention of 
colon cancer during early stages (141). The cells are non-malignant, well characterized, 
morphologically primitive epithelial cells with no evidence of differentiation. The cell 
line was established from epithelial mucosa of a transgenic mouse expressing 
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temperature sensitive SV40 large T antigen gene constitutively. At permissive conditions 
(33 °C and the presence of interferon-γ), SV40 large T proteins in the cells are active and 
bind to p53, thus facilitating immortalization of the cells, whereas in non-permissive 
conditions (37-39 °C without interferon-γ), the conformation of the protein changes so 
that it can not bind to p53 or immortalize cells (142, 143). Under these non-permissive 
conditions the cells behave as slow-proliferating, differentiated colonic epithelial cells 
and undergo apoptosis if they achieve maximal confluence. Therefore, the conditions are 
optimized for cells to proliferate slowly for 24 h at 39 °C and then undergo cell death 
over 5–8 days, similar to the life cycle of normal colon epithelium (141). Studies 
administrating test compounds at non-permissive conditions to this cell model provide 
mechanistic information on colon cancer prevention that correlate with in vivo studies 
(11, 144). 
        
In vivo Ovariectomized Rodent Models 
In vitro cell culture studies have some inherent disadvantages in providing 
microenvironment during normal colon tumorigenesis and interventions that can be 
applied to humans. Therefore, controlled in vivo animal studies are necessary to translate 
the hypothesis of potential chemopreventive compounds and targets derived from cell 
culture models to the physiology of colon (145). Rodent models (rats and mice) injected 
with colon specific carcinogens (most commonly 1,2-dimethylhydrazine, DMH and 
azoxymethane, AOM) are the most widely used models to study the pathogenesis of 
sporadic (adenoma-carcinoma sequence) colorectal cancer (146). The advantages of 
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carcinogen-induced rodent model include high reproducibility, similar pathogenesis as 
human colorectal cancer, especially at early stages, and ease of adaptation to animals 
with various genetic backgrounds (146). Ovariectomized animals are used in estrogenic 
compound studies to remove the effect from endogenous estrogens.  
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Figure 4. A scheme for the in vivo metabolism of colon carcinogens (1,2-
dimethylhydrazine and azoxymethane) and corresponding G  A mutation of DNA. 
Figure adapted from Rosenberg et al. (146); Cyp2E1: a cytochrome P450 isoform; ADH: 
adenine dinucleotide+-dependent dehydrogenase; Cyps: cytochromes P450.  
 
 
 30 
 
 
Azoxymethane (AOM) is a colonic procarcinogen. The in vivo metabolized form 
of AOM is a DNA methylating agent, and guanine is its main target (147). Injection of 
AOM into rodent models induces formation of O6-methylguanine adducts (148), which 
results in G  A mutations of DNA (Figure 4). This leads to formation of preneoplastic 
lesions, aberrant crypt foci (ACF), in the colon in a relatively short time (43). Pretlow et 
al. (44) observed ACFs in patients with colon cancer and suggested that these 
preneoplastic lesions were putative precursors of colon adenomas and carcinomas. 
Hence the preneoplastic lesion ACF induced by AOM has been used as a biomarker to 
evaluate the function and mechanisms of chemopreventive agents against colon cancer 
(149, 150). 
In order to investigate estrogenic activity of sorghum phenolics and associated 
colon carcinogenesis protective mechanisms, in vitro cell models were first used to 
screen sorghum extracts of various phenolic profiles for estrogenic activity. For initial 
and primary screening to identify estrogenic potential of sorghum extracts, the human 
breast cancer cell line MCF-7 was used to identify estrogenic compounds. Thereafter, 
young adult mouse colonocytes (YAMCs) cells expressing primarily ERβ were used to 
investigate ERβ mediated activities induced by sorghum extracts in the early events of 
colon carcinogenesis. The major phenolic compounds in sorghum extracts were 
characterized and quantified by UPLC-MS and HPLC. The information on phenolic 
composition was used to identify possible estrogenic compounds in these extracts. With 
the information gathered from cell culture studies, specific sorghum extracts were tested 
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for their effects on mitigating the formation of ACFs in ovariectomized mice treated 
with AOM. 
   
Effect of Thermal Processing on Sorghum Phenolics 
Sorghum grains are typically thermally processed to make food for humans. The 
thermal processes include boiling, steaming, baking, flaking and extrusion, among the 
others. Structural changes induced by thermal processing can impact food quality and 
bioactive properties of polyphenols. Understanding the extent of degradation and 
degradation mechanisms of polyphenols would be helpful in predicting food product 
quality changes over time and exploring methods to stabilize the polyphenols during 
thermal processing.  
Like other plant polyphenols, the amount and antioxidant capacity of sorghum 
phenolics are affected by heat treatments. After steam exposure at 220 °C for 120 s, 
extractable free phenolic acids in barley bran increase as high as 9-fold (151). Cooking 
(boiling water bath 12 min) whole sorghum meal (non-tannin local cultivar) increased 
free phenolic acids content, probably due to better extractability, which was 
accompanied by decrease of bound phenolic acids (152). Heat treatment increases 
hydrolysis of glycosidic bonds and ester/ether bonds between phenolic compounds, 
lignins, and hemicelluloses/cellulose, which results in the release of bound phenolic 
acids (151). 
The antioxidant capacity of cooked sorghum meal reduced by roughly 50%, 
while the 3-deoxyanthocyanidin content reduced by 50-73% (152). The total phenols of 
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cooked sorghum grain meals was 38-65% lower compared to the uncooked meals (153). 
The antioxidant capacity of different types of sorghum (white, black and tannin) 
decreased 22-43% after baking in cookies and breads (154). Extrusion seems to decrease 
the antioxidants in sorghum the most: The total phenols of different varieties of sorghum 
grains and brans (white, black and tannin) reduced 59-87% after extrusion (155). Since 
degradation of polyphenols is temperature dependent, higher process temperature, such 
as frying and extrusion, results in higher loss of free phenolic compounds and 
antioxidant capacity. The decrease in antioxidant capacity could be because of heat 
induced structural degradation of phenolics (156).  
The common reactions of flavonoids inducing by heat treatment include 
deglycosylation (157), break-down of ester bond, generation of C6-C3-C6 structure 
fragments (e.g. protocatechuic acid) (158-160), as well as formation of neo-formation 
compounds (e.g. hydroxymethylfurfural, melanoidins) (161). These reactions contribute 
to flavor and color development during cooking (161), but the degraded and/or oxidized 
compounds may be involved in unfavorable reactions, such as oxidation (162). Heat 
treatment depolymerizes proanthocyanidins into lower molecular weight units (91), 
which are known to be more bioavailable. Some polyphenols, e.g. anthocyanins, can 
polymerize during thermal processing, which are considered to retain more color during 
storage than the simple anthocyanins (163, 164).  
Since thermal processing could affect the phenolic profiles and bioactivities of 
sorghum, such as estrogenic properties, it is important to consider the impact of this 
change on potential health benefits of sorghum phenolics. Among the sorghum 
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phenolics, the knowledge of thermal stability of 3-deoxyanthocyanins is very limited. 
These pigments possess unique characteristics as potential food colorants and 
chemopreventive agents. Therefore, determining their thermal stability would add 
valuable information on the potential of these pigments as bioactive food ingredients. In 
addition, knowing the degradation mechanisms and products is valuable in looking for 
strategies to stabilize the 3-deoxyanthocyanins during processing.  
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CHAPTER III 
 SORGHUM PHENOLIC EXTRACTS DEMONSTRATE ESTROGENIC ACTIVITY 
IN NON-MALIGNANT COLONOCYTES: RELATIONSHIP TO PHENOLIC 
PROFILES* 
 
Introduction 
Colon cancer is the third most prevalent type of cancer in the US, with 102,480 
new cases and 50,830 deaths expected in 2013 (1). Colon cancer is also a common type 
of cancer worldwide, ranked as third most diagnosed cancer in males (663,600 new 
cases) and second in females (570,100 new cases), as well as the most commonly 
diagnosed malignancy in the digestive tract (2). Incidence of colon cancer in developing 
countries has increased significantly. Adaptation to Western diet is considered a likely 
contributor to this trend (33, 34). With increasing colon cancer medical expenditure on 
the patients (49) and public health sector (50), colon cancer is indeed a major public 
health burden in both developed and developing countries. Prospective studies suggest 
that as much as 70% of current colon cancer burden can be prevented by moderate 
modifications in dietary pattern and lifestyle (51, 52). Hence primary prevention seems 
to be the most effective strategy to “fight” colon cancer.  
 
 
____________ 
*Portions of this chapter were reprinted with permission from “Sorghum phenolics demonstrate estrogenic 
action and induce apoptosis in non-malignant colonocytes” by Yang, L., Allred, K. F., Geera, B., Allred, 
C. D., and Awika, J.M. Nutrition and Cancer 2012, 64, 419-427. Copyright 2012 by Taylor & Francis. 
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Consumption of whole grains has been associated with reduced risk of colon 
cancer (3). Besides the benefits from dietary fiber, minerals and vitamins, phenolic 
compounds present in whole grains are also important in preventing the onset of cancer, 
especially malignancies in the gastrointestinal tract. Consumption of sorghum was 
associated with lower incidence and mortality from esophageal cancer, a protection not 
associated with consumption of other cereal grains (17, 73-75). Sorghum bran and 
phenolic extracts inhibited colonic premalignant lesion formation (18) and breast/lung 
tumor progression in animal models (76, 77). Our previous studies showed that phenolic 
extracts of sorghum inhibited the growth of human esophageal (OE33) and colon (HT-
29) adenocarcinoma cell growth in vitro at lower concentration than phenolic extracts 
from nuts (20) and grapes (21). However, the mechanisms involved and the active 
components are still unknown. 
Of the many phenolic compounds in sorghum grains, flavones (e.g. apigenin and 
luteolin), flavanones (e.g. naringenin) and 3-deoxyanthocyanins are not present in large 
quantities in other cereal grains (24, 25). These compounds are known to contribute to 
chemoprevention via mechanisms other than antioxidant activity; for example, phase II 
enzyme inducing capacity and estrogenic activity. Estrogenic compounds are known to 
activate estrogen receptor-β (ERβ), the predominant estrogen receptor in the colon, thus 
in turn can induce apoptosis in damaged colonocytes, and activate tumor suppressor 
gene p53 (11, 12), among other mechanisms. The aim of this study is to determine if 
inherent estrogen-like property of sorghum polyphenols could contribute to colon cancer 
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prevention. The hypothesis is that sorghum polyphenols possess estrogen-like properties 
and could consequently contribute to colon cancer prevention.  
In this chapter, we first used in vitro cell models to screen for estrogenic potential 
of sorghum extracts of various phenolic profiles. The human breast cancer cell line 
MCF-7 is routinely used to identify estrogenic compounds; hence it was used for 
primary screening in this study. Thereafter, we used the young adult mouse colonocytes 
(YAMCs) expressing primarily ERβ to investigate ERβ mediated activities induced by 
sorghum extracts in the early events of colon carcinogenesis. The major phenolic 
compounds in sorghum extracts were characterized and quantified by UPLC-MS and 
HPLC. The information on phenolic composition was used to identify possible 
estrogenic compounds in these extracts. 
 
Materials and Methods 
 
Materials  
 
Sorghum grains. Three varieties of sorghum with distinct differences in phenolic profiles 
were used: a white variety (ATX635×RTX436), a bright red variety (TX2911), and a 
black variety (TX430 black) (Table 4). The grains were kindly provided by Dr. W. L. 
Rooney in the Department of Soil & Crop Sciences, Texas A&M University. The White 
variety was harvested in 2001 and the others in 2008 in College Station, Texas. The 
seeds were stored at -20 °C till use. 
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Table 4. Characteristics of sorghum varieties used in this study (26). 
Variety Pericarp color 
Secondary 
plant color Major compounds 
ATX635×
RTX436 
White Tan Phenolic acids, apigenin 
TX2911 Bright red Red 
Phenolic acids, 3-deoxyanthocyanins, 
naringenin glycoside 
TX430 
(black) 
Black Purple 
3-Deoxyanthocyanins, luteolin, apigenin, 
phenolic acids 
 
 
Commercial standards of phenolic compounds. Pure standards were used to characterize 
and quantify phenolic compounds in sorghum. Apigenin and luteolin were from Indofine 
(Indofine Chemical Company, Inc., Hillsborough, NJ); eriodictyol and its 7-O-glucoside 
as well as apigenin- and luteolin-7-O-glucoside were from Extrasynthese (Extrasynthese, 
Genay Cedex, France); naringenin was from MP Biomedicals (Solon, Ohio); ferulic 
acid, caffeic acid, p-coumaric acid, and naringin were from Sigma-Aldrich (St. Louis, 
MO); 3-deoxyanthocyanidins, i.e. apigeninidin, luteolinidin, 7-O-methyl-apigeninidin, 
and 5-O-methyl-apigeninidin were from AlsaChim (Strasbourg, France). 
 
Cell lines. MCF-7 cells were purchased from ATCC (Manassas, VA). The MCF-7 cells 
are estrogen-dependent tumor cells isolated from a postmenopausal woman with 
metastatic infiltrating ductal carcinomas and predominantly express ERα. Young Adult 
Mouse Colonocytes (YAMCs) cells were supplied by Dr. Robert Chapkin (Department 
of Nutrition and Food Science, Texas A&M University). These cells are a well-
characterized non-malignant cell line derived from the Immortomouse, and are 
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morphologically primitive epithelial cells with no evidence of differentiation. The 
YAMC cells are conditionally immortalized by the expression of the temperature-
sensitive SV40 large T antigen, and do not form tumors in athymic mice (143). 
 
Methods 
 
Extraction. Whole kernels of sorghum grain were ground in a cyclone mill (UDY, 
Boulder, CO) to pass through 0.1 mm screen before extraction. Ground samples were 
defatted using hexane at a ratio of 1:2 (w:v) by stirring for 2 h. The matrix was then 
centrifuged at 3100 ×g and the residue was dried inside a fume hood over-night at room 
temperature. Defatted samples were extracted with 70% (v/v) aqueous acetone with 
stirring for 30 min. Supernatant was collected by centrifuging (3100 ×g) for 15 min at 4 
°C. Acetone was immediately removed from the supernatant under vacuum at 40 °C by a 
rotary evaporator (Rotovap, Büchi, Flawil, Switzerland). The aqueous phase was freeze-
dried and used as a crude extract. Extracts were kept at -20°C till use. 
 
Reconstitution of sorghum extracts. Freeze-dried sorghum grain extracts were 
reconstituted at 10 mg/mL with 100% methanol (HPLC grade, EMD Millipore, 
Billerica, MA) then diluted 5 times with 50% aqueous methanol for UPLC-MS 
identification and HPLC quantification. 
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UPLC-ESI-MS analysis. A Waters-ACQUITY UPLC/MS system (Waters Corp., 
Milford, MA) was used, which consisted of a binary solvent manager, autosampler 
(sample manager), column heater, and photodiode array eλ detector (PDA) and 
interfaced with a tandem quadrupole (TQD) mass spectrometer equipped with an ESI 
source. The separation was performed on a Kinetex C18 column (150 mm × 2.10 mm, 
2.6 μm, Phenomenex, Torrance, CA) at 40 °C with following gradient at 0.4 mL/min: 
solvent A (0.05% formic acid in water), solvent B (acetonitrile), and the percentage of 
solvent B was 12-41% from 0-23.5 min, 41-75% from 23.5-25.5 min, 75% isocratic 
from 25.5-28.5 min, then 75-12% from 28.5-29.5 min, and 12% isocratic for 5 minutes 
to equilibrate the column. The injection volume was 1 µL. The monitoring wavelength 
for 3-deoxyanthocyanidins and derivatives was 485 nm; for phenolic acids and flavones 
was 340 nm; for flavanones and other polyphenols was 280 nm. Mass spectrometric data 
were acquired in positive mode for 3-deoxyanthocyanidins as well as its derivatives, and 
in negative mode for all the rest of compounds. Empower 2 software (Waters Corp.) was 
used to acquire and analyze data. The MS scan was recorded in the range of 100−1200 
Da. Nitrogen was used both as a drying gas and as nebulizing gas, while argon was used 
as the collision gas (AOC, Bryan, TX). The nitrogen gas flow conditions were 800 and 
50 L/h for desolvation and at the cone, respectively. The source block temperature and 
desolvation temperature were set at 150 and 400 °C, respectively. Optimization of 
ionization conditions was based on the intensity of the mass signals of 
protonated/deprotonated molecules and aglycones fragments and was performed for each 
individual peak/compound detected. Mass parameters were optimized as follows: 
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capillary voltage, 3.5/3.0 kV; and cone voltage, 60/30 V for positive/negative ionization, 
respectively. The MS/MS scan was optimized as follows: cone voltage of 60/(30−50) V 
and collision energy of (35-45)/(15−40) V. Compound identification was based on 
matching UPLC retention profile, UV-vis spectra and MS data with authentic standards. 
Where standards were not available, compounds were identified based on the fragment 
patterns compared with reports in the literature. 
 
 Quantitative analysis by HPLC. An Agilent 1200 series HPLC system (Agilent 
Technologies, Santa Clara, CA) was used for this analysis, which included a quadratic 
pump (with degaser), an autosampler, a column compartment, and a diode array detector 
(DAD). A Luna C-18 column (150 mm × 4.6 mm, 5.0 µm, Phenomenex, Torrance, CA) 
was used to carry out the separation with a two solvent gradient. Solvent A was 1% 
formic acid in water and solvent B was 1% formic acid in acetonitrile. The gradient 
based on solvent B was as follows: 0-3 min, 10%; 5 min, 18%; 10 min, 20%; 23 min, 
26%; 25 min, 28%; 28 min, 40%; 30 min, 60%; 30-32 min, 60%; 34-40 min 10%. The 
column was kept at 40 °C during analysis and the flow rate was 1.0 mL/min. The 
injection volume was 10 μL. 3-Deoxyanthocyanins were quantified based on the signal 
at 480 nm, flavones and phenolic acids at 330 nm, and flavanones at 280 nm. The 
quantities of each compound were calculated based on standard curves obtained from 
pure compounds run under the same conditions. 
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Effect of sorghum extracts on MCF-7 cell growth. Potential of sorghum extracts to 
activate ERα was screened using an estrogen dependent human breast cancer cell line 
(MCF-7) expressing predominantly ERα. The MCF-7 cells were cultured in DMEM 
high glucose media (Sigma-Aldrich, St. Louis, MO) supplemented with 10% FBS 
(Hyclone, Logan, UT) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA), at 
37°C with 5% CO2. The cells were sub-cultured every 7 days when 80-85% confluence 
was reached; media was changed every 2 or 3 days for the same passage of cells. The 
MCF-7 cells were cultured in DMEM media supplemented with charcoal-dextran treated 
FBS (CDFBS) for 48 hr prior to plating in order to eliminate the estrogen present in FBS 
supplemented media. DMEM media with CDFBS were used hereafter in the process. 
The MCF-7 cells were plated at 150,000 cells per well in 6-well plates. After incubating 
for 24 hr, cells were treated with sorghum extracts (White, TX2911 and TX430 (black)) 
at 1, 5, 10, 50, 100, 150 µg/mL. DMSO (0.1 %) in culture media served as the control in 
the dose-response curve. Estradiol (E2, 1 nM) served as a positive control. Each dose for 
each extract was applied to 3 wells. The treatments in DMEM-CDFBS media were 
prepared by adding 1 µL of 1000X sorghum extract stock (reconstituted in DMSO) to 1 
mL of DMEM-CDFBS media. Treatment media was changed after 48 hr to ensure the 
supply of treatment and essential nutrients. After 96 hr incubation with treatment, cells 
were trypsinized and harvested into microcentrifuge tubes. An aliquot of 20 µL of 
harvested cells was then added to 10 mL ISOTON II diluent (Beckman, Brea, CA) to 
determine cell number using a Z1 Coulter particle counter (> 4 µm, Beckman Coulter, 
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Brea, CA). The experiment was repeated on 3 different days; cell growth was reported 
by comparing the number of cells for each treatment with that of the control. 
 
Estrogen response element-luciferase (ERE-luc) reporter assay. To confirm that the cell 
growth observed in MCF-7 cells was mediated by ER, estrogen response element-
luciferase (ERE-luc) reporter assay was conducted. The MCF-7 cells were handled the 
same way as for determination of cell growth. Cells were plated at 80,000 cells per well 
in 24-well plates. After 24 hr, each well received in total 0.167 µg of ERE-luc plasmid 
DNA and 0.021 µg of β-galactosidase (β-GAL) plasmid DNA. The plasmid DNAs were 
distributed equally to each well with the aid of the transfection agent ESCORT (Sigma-
Aldrich, St. Louis, MO). Transfection matrices were removed after incubating for 4 hr, 
and treatments (control, 0.1 % DMSO in culture media), positive control (1 nM 
estradiol), white sorghum (5, 10, 100 µg/mL), and TX430 (black) sorghum extracts (5, 
10, 100 µg/mL) in DMEM-CDFBS media were added to cells (3 wells per treatment). 
Cells were further incubated for 18 hr; then lysed to determine the transcriptional 
activities by measuring firefly luciferase activity (luciferase assay kit, Promega E1500, 
Madison, WI) and constitutive β-galactosidase activity (β-galactosidase assay kit, 
Promega E2000, Madison, WI), according to the instructions of the manufacturer, by an 
Infinite M200 TECAN plate reader (Tecan Group, Männedorf, Switzerland). This 
experiment was performed in duplicates. 
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Effect of sorghum extracts on YAMC cell growth. Potential of sorghum extracts to 
activate ERβ was determined in a cell model predominantly expressing ERβ, non-
malignant young adult mouse colonocytes (YAMCs). YAMC cells were cultured in 
RPMI 1640 media (Sigma-Aldrich, St. Louis, MO) supplemented with 5% FBS, 0.1% 
insulin, transferrin, selenious acid (ITS, BD Biosciences, Franklin Lakes, NJ), 1% 
Glutamax-1 (Invitrogen, Carlsbad, CA), and 1% penicillin/streptomycin (Invitrogen, 
Carlsbad, CA). Cells were maintained under permissive conditions, 33˚C, with 10 units 
of interferon gamma (IFNγ) (Roche, Indianapolis, IN) per mL medium. Cells were 
cultured in CDFBS supplemented RPMI 1640 media 48 hr before plating and thereafter. 
Cells were plated at 25,000 cells per well in 6-well plates; then incubated at 33°C, 
without INFγ for 24 hr to allow attachment to the bottom of plate. Cells were then 
treated with control (0.1 % DMSO), positive control (1 nM estradiol), and treatments 
(sorghum extract, 1, 5, 10, 50 or 100 µg/mL) for 96 hr under non-permissive conditions 
(37 °C, without INFγ). Each treatment was applied to 3 wells. Treatment media was 
changed after the first 48 hr to ensure steady supply of treatments and nutrients. At the 
end of 96 hr incubation, cells were harvested with trypsin and counted with a Beckman 
Coulter particle counter (> 20 µm), as described earlier for MCF-7 cells. Relative growth 
of each treatment was calculated by comparing the cell numbers of each treatment with 
that of the control. Each experiment was repeated 3 times. 
 
ER antagonist assay. In order to confirm the effect of sorghum extracts on YAMC cell 
growth was mediated through ER, ER antagonist ICI (ICI 182, 780; Fulvestrant, Sigma-
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Aldrich, St. Louis, MO) was used. All the handling and plating procedures were the 
same as in determining YAMC cell growth. The only difference was in this set of 
experiments, each treatment was treated alone and co-treated with 1 μM ICI, each to 3 
wells, respectively. Estradiol (1 nM) and estradiol co-treated with 1 μM ICI were used as 
the positive control and the concentration of DMSO in each treatment media was 
adjusted to 0.2%, as well as controls. Cell number and relative cell growth was 
determined as previously described using a Beckman Coulter particle counter. Each 
experiment was repeated 3 times. 
 
Caspase-3 activity assay. In order to determine a possible mechanism for the growth 
inhibitory effect of sorghum extracts on YAMC cells, apoptosis was measured using a 
Caspase-3 Kit (EnzChek Caspase-3 Assay Kit No. 2, Invitrogen, Carlsbad, CA). The 
YAMC cells were cultured and treated the same way as in ER antagonist assay. After 96 
hr of treatment, the cells were trypsinized and collected into microcentrifuge tubes. The 
cells were then lysed and the activity of caspase-3 was measured according to the 
instructions of the manufacturer. Relative apoptosis was determined by fluorescence 
intensity measured on a TECAN Infinite M200 plate reader. Three wells per treatment 
per experiment were used and four replicate experiments were conducted. 
 
Identifying possible estrogenic compounds in sorghum extracts. From the results 
obtained from previous sorghum extracts and YAMC cell growth experiments, flavones 
and flavanones were identified as key components affecting estrogenic potential of 
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sorghum phenolic extracts. Hence two additional sorghum varieties with contrasting 
composition of flavones and flavanones were selected to test the hypothesis that flavones 
in sorghum are agonists while flavanones are antagonists of ERβ. The two new varieties 
were a dark red pericarp variety with tan secondary plant color (99LGWO50), which is 
high in flavones, mainly apigenin and luteolin; as well as a lemon-yellow pericarp 
variety with purple secondary plant color (SC748), which is high in flavanones, mainly 
glycosides of eriodictyol and naringenin (26). The sorghum grains were kindly provided 
by Dr. W. L. Rooney and Dr. Gary Peterson in the Department of Soil & Crop Sciences 
of Texas A&M University. The sorghum grains were harvested in 2008 at College 
Station, TX. The YAMC cells were used as a model in this set of experiments. ER 
antagonist assay was used to confirm the estrogenic effect. Pure commercially available 
apigenin and naringenin were used to further investigate relative contributions of 
flavones and flavanones to estrogenic properties of sorghum. 
 
Hydrolysis of SC748 sorghum crude extract. From previous studies (26) we know that 
the flavanones in SC748 sorghum are mainly glycosides. In order to better evaluate the 
biological function of the flavanone aglycones, SC748 crude extract was hydrolyzed in 
acidified aqueous methanol (HCl : water : methanol = 0.1 : 49.9 : 50, v/v/v), at 60 °C for 
27 hr in a water bath. Based on HPLC peak areas, 90% of the flavanone glycosides were 
hydrolyzed. Methanol was rotary evaporated and the aqueous fraction was freeze-dried. 
Total recovered solids after hydrolysis was 64.4% of that of before hydrolysis. 
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Statistical analysis. The data were analyzed with one way analysis of variance 
(ANOVA). Least square means were compared by Dunnett’s t-test as a multiple 
comparison technique to determine the difference between treatments and their 
corresponding control. All statistical analysis was analyzed by SAS 9.2 (Cary, NC). 
 
Results and Discussion 
 
Characterization and Quantification of Major Phenolic Compounds in Sorghum 
Extracts 
 The White, red TX2911, and TX430 (black) sorghum varieties were initially 
selected to test their estrogenic activity based on the distinct differences in the 
compositions of 3-deoxyanthocyanins, phenolic acids, flavanones and flavones. The 
selection was based on our hypothesis that 3-deoxyanthocyanins, flavanones and 
flavones were estrogenic compounds in sorghum. Cell culture screening studies of these 
3 sorghum varieties showed that White and TX430 (black) sorghum extracts possessed 
estrogenic activity while red TX2911 extract did not. The differences in flavones and 
flavanones seemed to be the most reasonable explanation for the differences in 
estrogenic activity. Hence two additional sorghum varieties were selected to confirm the 
roles of flavones and flavanones on estrogenic properties of sorghum. The two varieties 
were a dark red  sorghum variety (99LGWO50) high in flavones and a lemon-yellow 
sorghum variety (SC748) high in flavanone glycosides (26). The phenolic composition 
of the 5 sorghum extracts were presented together in this session for simplicity. 
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Effect of hydrolysis on SC748 sorghum extract. SC748 sorghum extract contained 
glycosides of eriodictyol and naringenin as the major phenolic compounds (Figure 5). In 
order to better evaluate the estrogenic potential of flavanone aglycones, the SC748 
extract was hydrolyzed in acidified methanol (HCl : water : methanol = 0.1 : 49.9 : 50, 
v/v/v) at 60 °C. After 27 hr of hydrolysis, more than 90% of the flavanone glycosides 
were hydrolyzed to corresponding aglycones, eriodictyol and naringenin (Figure 5). 
Hydrolysis also produced luteolin aglycone from its glycosides. Gallic acid (or an 
isomer) was also formed (Figure 5), probably as a degradation product of phenolic 
compounds due to heat and acid. Levels of other constituents, such as flavanone 
chalcones and phenolic acids, were not significantly affected (Figure 5). The hydrolyzed 
SC748 extract was denoted as SC748-H. In the hydrolyzed lemon-yellow sorghum 
extract SC748-H, the flavanone aglycones were the major phenolic constituents. The 
composition of SC748-H extract should fulfill our objectives in determining the role of 
flavanone aglycones on estrogenic property of sorghum.  
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Figure 5. HPLC chromatograms of lemon-yellow sorghum extract before (SC748) and 
after acid hydrolysis (SC748-H) at 280 nm and 330 nm. 
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Phenolic acids and their esters. Phenolic acids, in their free and glycerol ester forms 
were detected in all sorghum extracts (Table 5, Figure 6). All were hydroxycinnamic 
acid derivatives, mainly caffeic acid and ferulic acid derivatives (Figure 7). 
 Peak 1 (tR = 1.564 min, λmax = 316 nm) had a [M-H]- at m/z 415. The MS/MS 
fragmentation pattern showed a dominant ion (100% intensity) at m/z 253 (M-162 amu, 
loss of a hexose unit). Peak 2 (tR = 1.749 min, λmax = 325 nm) had the same [M-H]- at 
m/z 415. Besides the fragment ion of m/z 253, it also had ions of m/z 179 and m/z 161, 
which matched fragmentation pattern of caffeoylglycerol (Table 5). According to Ma et 
al. (165), caffeoyl moiety substitutes at the 2-O- position elutes earlier than the one at the 
1-O- position. Thus, peak 1 was identified as 2-O-caffeoylglycerol-O-glucoside and 
peak 2 as 1-O-caffeoylglycerol-O-glucoside. These two isoforms of glucosylated 
caffeoylglycerol were only detected in White sorghum extract. The presence of 
caffeoylglycerol has been reported in red sorghum (82). 
 Peak 3 (tR = 1.813 min, λmax = 325 nm) had a [M-H]- at m/z 253. Peak 4 (tR = 
2.199 min, λmax = 325 nm) had the same [M-H]
- at m/z 253. The MS/MS fragmentation 
pattern of these two compounds was the same: Both showed a dominant ion at m/z 161 
and ions of m/z 179 and m/z 135, which matched fragmentation pattern of 
caffeoylglycerol (Table 5). Thus, peak 3 was identified as 2-O-caffeoylglycerol and 
peak 4 as 1-O-caffeoylglycerol. The 2-O-caffeoylglycerol was found in all sorghum 
extracts except SC748-H, and the 1-O-caffeoylglycerol was found in all sorghum 
extracts as a dominant peak. The presence of caffeoylglycerol has been reported in red 
sorghum (82). 
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Peak 5 (tR = 2.286 min, λmax = 325 nm) had a [M-H]- at m/z 179. The MS/MS 
showed only one dominant ion at m/z 135 (M-44 amu, loss of a carboxyl unit), which 
matched the pattern for caffeic acid (Table 5). Thus, peak 5 was identified as caffeic 
acid. All 5 sorghum extracts contained caffeic acid, which was in accordance with 
previous reports (24, 25). 
 
 
Table 5. Identification of phenolic acids and their esters in sorghum extracts (monitored 
at 340 nm) based on UPLC retention time (tR), UV-vis spectroscopic characteristics 
(λmax), and MS-MS/MS spectroscopic pattern. Ionization was performed in the negative 
mode. Peak numbers are referenced to Figure 6. 
Peak 
No. tR (min) 
λ max 
(nm) 
[M-H]-
(m/z) MS/MS Fragments (m/z) Proposed Identification 
1 1.564 316 415 253 
2-O-Caffeoylglycerol-O-
glucoside 
2 1.749 325 415 253, 179, 161, 135, 119 
1-O-Caffeoylglycerol-O-
glucoside 
3 1.813 325 253 179, 161, 135 2-O-Caffeoylglycerol 
4 2.199 325 253 179, 161, 135 1-O-Caffeoylglycerol 
5 2.286 325 179 135 Caffeic acid 
6 3.735 294 355 193 
Ferulic acid-O-galactoside or 
galactosyl ferulate 
7 4.355 316 355 193 
Ferulic acid-O-glucoside or 
glucosyl ferulate 
8 6.709 325 193 161, 134 Ferulic acid 
9 9.841 327 415 253, 179, 161, 135 Dicaffeoylglycerol 
10 10.228 326 415 253, 235, 179, 161, 135 Dicaffeoylglycerol 
11 10.703 322 415 253, 179, 161, 135 Dicaffeoylglycerol 
12 12.568 315 399 253, 235, 179, 163, 161, 145 p-Coumaroyl-caffeoyl-glycerol 
13 15.655 314 413 193, 177, 163, 145, 134, 119 p-Coumaroyl-feruloyl-glycerol 
14 16.135 329 443 193, 175, 149, 134 Diferuloylglycerol 
15a 13.075-a 296 399 253, 235, 163, 145, 119 p-Coumaroyl-caffeoyl-glycerol 
15b 13.075-b 296 429 253, 249, 193, 179, 161, 134 Feruloyl-caffeoyl-glycerol 
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Figure 6. Reverse-phase UPLC chromatograms of sorghum extracts at 340 nm. Peak 
numbers are referenced to Tables 5 and 9. 
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Figure 7. Chemical structures of phenolic acids and their glycosyl and glycerol ester 
dirivatives detected in sorghum.  
  
 
Peak 6 (tR = 3.735 min, λmax = 294 nm) had a [M-H]- at m/z 355. Peak 7 (tR = 
4.355 min, λmax = 316 nm) had the same [M-H]
- at m/z 355. The MS/MS of these two 
compounds included only one dominant ion at m/z 193 (M-162 amu, loss of a hexose 
unit), which matched fragmentation pattern of ferulic acid-O-glycoside or ferulic acid 
glycoside ester (Table 5). In reverse-phase HPLC, the eluting sequence of glycosides is 
reported to be galactoside, glucoside, then arabinoside (166). Thus, peak 6 was 
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tentatively identified as ferulic acid-O-galactoside (or galactosyl ferulate) and peak 7 as 
ferulic acid-O-glucoside (or glucosyl ferulate). Peak 6 was identified in White, TX2911, 
and SC748-H extracts, and peak 7 was only found in 99LGWO50 extracts. 
 Peak 8 (tR = 6.709 min, λmax = 325 nm) had a [M-H]- at m/z 193. The MS/MS 
fragments included ions at m/z 161 and at m/z 134 (dominant ion, M- 59 amu, loss of a 
C-COOH unit). Thus, peak 8 was identified as ferulic acid (Table 5). Interestingly, the 
free form of ferulic acid was only detected in 99LGWO50 as a major peak, but not in 
other sorghum samples. The free form of ferulic acid was also detected in SC748 after 
hydrolysis (SC748-H). Glycosides (or esters) of ferulic acids were detected in each 
variety of sorghum, indicating most sorghum varieties contain the ester forms of 
phenolic acids. 
 Peak 9 (tR = 9.841 min, λmax = 327 nm), Peak 10 (tR = 10.228 min, λmax = 326 
nm), and Peak 11 (tR = 10.703 min, λmax = 322 nm) all had a [M-H]- at m/z 415. The 
MS/MS fragmentation patterns of these three compounds were almost identical: ions at 
m/z 253 (M- 162 amu), m/z 179 (M- 162 amu – 74 amu) and m/z 135 (M- 162 amu – 74 
amu – 44 amu), matched the fragments of caffeoylglycerol, caffeoyl, and caffeoyl unit - 
COOH, respectively (Table 5) (165). Thus, peaks 9, 10, 11 were identified as 
dicaffeoylglycerols. The substitution pattern can be 1, 3-, 1, 2-, and 2, 3-
dicaffeoylglycerol. Peak 9 was detected in White, TX2911, and 99LGWO50 sorghum 
extracts. Peak 10 was detected in White, TX2911, 99LGWO50, and SC748-H extracts. 
Peak 11 was only detected in the White sorghum extract. The presence of 
dicaffeoylglycerol has been reported in red sorghum (82). 
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 Peak 12 (tR = 12.568 min, λmax = 315 nm) had a [M-H]- at m/z 399. The MS/MS 
fragmentation pattern included ions at m/z 253, m/z 179 and m/z 163, matched 
characteristic fragments of caffeoylglycerol, caffeoyl, and coumaroyl units, respectively 
(Table 5). The ion corresponding to the backbone structure of a glycerol without two 
substituted –COO unit is C3H5O, which also matched the pattern of the fragments (M-
179 amu- 163 amu = 57 amu = C3H5O). Thus, peak 12 was identified as p-coumaroyl-
caffeoyl-glycerol. It was detected in all the sorghum extracts except TX430 (black) 
extract. The presence of p-coumaroyl-caffeoyl-glycerol was reported in red sorghum 
(82). 
 Peak 13 (tR = 15.655 min, λmax = 314 nm) had a [M-H]- at m/z 413. The MS/MS 
fragmentation pattern included ions at m/z 193 and m/z 163, which matched 
characteristic fragments of feruloyl and coumaroyl units, respectively (Table 5). The 
mass of this compound also matched the pattern of phenolic acid glycerol ester (M- 193 
amu - 163 amu = 57 amu = C3H5O). Thus, peak 13 was identified as p-coumaroyl-
feruloyl-glycerol. It was only detected in TX430 (black) extract. The presence of p-
coumaroyl-caffeoyl-glycerol was reported in red sorghum (82).  
 Peak 14 (tR = 16.135 min, λmax = 329 nm) had a [M-H]- at m/z 443. The MS/MS 
fragmentation pattern included one dominant ion at m/z 193, which matched 
characteristic fragments of a feruloyl unit (Table 5). Thus, peak 14 was identified as 
diferuloylglycerol. It was only detected in TX430 (black) extract. The presence of 
diferuloylglycerol has not been reported in sorghum so far. 
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Peak 15 (tR = 13.075 min, λmax = 296 nm) was a mixture. In the White sorghum 
extract, this peak had a [M-H]- at m/z 399 (75% intensity) and a [M-H]- at m/z 429 
(100% intensity); in the TX2911 extract, this peak was pure and had a [M-H]- at m/z 
429. Hence we designated compound with m/z 399 as peak 15a and compound with m/z 
429 as peak 15b. The MS/MS fragmentation pattern of m/z 399 was almost identical to 
that of peak 12, thus peak 15a was identified as p-coumaroyl-caffeoyl-glycerol (Table 
5). It was only detected in the White sorghum extract. Peak 15a is an isomer of peak 12, 
the substitution pattern can be 1, 3- or 1, 2- p-coumaroyl-caffeoyl-glycerol. The MS/MS 
fragments of peak 15b included ions at m/z 253 and m/z 193, matched characteristic 
fragments of caffeoylglycerol and feruloyl units, respectively (Table 5). The mass of this 
compound also matched the pattern of phenolic acid glycerol ester (M-179 amu -193 
amu = 57 amu = C3H5O). Thus, peak 15b was identified as feruloyl-caffeoyl-glycerol. 
The presence of feruloyl-caffeoyl-glycerol has not been reported in sorghum, but has 
been identified by Ma et al. in Ananas comosus L. leaves (165). 
 
Quantification of phenolic acids and esters in sorghum extracts. The contents of phenolic 
acids and esters in 5 sorghum extracts are shown in Table 6. The bright red sorghum 
TX2911 extract had the highest amount of phenolic acid derivatives among the 5 
sorghum extracts (119.7 mg/g extract) followed by the dark red sorghum 99LGWO50 
extract (79.3 mg/g extract). The black sorghum TX430 (black) and the hydrolyzed 
lemon-yellow sorghum extract (SC748-H) contained the least amount of phenolic acid 
derivatives (4.25 and 5.10 mg/g extract, respectively).  
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Table 6. Contents (mg/g extract) of phenolic acids and their esters in sorghum extracts 
as quantified by HPLC-DAD systema. 
Compound Peak No. White 
TX2911 
(red) 
TX430 
(black) 
99LGWO50 
(red) 
SC748-H 
(hydrolyzed 
lemon-
yellow) 
2-O-Caffeoyl-
glycerol-O-
glucosideb 
1 Trace ND ND ND ND 
1-O-Caffeoyl-
glycerol-O-
glucosideb 
2 Trace ND ND ND ND 
2-O-Caffeoyl-
glycerolb 
3 0.479 ± 0.08 2.25 ± 0.007 0.138 ± 0.01 1.85 ± 0.32 0.211 ± 0.014 
1-O-Caffeoyl-
glycerolb 
4 3.60 ± 0.94 15.71 ± 0.004 1.54 ± 0.07 12.36 ± 2.04 1.33 ± 0.016 
Caffeic acid 5 1.16 ± 0.26 7.65 ± 0.66 0.547 ± 0.03 6.86 ± 1.11 0.175 ± 0.006 
Ferulic acid-O-
galactosidec 
6 0.594 ± 0.15 0.954 ± 0.04 ND ND 0.334 ± 0.006 
Ferulic acid-O-
glucosidec 
7 ND ND ND 0.746 ± 0.14 ND 
Ferulic acid 8 ND ND ND 0.512 ± 0.08 0.378 ± 0.002 
Dicaffeoyl-glycerolb 9 2.18 ± 0.93 10.2 ± 1.08 ND 8.15 ± 1.14 ND 
Dicaffeoyl-glycerolb 10 10.97 ± 5.0 64.8 ± 6.77 ND 38.29 ± 5.15 1.48 ± 0.15 
Dicaffeoyl-glycerolb 11 Trace ND ND ND ND 
p-Coumaroyl-
caffeoyl-glycerolb,d 
12 4.76 ± 1.56 11.0 ± 1.39 ND 5.50 ± 0.22 1.19 ± 0.25 
p-Coumaroyl-
feruloyl-glycerolc,d 
13 ND ND 1.14 ± 0.06 ND ND 
Diferuloylglycerolc 14 ND ND 0.880 ± 0.07 ND ND 
Feruloyl-caffeoyl-
glycerolb,c 
15b 3.05 ± 1.26 7.09 ± 0.86 ND 5.02 ± 0.66 ND 
Total phenolic acids 
and esters 
 26.8 ± 10.2 119.7 ± 10.8 4.25 ± 0.02 79.3 ± 10.9 5.10 ± 0.08 
 aAll values are expressed as mean ± SD of two separate runs. bBased on molar extinction 
coefficient of caffeic acid. cBased on molar extinction coefficient of ferulic acid. dBased 
on molar extinction coefficient of p-coumaric acid. ND = not detected. Peak numbers 
are referenced to Figure 6. 
 
  
Despite the differences in quantities, composition of phenolic acid and their 
derivatives were generally similar across all samples. Caffeoylglycerols and 
dicaffeoylglycerols were the major phenolic acids identified. Two isomers of 
caffeoylglycerols were found in all sorghum extracts; while dicaffeoylglycerol isomers 
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were detected in all sorghum extracts except TX430 (black). On the other hand, the 
TX430 (black) extract contained two derivatives feruloyl-glycerol, p-coumaroyl-
feruloyl-glycerol and diferuloylglycerol, which were not present in other sorghum 
extracts. Besides the common phenolic acid esters found in all sorghum extracts, White 
sorghum extract also contained  two glucosides of caffeoylglycerol, and an additional 
dicaffeoylglycerol isomer, though in trace amounts. 
Free phenolic acids were previously assumed to be the major constituents of 
readily extractable phenolic acids in sorghum, which resulted in very low quantitative 
data (87). Recently, Svensson et al. (82) reported that most extractable phenolic acids in 
a red pericarp sorghum were actually glycerol esters. Our data confirm this finding, and 
demonstrate significant variation in types and quantities of the phenolic acid esters in 
different sorghum varieties. 
   
Flavanones. Flavanones were identified mainly as eriodictyol and naringenin derivatives 
(Table 7, Figure 8). 
Peak 16 (tR = 2.598 min, λmax = 285 nm) had a [M-H]- at m/z 449. Peak 17 (tR = 
2.905 min, λmax = 283 nm) had the same [M-H]
- at m/z 449. The MS/MS of these two 
compounds included a dominant ion at m/z 287 (M- 162 amu, loss of a hexose unit), 
which matches fragmentation pattern of eriodictyol glycoside (Table 7) (82). In reverse-
phase HPLC, galactosides elute sooner than glucosides and arabinosides (166), the 
retention time of eriodictyol-7-O-glucoside standard was at 4.434 min, which was later 
than the two glycosides detected. Thus we inferred these two compounds were 
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galactosides of eriodictyol, but substituted at different positions. Though 7-O-glycosides 
are more common, both 5-O- and 7-O-glucosides of eriodictyol have been reported in 
sorghum (82, 167). According to Chang et al., glycosides substituted at the C-7 position 
increases polarity hence elutes earlier than those substituted at the C-5 position (168). 
Thus, peak 16 was tentatively identified as eriodictyol-7-O-galactoside and peak 17 as 
eriodictyol-5-O-galactoside. Both of these two compounds were identified in the lemon-
yellow sorghum extracts only, both SC748 and hydrolyzed SC748-H extracts. 
Peak 19 (tR = 3.982 min, λmax = 289 nm) and Peak 20 (tR = 4.385 min, λmax = 
283 nm) had the same [M-H]- at m/z 433. The MS/MS of these two compounds included 
a dominant ion at m/z 271 (M- 162 amu, loss of a hexose unit) and a diagnostic ion at 
m/z 151, which matched fragmentation pattern of naringenin glycoside (Table 7) (82). 
The retention time of eriodictyol-7-O-glucoside standard was at 4.43 min, and naringin 
(naringenin-7-O-rutinoside) standard was at 6.28 min. Naringenin mono-glucosides 
should elute in between of these two compounds. Generally, galactosides elute sooner 
than glucosides, which elute earlier than rutinosides. Thus we inferred the two 
naringenin isomers were galactosides of naringenin substituted at different positions. 
According to the eluting sequence of glycosides substituted at different A-ring positions 
(168), peak 19 was tentatively identified as naringenin-7-O-galactoside and peak 20 as 
naringenin-5-O-galactoside. Naringenin-7-O-glucoside has been identified in red 
sorghum (82). Peak 19 and peak 20 were detected in SC748-H extracts; whereas peak 
20 was also detected in TX430 (black), TX2911, and 99LGWO50 extracts (as minor 
peaks). Flavanones are intermediates of 3-deoxyanthocyanin biosynthesis (169), thus the 
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presence of naringenin galactoside in TX430 (black) and the two red sorghum extracts 
(TX2911 and 99LGWO50) may be related to 3-deoxyanthocyanins present in these 
extracts. 
 
Table 7. Identification of flavanones and their derivatives in sorghum extracts 
(monitored at 280 nm) based on UPLC retention time (tR), UV-vis spectroscopic 
characteristics (λmax), and MS-MS/MS spectroscopic pattern. Ionization was performed 
in the negative mode. Peak numbers are referenced to Figure 8. 
Peak 
No. 
tR 
(min) 
λ max 
(nm
) 
[M-H]- 
(m/z) MS/MS fragments (m/z) Proposed Identification 
16 2.598 285 449 287 Eriodictyol-7-O-galactoside 
17 2.905 283 449 287, 151, 135 Eriodictyol-5-O-galactoside 
18 3.535 284 883 721, 595, 541, 433, 405, 297, 287 
Pyrano-3', 4', 5', 5, 7-
pentahydroxyflavanone-(3 
 4)-catechin-7-O-
glucoside 
19 3.982 289 433 271, 151 Naringenin-7-O-galactoside 
20 4.385 283 433 271, 151 Naringenin-5-O-galactoside 
21 4.735 284 867 705, 579, 551, 525, 431, 417, 389, 271 
Pyrano-eriodictyol-(3  4)-
catechin-7-O-glucoside 
22 4.884 278 449 287, 193, 147, 139 Unknown 
23 6.552 283 851 689, 563, 551, 401, 389, 125 
Pyrano-naringenin-(3  4)-
catechin-7-O-glucoside 
24 9.365 287 287 151, 135, 107 Eriodictyol 
25 10.227 279 287 193, 191, 151, 147, 139, 135 Unknown 
26 10.962 295 689 509, 401, 389, 281, 271, 255, 125 
Pyrano-naringenin-(3  4)-
catechin 
27 11.552 295 689 509, 401, 389, 281, 271, 255, 125 
Pyrano-naringenin-(3  4)-
catechin 
28 11.813 295 689 509, 401, 389, 271, 255, 125 
Pyrano-naringenin-(3  4)-
catechin 
29 11.821 295 1107 705, 673, 417, 401, 271 
Pyrano-naringenin-(3  7)-
pyrano-eriodictyol-(3  4)-
catechin 
30 12.422 289 271 177, 151, 119, 107 Naringenin 
31 13.073 326 301 286, 177, 164, 151, 149, 123, 107 
3'-O-methyl-Eriodictyol or 
4'-O-methyl-Eriodictyol 
32 13.843 302 773 473, 441, 401, 209 
Pyrano-3-deoxyflavan-3-ol-
(3  3)-pyrano-naringenin 
33 14.097 302 773 473, 401, 209 
Pyrano-3-deoxyflavan-3-ol-
(3  3)-pyrano-naringenin 
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Figure 8. Reverse-phase UPLC chromatograms of sorghum extracts at 280 nm. Peak 
numbers are referenced to Tables 7 and 13. 
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Peak 22 (tR = 4.884 min, λmax = 278 nm) had a [M-H]- at m/z 449. The MS/MS 
fragmentation pattern included ions at m/z 287 (dominant ion, M- 162 amu, loss of a 
hexose unit), m/z 193 and m/z 147 (Table 7). Though the dominant fragment ion 
matched the mass of eriodictyol, the UV-vis characteristics and fragmentation pattern of 
peak 22 did not match a typical pattern for flavanones (Figure 9). Peak 22 was thus 
denoted as unknown, but it could be related to eriodictyol. It was detected in TX430 
(black) extract only. 
Peak 24 (tR = 9.365 min, λmax = 287 nm) had a [M-H]- at m/z 287. The MS/MS 
fragmentation pattern included ions at m/z 151 and m/z 135 (Table 7), which matched the 
fragments of eriodictyol (82). In addition, the retention time of peak 24 matched that of 
eriodictyol standard (9.395 min). Hence peak 24 was identified as eriodictyol. It was 
only detected in SC748-H extract. Eriodictyol was the product of hydrolysis of 
eriodictyol glycosides in lemon-yellow sorghum extract SC748. It is a major peak in 
hydrolyzed lemon-yellow sorghum extract SC748-H due to the abundance of eriodictyol 
glycosides in SC748 (Figure 5).  
 Peak 25 (tR = 10.227 min, λmax = 279 nm) had a [M-H]- at m/z 287. The MS/MS 
fragmentation pattern included ions at m/z 151 and m/z 135 (Table 7). Peak 25 had the 
mass of eriodictyol, but its UV-vis characteristics and fragmentation pattern did not 
match those of eriodictyol (Figure 9), thus peak 25 was denoted as unknown, but could 
be related to eriodictyol. It was only detected in TX430 (black) extract.  
 Peak 30 (tR = 12.422 min, λmax = 289 nm) had a [M-H]- at m/z 271. The MS/MS 
fragments included a dominant ion at m/z 151 and a diagnostic ion at m/z 119 (M-152 
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amu) (Table 7), which matched the pattern for naringenin (82). In addition, the retention 
time of peak 30 matched that of naringenin standard (12.452 min). Hence peak 30 was 
identified as naringenin. It was detected in TX2911, 99LGWO50, and SC748-H extracts. 
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Figure 9. Chemical structures of flavanone monomers and their glycosyl derivatives 
detected in sorghum extracts. 
 
 
Peak 31 (tR = 13.073 min, λmax = 326 nm) was a mixture and with a dominant 
[M-H]- at m/z 301. The MS/MS fragments pattern included ions at m/z 286 (M- 15 amu, 
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loss of a methyl unit) and m/z 151 (diagnostic ion of flavanones, fragment from Retro-
Diels-Alder fission) (Table 7 and Figure 9). The mass and fragments matched the pattern 
for a –O-methyl- substituted derivative of eriodictyol. Based on the existence of ion at 
m/z 151, we inferred that the methyl group should be substituted in the B-ring (Figure 9). 
Hence peak 31 was identified as 3’-O-methyl-eriodictyol or 4’-O-methyl-eriodictyol. It 
was only detected in SC748-H extract, most likely as a result of hydrolysis. 
Peaks 26, 27, 28 (tR = 10.962, 11.552, 11.813 min, λmax = 295 nm) all had a [M-
H]- at m/z 689. The MS/MS fragmentation pattern was almost identical among the three 
compounds, which included ions at m/z 401 (M- 288 amu), m/z 281, m/z 271, m/z 255, 
and m/z 125 (Table 7). Based on the UV-vis absorption pattern (Table 7), the structure 
should not have C2-C3 double bonds which would shift the λmax to above 310 nm. These 
compounds are likely derivatives of pyrano-flavanones, based on similar pyrano-
apigeninidin structure detected in red sorghum leaf sheath (170). The loss of 288 amu 
also matched the structures of common dimeric flavanone-flavanol molecules (171). 
Hence we inferred that these compounds are a catechin unit connected to a pyrano-
naringenin unit by C3-C4 linkage (Figure 10) (172). Due to the existence of three chiral 
carbons, the three peaks may represent isomers of the pyrano-compound. Thus peaks 26, 
27, and 28 were tentatively identified as isomers of pyrano-naringenin-(3  4)-catechin. 
Other structure elucidation strategies, such as the NMR, are needed to confirm this 
structure identification. Peaks 26 and 28 were only detected in dark red 99LGWO50 
sorghum extract as decent peaks. Peak 27 was detected as a major peak in dark red 
99LGWO50 sorghum extract and a minor peak in bright red TX2911 sorghum extract. 
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Figure 10. Schematic diagram showing fragmentation pattern of peak 26, 27, or 28 (A); 
MS/MS fragmentation pattern of peak 26 (B). 
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Peak 29 (tR = 11.821 min, λmax = 295 nm) had a [M-H]- at m/z 1107. The 
MS/MS fragments included major ions at m/z 705 (14% intensity, M-402 amu), m/z 401 
(100% intensity, M-705 amu), m/z 417 (M- 402 amu – 288 amu) (Table 7), which 
indicated the inclusion of 417 amu unit, 401 amu unit, and a 288 amu unit. Based on 
previous elucidation pattern (Figure 10), peak 29 was tentatively identified as a trimer of 
pyrano-naringenin-(3  7)-pyrano-eriodictyol-(3  4)-catechin (Figure 11). Peak 29 
was only detected in TX2911 extract. 
Both peak 32 (tR = 13.843 min, λmax = 302 nm) and peak 33 (tR = 14.097 min, 
λmax = 302 nm) had [M-H]
- at m/z 773. The MS/MS fragments included major ions at 
m/z 401 (100% intensity, M-372 amu), m/z 473, and m/z 209 (Table 7), which indicated 
the inclusion of 401 amu unit and 372 amu unit. Based on previous elucidation pattern 
(Figure 10), it is reasonable to believe that this 372 amu unit is a pyrano-flavonoid 
derivative. The λmax (302 nm) of these two peaks were different from the other pyrano-
flavanones (295 nm), which indicated that there may have a different pyrano conjugation 
pattern. The proposed structure was pyrano-3-deoxyflavan-3-ol; thus peaks 32 and 33 
were identified as pyrano-3-deoxyflavan-3-ol-(3  3)-pyrano-naringenin (Figure 11). 
The two peaks are probably isomers of this compound. Both peaks 32 and 33 were only 
detected in 99LGWO50 extract. 
Glycosides of compounds proposed as pyrano-flavanone-flavanol dimers were 
also detected (peaks 18, 21 and 23; Figure 11). 
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Figure 11. Chemical structures of pyrano-flavanone derivatives detected in sorghum 
extracts.  
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Peak 18 (tR = 3.535 min, λmax = 284 nm) had a [M-H]- at m/z 883. The MS/MS 
fragments included major ions at m/z 721 (21% intensity, M- 162 amu, loss of a hexose 
unit), m/z 433 (100% intensity, M- 162 amu - 288 amu) as well as ions at m/z 287 (Table 
7). The ion at m/z 433 represented an M+32 (2 –OH group) pattern compared with the 
dominant ion at m/z 401 of peaks 26, 27 and 28. Thus peak 18 was tentatively identified 
as pyrano-3ʹ, 4ʹ, 5ʹ, 5, 7-pentahydroxyflavanone-(3  4)-catechin-7-O-glucoside dimer 
(Figure 11). Peak 18 was only detected in TX430 (black) extract. 
 Peak 21 (tR = 4.735 min, λmax = 284 nm) had a [M-H]- at m/z 867. The MS/MS 
fragments included major ions at m/z 705 (19% intensity, M-162 amu, loss of a hexose 
unit), m/z 417 (100% intensity, M- 162 amu - 288 amu) as well as ions at m/z 271 (Table 
7). The ion at m/z 417 represented an M+16 amu (-OH group) pattern compared with the 
dominant ion m/z 401 of peaks 26, 27 and 28. Thus peak 21 was tentatively identified as 
pyrano-eriodictyol-(3  4)-catechin-7-O-glucoside dimer (Figure 11). Peak 21 was only 
detected in TX430 (black) extract. 
Peak 23 (tR = 6.552 min, λmax = 283 nm) had a [M-H]- at m/z 851. The MS/MS 
fragments included major ions at m/z 689 (14% intensity, M- 162 amu, loss of a hexose 
unit) and m/z 401 (100% intensity, M- 162 amu - 288 amu) as well as ions at m/z 125 
(Table 7). The ion at m/z 689 matched the fragmentation pattern of peaks 26, 27 and 28; 
thus peak 23 was tentatively identified as pyrano-naringenin-(3  4)-catechin-7-O-
glucoside dimer (Figure 11). Peak 23 was detected in TX2911 and TX430 (black) 
extracts. Further structure elucidation is needed for all the compounds that are proposed 
as pyrano-flavanone-flavanol derivatives. 
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Table 8. Contents (mg/g extract) of flavanone monomers in sorghum extracts as 
quantified by HPLC-DAD systema. 
Compound Peak No. 
TX2911 
(red) 
99LGWO50 
(red) 
SC748-H 
(hydrolyzed 
lemon-
yellow) 
SC748 
(lemon-
yellow) 
Eriodictyol-5-O-galactosideb 16 ND ND 0.69 ± 0.007 8.53 ± 0.36 
Eriodictyol-7-O-galactosideb 17 ND ND 1.21 ± 0.006 35.0 ± 1.1 
Eriodictyol 24 ND ND 11.0 ± 0.66 0.22 ± 0.005 
Naringenin-5-O-galactosidec 19 ND ND 0.94 ± 0.004 6.80 ± 0.18 
Naringenin-7-O-galactosidec 20 0.52 ± 0.002 2.55 ± 0.29 1.83 ± 0.01 35.9 ± 1.00 
Naringenin 30 ND 0.062 ± 0.014 12.2 ± 0.002 2.17 ± 0.06 
3'-OMe-Eriodictyold 31 ND ND 0.24 ± 0.004 ND 
Total flavanone monomers  0.52 ± 0.002 2.61 ± 0.30 28.1 ± 0.67 88.6 ± 2.70 
aAll values are expressed as mean ± SD of two separate runs. bExpressed as eriodictyol-
7-O-glucoside. cExpressed as naringin (naringenin-7-O-rutinoside). dExpressed as 
eriodictyol. ND = not detected. Peak numbers are referenced to Figure 8. 
 
 
Quantification of flavanones and their glycosyl derivatives in sorghum extracts. The 
contents of flavanone monomers and their glycosyl derivatives in sorghum extracts are 
shown in Table 8. Due to lack of standards and absolute certainly of the pyrano-
flavanone structures, the oligomers were not quantified. Only TX2911, 99LGWO50, and 
SC748-H extracts contained detectable levels of flavanone monomers. Among the 3 
sorghum extracts, the hydrolyzed lemon-yellow sorghum extract (SC748-H) had the 
highest amount of flavanone monomer derivatives (28.1 mg/g extract), consisting mainly 
of eriodictyol and naringenin aglycones. The Aglycones were products of acid 
hydrolysis (Figure 5). The red sorghum extracts, 99LGWO50 and TX2911 had 2.61 and 
0.52 mg/g, respectively, of flavanone monomers, mostly as naringenin-7-O-galactoside. 
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The compositional differences among red and lemon-yellow sorghums were in 
accordance with Dykes et al. (24, 25). 
 
 
Table 9. Identification of flavones in sorghum extracts (monitored at 340 nm) based on 
UPLC retention time (tR), UV-vis spectroscopic characteristics (λmax), and MS-MS/MS 
spectroscopic pattern. Ionization was performed in the negative mode. Peak numbers are 
referenced to Figure 6. 
Peak 
No. 
tR 
(min) 
λ max 
(nm
) 
[M-H]- 
(m/z) MS/MS fragments (m/z) Proposed Identification 
34 3.124 338 563 475, 395, 383, 353, 311, 264 
6-C-glucosyl-8-C-arabinosyl-
Apigenin 
35 3.905 341 447 285 Luteolin-7-O-galactoside 
36 5.073 346 447 285 Luteolin-7-O-glucoside 
37 6.762 349 607 299, 284 Luteolin-3'-OMe-7-O-rutinoside 
38 10.57 351 285 133 Luteolin 
39 10.955 341 315 300, 228, 201, 137 
3'-OMe- 4', 5', 5, 7-
tetrahydroxylflavone 
40 13.385 338 269 117, 135, 119 Apigenin 
41 14.587 343 329 314, 299, 271, 243, 199, 133 
Tricin (3', 5'-OMe-4', 5, 7-
trihydroxylflavone) 
42 18.5 340 343 313, 298, 270 
3', 5'-OMe-4', 5, 6, 7-tetrahydroxyl 
flavone 
 
 
 
Identification of flavones and their derivatives. Flavones identified in sorghum were 
mainly apigenin and luteolin derivatives (Table 9, Figure 6). 
Peak 34 (tR = 3.124 min, λmax = 338 nm) had a [M-H]- at m/z 563. The MS/MS 
fragments included two major ions at m/z 383 (100% intensity) and m/z 353 (98% 
intensity) as well as ions at m/z 475, m/z 395, and m/z 311, which matched fragmentation 
pattern of C-glycosides (95) (Table 9). Based on mass and elution characteristics, peak 
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34 was identified as 6-C-glucosyl-8-C-arabinosyl apigenin (95) (Figure 12). Peak 34 
was only detected in White and 99LGWO50 extracts. The presence of 6-C-glucosyl-8-
C-arabinosyl apigenin has been reported in millet grains (95), but not in sorghum. 
Peak 35 (tR = 3.905 min, λmax = 341 nm) had a [M-H]- at m/z 447. Peak 36 (tR = 
5.073 min, λmax = 346 nm) had the same [M-H]
- at m/z 447. The MS/MS of these two 
compounds included only a dominant ion at m/z 285 (M-162 amu, loss of a hexose unit), 
which matched fragmentation pattern of luteolin glycoside (Table 9). The retention time 
of luteolin-7-O-glucoside standard was 5.099 min, so peak 36 was identified as luteolin-
7-O-glucoside. Galactosides elute sooner than glucosides in reverse-phase HPLC (166), 
thus, peak 35 was tentatively identified as luteolin-7-O-galactoside. Both luteolin 
glycosides were identified in SC748-H extracts, likely a consequence of incomplete 
hydrolysis of SC748. 
Peak 37 (tR = 6.762 min, λmax = 349 nm) had a [M-H]- at m/z 607. The MS/MS 
fragmentation pattern included ions at m/z 299 (M-308 amu, loss of a rutinoside unit) 
and m/z 284 (M-308 amu -15 amu, loss of a –O-methyl unit of m/z 299) (Table 9). 
According to the mass and fragments, peak 37 was identified as luteolin-3ʹ-O-methyl-7-
O-rutinoside. It was detected in TX430 (black) extract only. 
Peak 38 (tR = 10.570 min, λmax = 351 nm) had a [M-H]- at m/z 285. The MS/MS 
fragments showed one dominant ion at m/z 133, which reflected the Retro-Diels-Alder 
fission of the C-ring. Base on authentic standard, peak 38 was identified as luteolin 
(Table 9), and was detected in White, TX430 (black), 99LGWO50 and SC748-H 
extracts. 
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Figure 12. Chemical structures of flavones and their glycosyl derivatives identified in 
sorghum extracts. 
 
 
 Peak 40 (tR = 13.385 min, λmax = 338 nm) had a [M-H]- at m/z 269. The MS/MS 
fragments showed ions at m/z 117, m/z 135, and m/z 119, which reflected the Retro-
Diels-Alder fission of the C-ring. Based on authentic standard, peak 40 was identified as 
apigenin (Table 9), and was detected in White, TX430 (black), and 99LGWO50 extracts. 
 Besides flavones and their glycosides, various methoxylated flavones were also 
detected. Peak 39 (tR = 10.955 min, λmax = 341 nm) had a [M-H]- at m/z 315. The 
MS/MS fragment included one dominant ion at m/z 300 (M-15 amu, loss of a methyl 
group) (Table 9). Peak 41 (tR = 14.587 min, λmax = 343 nm) had a [M-H]- at m/z 329. 
The MS/MS fragments included ions at m/z 314 (M-15 amu, loss of a methyl group) and 
at m/z 299 (M-15 amu – 15 amu, loss of two methyl groups) (Table 9). Peak 42 (tR = 
 72 
 
 
18.5 min, λmax = 340 nm) had a [M-H]
- at m/z 343. The MS/MS fragments included ions 
at m/z 313 (M-30 amu, loss of two methyl groups) and at m/z 298 (M-30 amu – 15 amu, 
loss of three methyl groups) (Table 9). The UV-vis spectroscopic characteristics 
indicated that these three compounds are flavone derivatives. Methoxylated flavone, 
tricin, was detected in millet grains (95), therefore, peak 39 was identified as 3'-OMe- 4', 
5', 5, 7-tetrahydroxyflavone (Figure 12), peak 41 was identified as tricin (3', 5'-OMe-4', 
5, 7-trihydroxyflavone) (Figure 12) and peak 42 as 3', 5'-OMe-4', 5, 6, 7-tetrahydroxyl 
flavone (Figure 12). These three compounds were detected in TX430 (black) extract. 
Tricin (peak 41) was also detected in SC748-H extract. 
 
Quantification of flavones in sorghum extracts. Flavones and their glycosyl derivatives 
were detected in all sorghum extracts except the red sorghum TX2911 extract. The 
99LGWO50 extract had the highest amount of flavones (4.84 mg/g), followed by TX430 
(black) (2.50 mg/g), White (2.27 mg/g), and the lemon-yellow extract SC748-H (1.12 
mg/g). The White and 99LGWO50 extracts contained higher amount of apigenin and 
apigenin glycosides than luteolin. On the other hand, TX430 (black) and SC748-H 
extracts contained higher luteolin than apigenin derivatives. This difference was 
attributed to their secondary plant color. Sorghum varieties with tan secondary plant 
color accumulate more apigenin while those with purple secondary plant color 
accumulate more luteolin (24, 25). The methoxylated flavones were almost exclusively 
present in TX430 (black) sorghum extract, except that SC748-H extract contained a 
small amount of tricin. 
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Table 10. Contents (mg/g extract) of flavones and their glycosyl derivatives in sorghum 
extracts as quantified by HPLC-DAD systema. 
Compound Peak No. White 
TX430 
(black) 
99LGWO50 
(red) 
SC748-H 
(hydrolyzed 
lemon-yellow) 
Luteolin-7-O-
galactosideb 
35 ND ND ND Trace 
Luteolin-7-O-
glucosideb 
36 ND ND ND 0.592 ± 0.004 
3'-OMe-Luteolin-7-O-
rutinosideb 
37 ND 0.246 ± 0.038               ND ND 
Luteolin 38 0.572 ± 0.176 0.528 ± 0.097 0.712 ± 0.089 0.444 ± 0.018 
6-C-glucosyl-8-C-
arabinosyl-Apigeninc 
34 0.171 ± 0.053 ND  0.100 ± 0.015               ND 
Apigenin 40 1.70 ± 0.59 0.223 ± 0.036 4.13 ± 0.17 Trace 
3'-methoxy-4', 5', 5, 7-
tetrahydroxyflavoned 
39 ND 0.474 ± 0.087                ND ND 
Tricind 41 ND 0.631 ± 0.168                ND 0.081 ± 0.003 
3', 5'-methoxy-4', 5', 6, 
7-tetrahydroxyflavoned 
42 ND 0.395 ± 0.094                ND ND 
Total flavones  2.27 ± 0.77 2.50 ± 0.52 4.84 ± 0.26 1.12 ± 0.018 
aAll values are expressed as mean ± SD of two separate runs. bExpressed as luteolin-7-
O-glucoside. cExpressed as apigenin-7-O-glucoside. dExpressed as luteolin. ND = not 
detected. Peak numbers are referenced to Figure 6. 
 
 
Identification of 3-deoxyanthocyanidins. 3-Deoxyanthocyanidins were detected in the 
red and black pericap sorghum extracts. Five peaks of 3-deoxyanthocyanidins were 
identified as summarized in Table 11. Peak 1a (tR = 3.311 min, λmax = 487 nm, [M+H]+ 
= 271) and peak 2a (tR = 4.388 min, λmax = 473 nm, [M+H]+ = 255) was identified as 
luteolinidin and apigeninidin, respectively, by comparing with the retention times and 
mass with those of pure standards. Peak 4a (tR = 5.584 min, λmax = 460 nm) had a 
[M+H]+ at m/z 309, which matched the mass of pyranoluteolinidin (Figure 13). This type 
of pigment is not naturally present in sorghum and is formed by reacting with acetone 
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(173), which was the extraction solvent. Peak 5a (tR = 5.710 min, λmax = 468 nm, 
[M+H]+ = 269) showed MS/MS fragment at m/z 254 (M-15 amu, loss of a methyl 
group), which matched the fragmentation pattern of methoxylated apigeninidin. By 
confirming with the retention times of pure standards, peak 5a was identified as 7-O-
methyl-apigeninidin. Peak 3a (tR = 4.555 min, λmax = 484 nm, [M+H]+ = 285) had an 
MS/MS fragment at m/z 270 (M-15 amu, loss of a methyl group), which matched the 
fragmentation pattern of methoxylated luteolinidin. Thus peak 3a was identified as 7-O-
methyl-luteolinidin based on evidence from previous study (78). 
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Figure 13. Reverse-phase UPLC chromatograms of 3-deoxyanthocyanins detected in 
TX430 (black) sorghum extracts at 485 nm (A) and chemical structures of these 3-
deoxyanthocyanins (B). Peak numbers are referenced to Tables 11 and 12. 
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Table 11. Identification of 3-deoxyanthocyanidins in sorghum extracts (monitored at 485 
nm) based on UPLC retention time (tR), UV-vis spectroscopic characteristics (λmax), and 
MS-MS/MS spectroscopic pattern. Ionization was performed in the positive mode. Peak 
numbers are referenced to Figure 13. 
Peak No. tR (min) λ max (nm) [M+H]+ (m/z) MS/MS (m/z) Proposed Identification 
1a 3.311 487 271 n.f. Luteolinidin 
2a 4.388 473 255 n.f. Apigeninidin 
3a 4.555 484 285 270, 242 7-OMe-Luteolinidin 
4a 5.584 460 309 n.f Pyranoluteolinidin 
5a 5.710 468 269 254, 226 7-OMe-Apigeninidin 
n.f. = not fragmented. 
 
 
Quantification of 3-deoxyanthocyanidins. The TX430 (black) sorghum extract had the 
highest amount of 3-deoxyanthocyanidins (3.04 mg/g), followed by the red TX2911 
sorghum extract (1.29 mg/g) (Table 12). The 99LGWO50 red sorghum extract contained 
the least amount of 3-deoxyanthocyanidins (0.23 mg/g) (Table 12). The composition of 
3-deoxyanthocyanidins was different among the 3 extracts: TX430 (black) had higher 
amount of luteolinidin than apigeninidin, while the 99LGWO50 extract contained 
exclusively apigeninidin and TX2911 extract contained similar amount of luteolinidin 
and apigeninidin. The difference in luteolinidin and apigeninidin composition can also 
be attributed to secondary plant color. Similarly to flavones, sorghum varieties with tan 
secondary plant color, e.g. 99LGWO50, accumulate more apigeninidin, and those with 
purple secondary plant color, e.g. TX430 (black), accumulate more luteolinidin (25). 
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Table 12. Contents (mg/g extract) of 3-deoxyanthocyanidins in sorghum extracts as 
quantified by HPLC-DAD systema. 
Compound Peak No. TX430 (black) TX2911 (red) 99LGWO50 (red) 
Luteolinidin (LUT) 1a 1.63 ± 0.17 0.303 ± 0.048 ND 
Apigeninidin (APG) 2a 0.978 ± 0.12 0.496 ± 0.062 0.231 ± 0.076 
7-OMe-LUTb 3a 0.200 ± 0.0018 0.222 ± 0.060 ND 
7-OMe-APG 5a 0.231 ± 0.012 0.265 ± 0.023 ND 
Total 
3-deoxyanthocyanins 
 3.04 ± 0.29 1.29 ± 0.19 0.231 ± 0.076 
aAll values are expressed as mean ± SD from two separate runs. bExpressed as 
luteolinidin equivalent. ND = not detected. Peak numbers are referenced to Figure 13. 
 
 
Identification of other phenolic compounds. Phenolic compounds other than phenolic 
acids, flavanones, or flavones, were also identified in sorghum grain extracts, but mostly 
as minor peaks (Table 13, Figures 6 & 8). 
Peak 43 (tR = 2.614 min, λmax = 292/319 nm) had a [M-H]- at m/z 468. The 
MS/MS fragments included ions at m/z 306 (67% intensity, M-162 amu) and m/z 161 
(35% intensity, M-307 amu). This fragmentation pattern matched that of N, N’-
dicaffeoylspermidine (174). The dominant ion was at m/z 332 (M-136 amu), which 
represented the loss of a fragment of a caffeoyl unit without the carboxylic bonds (Table 
13). Thus, we inferred that peak 43 was N, N’-dicaffeoylspermidine, a polyamine 
(Figure 14). This compound was detected in all sorghum extracts. The presence of N, Nʹ-
dicaffeoylspermidine has been reported in eggplant pulps (174), but not in sorghum. 
Peak 44 (tR = 3.679 min, λmax = 281 nm) had a [M-H]- at m/z 289. The MS/MS 
fragments included ions at m/z 151, m/z 137 (fragments of Retro-Diels-Alder fission), 
m/z 125 (dominant ion, fragment of heterocyclic fission), and m/z 109 (Table 13), which 
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matched the fragment pattern for catechin or epicatechin. Hence peak 44 was proposed 
to be identified as (epi)catechin. Peak 44 was only detected in TX430 (black) sorghum 
extract as a small peak.   
 
Table 13. Identification of other phenolic compounds in sorghum extracts (monitored at 
280 nm and 340 nm) based on UPLC retention time (tR), UV-vis spectroscopic 
characteristics (λmax), and MS-MS/MS spectroscopic pattern. Ionization was performed 
in the negative mode. Peak numbers are referenced to Figure 6 and Figure 8. 
Peak 
No. 
tR 
(min) 
λ max 
(nm) 
[M-H]- 
(m/z) MS/MS (m/z) Proposed Identification 
43 2.614 292/319 468 332, 306, 161, 135 N, N'-Dicaffeoylspermidine 
44 3.679 281 289 151, 137, 125, 109 Catechin or epicatechin 
45 5.169 295 177 177, 133, 107 Esculetin 
46 5.991 287 303 285, 193, 177, 133, 125, 109 Taxifolin 
47 6.848 379 449 287, 151 
Eriodictyol-7-O-galactoside 
chalcone 
48 7.378 377 301 191, 165, 161, 139, 109 7-OMe-Eriodictyol chalcone 
49 8.205 289 287 195, 125 Unknown 
50 8.221 371 433 271, 151 
Naringenin-7-O-galactoside 
chalcone 
51 9.521 370 285 191, 176, 165, 150 7-OMe-Naringenin chalcone 
 
 
Peak 45 (tR = 5.169 min, λmax = 295 nm) had a [M-H]- at m/z 177. The MS/MS 
fragments included ions at m/z 133 and m/z 107 (Table 13), which matched the 
fragmentation pattern of esculetin (175). Therefore, peak 45 was proposed to be 
esculetin (Figure 14). Esculetin is a lactone family compound commonly found in barks 
of herbs (175). Benincasa et al. (176) detected esculetin in the essential oils of lemon. 
Peak 45 was detected only in SC748-H sorghum extract as a minor peak. Since the 
lemon-yellow SC748 sorghum extract (and the hydrolyzed extract SC748-H) contains 
high levels of flavanones, which are commonly found in citrus fruit, the detection of 
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esculetin in this sorghum extract suggests that esculetin and flavanones may share 
similar biosynthetic pathways. 
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Figure 14. Chemical structures of minor phenolic compounds detected in sorghum 
extracts other than flavanones, flavones and phenolic acids. 
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Peak 46 (tR = 5.991 min, λmax = 287 nm) had a [M-H]- at m/z 303. The MS/MS 
fragments included ions at m/z 285 (5% intensity) and m/z 125 (100% intensity) (Table 
13), which matched the fragment pattern of taxifolin (95). Hence peak 46 was identified 
as taxifolin (Figure 14). Taxifolin belongs to flavanonol group. It was only detected in 
White sorghum extract as a small peak. The presence of taxifolin has been reported in 
millet grains (95).  
Four peaks with λmax ranging from 370-379 nm, which likely belong to chalcone 
derivatives, were identified. Peak 47 (tR = 6.848 min, λmax = 379 nm) had a [M-H]- at 
m/z 449. Peak 50 (tR = 8.221 min, λmax = 371 nm) had a [M-H]- at m/z 433. Both 
compounds had a dominant ion representing the loss of 162 amu (hexose unit): m/z 287 
(eriodictyol unit) and m/z 271 (naringenin unit) (Table 13). In addition, peak 47 and 
peak 50 also had the same fragment ion at m/z 151. The UV-vis absorption pattern and 
the existence of fragment m/z 151 suggested they were chalcone glycosides. Chalcones 
are precursors of flavanones in flavonoids biosynthesis (169, 177). These two 
compounds were only detected in lemon-yellow sorghum extract (SC748 and its 
hydrolyzed SC748-H), which contained flavanone glycosides, eriodictyol and naringenin 
galactosides. Hence it is logical to identify peak 47 as eriodictyol chalcone galactoside 
and peak 50 as naringenin chalcone galactoside (Figure 14). 
  Peak 48 (tR = 7.378 min, λmax = 377 nm) had a [M-H]- at m/z 301. Peak 51 (tR 
= 9.521 min, λmax = 370 nm) had a [M-H]
- at m/z 285. Both peaks had fragment ions at 
m/z 165 (Table 13). Compared with the characteristic fragment of chalcone (m/z 151), 
ion m/z 165 had an increase of 14 amu, indicating existence of a methyl group. Based on 
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the fragment pattern, the methyl group should be on the A-ring; thus peak 48 was 
identified as 7-O-methyl-eriodictyol chalcone and peak 51 as 7-O-methyl-naringenin 
chalcone (Figure 14). Both peak 48 and peak 51 were only detected in TX430 (black) 
extract, most likely as intermediates of 3-deoxyanthocyanin biosynthesis (169, 177). 
 
Table 14. Summary of compositions of phenolic compounds in sorghum extracts. 
Compounds White TX2911 (red) 
TX430 
(black) 
99LGWO50 
(red) 
SC748-H 
(hydrolyzed 
lemon-yellow) 
Total phenolic acidsa 26.8 ± 10.2 119.7 ± 10.8 4.25 ± 0.02 79.3 ± 10.9 5.10 ± 0.08 
Total flavanone 
monomersa 
N.D 0.52 ± 0.002 Trace 2.61 ± 0.30 28.1 ± 0.67 
Total flavonesa 2.27 ±0.77 N.D 2.50 ± 0.52 4.84 ± 0.26 1.12 ± 0.02 
Total 3-deoxy-
anthocyaninsa 
N.D 1.29 ± 0.29 3.07 ± 0.29 0.23 ± 0.08 N.D 
Total phenolsb (Folin-
Ciocalteu method) 
24.9 ± 4.3 88.4 ± 5.2 92.2 ± 4.3 103 ± 8.7 187.6 ± 2.6 
 aAll values (mg/g) are expressed as mean ± SD of duplicate runs, referenced to Tables 
6, 8, 10, 12. bExpressed as mg gallic acid equivalent per g of extract. 
 
Relative composition of major groups of phenolics in the sorghum extracts. The contents 
of each major group of phenolic compounds in all 5 sorghum extracts are summarized in 
Table 14. The phenolic compositional differences were expected based on previous 
studies (26). All sorghum varieties contained phenolic acids (mainly as glycerol esters). 
The two red varieties TX2911 and 99LGWO had the highest concentrations of phenolic 
acids. The 3-deoxyanthocyanin pigments were only detected in the red and black 
sorghum varieties. TX430 (black) sorghum extract had the highest level of 3-
deoxyanthocyanins. Flavanones (eriodictyol and naringenin derivatives) were detected 
as the major compounds in lemon-yellow sorghum extracts (SC748 and hydrolyzed 
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SC748). Naringenin glucosides were also detected in the red varieties TX2911 and 
99LGWO50. White and TX430 (black) did not contain detectable flavanones. Flavones 
(luteolin and apigenin derivatives) were present in all sorghum extracts except the red 
TX2911 extract. The dark red sorghum extract 99LGWO50 contained the highest level 
of flavones. The phenolic profile information will be useful to explain differences in 
estrogenic activity. 
 
Sorghum Extracts Promote the Growth of Human Breast Cancer Cells (MCF-7) 
Predominantly Expressing ERα 
The MCF-7 cell line was derived from estrogen dependent human breast 
adenocarcinoma, and ERα is the predominant ER in these cells. It is widely used to 
screen and identify estrogenic compounds in vitro. Cells were cultured in charcoal-
dextran treated FBS media for 48 hr before administration of treatment to deplete 
estrogen naturally present in the media, hence the estrogen added into the media was the 
only source of growth stimuli for MCF-7 cells. Estrogenic activity was shown as 
promotion of MCF-7 growth, similar to a physiological dose of estradiol (1 nM).  
Three sorghum extracts, White, TX2911, and TX430 (black), at concentrations 
of 1-150 µg/mL were tested for their estrogenic potential in MCF-7 cells. The White and 
TX430 (black) sorghum extracts promoted the growth of MCF-7 cells in a dose-response 
manner; while red TX2911 sorghum extract did not (Figure 15). The TX430 (black) 
sorghum extract significantly promoted MCF-7 cell growth, as 1 nM estradiol, at 5 
µg/mL. At the highest concentration tested (150 µg/mL), the TX430 (black) sorghum 
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extract showed a 2.3-fold increase in MCF-7 growth. The White sorghum extract 
showed less potency in promoting MCF-7 growth: The lowest concentration observed 
for a significant increase in cell growth was 50 µg/mL (38.6% increase). In general, the 
red TX2911 sorghum extract increased MCF-7 growth by 29.4-38.4%, which was only 
significant (p = 0.048) at the highest concentration (150 µg/mL). Thus in comparison to 
the effect of 1 nM estradiol (54.5%), it was concluded that TX2911 extract did not 
promote MCF-7 growth in a practically meaningful way. 
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Figure 15. The effect of sorghum extracts, White, TX2911, and TX430 (black) on the 
growth of MCF-7 cells. Data are expressed as mean ± SEM from three separate 
experiments. Dunnett’s t test was used to compare the least square means of each 
treatment with control post a one-way ANOVA analysis. Treatments with an asterisk 
indicate significant difference from the control (DMSO) (p < 0.05). 
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All sorghum extracts contained phenolic acids and their glycerol esters (Table 6). 
However, generally phenolic acids are not recognized as estrogenic, so the differences in 
phenolic acid profiles most likely did not contribute to the differences in estrogenic 
potential. The White and TX430 (black) sorghum extracts which promoted MCF-7 
growth, contained similar concentrations of flavones (primarily luteolin and apigenin 
derivatives): TX430 (black) had 2.50 mg/g and White extract had 2.27 mg/g (Table 10). 
The red TX2911 sorghum extract, on the other hand, did not contain any flavones. 
However, it contained the flavanone, naringenin-7-O-galactoside (0.52 mg/g, Table 8).  
Naringenin was reported as an ERα antagonist, and is believed to antagonize the 
estrogen action in ERα-dependent cancers (135). Apigenin and luteolin, in contrast, were 
reported as agonists of ERα (178). This may explain why TX2911 extract did not 
promote growth of MCF-7 cells, whereas TX430 (black) and White extracts did. 
Another difference in phenolic composition among the 3 extracts was the content of 3-
deoxyanthocyanins. The TX430 (black) extract had the highest 3-deoxyanthocyanins 
(3.04 mg/g, Table 12), followed by the TX2911 sorghum extract (1.29 mg/g, Table 12), 
and the White sorghum extract did not have any pigments. Whether 3-
deoxyanthocyanins contributed to MCF-7 growth promoting effect was not clear. 
However, considering that TX430 (black) extract exerted a stronger potency than the 
White extract, it is possible that the 3-deoxyanthocyanin  pigments could possess 
estrogenic activity. 
 
 
 84 
 
 
Sorghum Extracts Induce the Transcriptional Activity of ERE-luciferase Reporter 
The MCF-7 cells were transfected with ERE-luciferase reporter gene to monitor 
the transcriptional activity mediated through ERα. Administration of estradiol increases 
the activity of luciferase, which reflects the genomic action of estrogen via activation of 
ER and corresponding ERE binding. The White and TX430 (black) sorghum extracts (5, 
10, 100 µg/mL) were selected to test with ERE-luciferase reporter to confirm the growth 
promoting effect in MCF-7 cells was mediated through ER. The TX430 (black) extract 
induced luciferase activity by 57% at 5 µg/mL, and 67% at 10 µg/mL; White sorghum 
extract induced 66% luciferase activity at 10 µg/mL, which were similar to the effect of 
1 nM estradiol (67%). Other concentrations tested did not show any significant increase 
in luciferase activity (Figure 16). The results suggested that the growth promoting effect 
of White and TX430 (black) sorghum extracts observed in MCF-7 cells was possibly 
mediated through ERα.  
The TX430 (black) sorghum extract induced luciferase activity at 5 µg/mL while 
the White sorghum extract at the same concentration did not. This evidence again 
suggested some groups of compounds in the TX430 (black) extract exerted higher 
estrogenic potency. Besides the 3-deoxyanthocyanins, TX430 (black) extract also had 
higher levels of methoxylated flavones and luteolin, but had lower level of apigenin than 
White sorghum extract (Table 10). Hydroxylation and methoxylation could enhance 
apoptosis inducing (179) and antiproliferative potential (180) of flavones. It is possible 
that these methoxylated flavones in TX430 (black) sorghum extract contributed to higher 
estrogenic activity, but additional investigations are needed. 
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Figure 16. The effect of sorghum extracts, TX430 (black) and White (5, 10, 100 µg/mL), 
on transcriptional activity of ERE-luciferase reporter transfected in MCF-7 cells. Data 
are expressed as mean ± SEM from two separate experiments. Dunnett’s t test was used 
to compare the least square means of each treatment with control post a one-way 
ANOVA analysis. Treatments with an asterisk indicate significant difference from the 
control (DMSO) (p < 0.05). 
 
 
Sorghum Extracts Inhibit the Growth of Non-Malignant Young Adult Mouse Colonocytes 
(YAMCs) Predominantly Expressing ERβ  
The non-malignant young adult mouse colonocytes (YAMCs), when cultured at 
non-permissive conditions, is a suitable in vitro model to represent the physiology (life 
cycle) of normal colonic epithelium. It undergoes slow proliferation for 24 hr and cell 
death in the following 5-8 days (141); hence has been used as a model to study 
physiological changes during initiation and promotion stages of colon carcinogenesis. 
The YAMC cells express predominantly ERβ. Estradiol, administered at non-permissive 
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conditions, inhibits the growth of YAMC cells (11, 12). The induction of apoptosis and 
activation of tumor suppressor gene p53, are proposed as mechanisms to protect the 
damaged colonocytes from proliferating into malignancy (11, 12). 
In order to evaluate if sorghum extracts exert estrogenic activity and associated 
beneficial mechanisms through activation of ERβ, the effect of White, TX2911, and 
TX430 (black) sorghum extracts on growth of YAMC cells was determined.  All three 
sorghum extracts dose-dependently inhibited YAMC cell growth at concentrations of 1-
100 µg/mL, which suggested potential estrogenic activity (Figure 17). The TX2911 
extract showed significant reduction of YAMC cell growth (20%) at 1 µg/mL, the lowest 
concentration tested, which was similar to the effect of 1 nM estradiol (17% reduction); 
at this concentration White and TX430 (black) extracts decreased YAMC cell growth by 
8% and 11%, respectively. The White and TX430 (black) sorghum extracts significantly 
reduced YAMC growth by 16% and 19%, respectively, at the concentration of 5 µg/mL. 
In order to confirm that the growth reduction effect of sorghum extracts was 
mediated through ER, ER antagonist ICI 182, 780 (ICI, 1 µM) was used to treat YAMC 
cells with these sorghum extracts simultaneously. ICI binds to ER competitively then 
blocks the binding of estrogenic compounds to ER. The concentrations chosen for this 
experiment were 5 µg/mL for TX430 (black) and TX2911 extracts, and 10 µg/mL for 
White sorghum extract, for their consistent similar growth inhibitory effect as estradiol. 
Co-treatment of ICI with estradiol did not affect the growth of YAMC cells (Figure 18). 
Similarly, co-treatment of ICI reversed the growth reduction effect of White and TX430 
(black) sorghum extracts, which suggested the effect was mediated through ERβ (Figure 
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18). Interestingly, ICI co-treatment did not completely reverse the growth reducing 
effect of TX430 (black) sorghum extract (p < 0.22, Figure 18), which suggested some of 
the compounds in TX430 (black) extract inhibited YAMC growth through a mechanism 
other than the activities mediated through ER. On the other hand, the growth reducing 
effect of TX2911 extract on YAMC cell growth was not reversed by co-treating ICI, 
which indicates its antiproliferative effect was not mediated by ER. 
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Figure 17. The effect of sorghum extracts, White, TX2911, and TX430 (black) at 1, 5, 
10, 50 or 100 µg/mL, on the growth of non-malignant young adult mouse colonocytes 
(YAMCs). Data are expressed as mean ± SEM from three separate experiments. 
Dunnett’s t test was used to compare the least square means of each treatment with 
control post a one-way ANOVA analysis. The concentrations of TX2911 extracts are 
shown in parentheses. Treatments with an asterisk indicate significant difference from 
the control (DMSO) (p < 0.05). 
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Figure 18. The effect of co-treatment of 1 µM ICI 182, 780 (estrogen receptor 
antagonist) with sorghum extracts, White (10 µg/mL), TX2911 (5 µg/mL), and TX430 
(black) (5 µg/mL), on the growth of non-malignant young adult mouse colonocytes 
(YAMCs). Data are expressed as mean ± SEM from three separate experiments. 
Dunnett’s t test was used to compare the least square means of each treatment with 
control post a one-way ANOVA analysis. Treatments with an asterisk indicate 
significant difference from the control (DMSO) (p < 0.05). 
 
 
The red TX2911 sorghum extract did not show estrogenic potential in cell 
models that predominantly express either ERα or ERβ. Compared with the phenolic 
compositions of White and TX430 (black) sorghum extracts, TX2911 extract does not 
contain any detectable flavones, but contains naringenin-7-O-galactoside (Table 8 and 
Table 10). Flavones (apigenin and luteolin) (178), as well as naringenin (135) have been 
reported as ERα agonist and antagonist, respectively. Apigenin possesses stronger 
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estrogenic potency on ERα (tested with MCF-7 cells) than luteolin: at 10 µM, apigenin 
presents 60% of transcriptional activity shown by 1 nM estradiol while luteolin presents 
20% (178). On the other hand, naringenin did not increase MCF-7 cell proliferation up 
to 1 µM but was able to interfere with the proliferation promoting effect of 1 nM 
estradiol at 1 µM (135). In a different study (conducted by Harris et al.), both apigenin 
and naringenin induced higher ERβ transcriptional activity than activity induced by 
binding to ERα in human breast cancer cells (MCF-7) co-transfected with ERα and ERβ 
(31). However apigenin exerted higher estrogenic potency than naringenin. Compared to 
1 µM estradiol, apigenin (10 µM) showed 110% of the transcriptional activity via ERβ 
and about 70% via ERα, while naringenin (10 µM) showed approximately 70% and 
30%, respectively (31). Thus it is logical to infer that the varietal differences in 
estrogenic activity among the White, red TX2911 and TX430 (black) sorghum extracts 
may be attributed to the compositional differences of flavones and flavanones. However, 
further investigation is needed to confirm the effect of flavones and flavanones on 
estrogenic activity of sorghum. 
Besides flavones, the 3-deoxyanthocyanins are possible agonists of both ERα and 
ERβ. Considering the TX430 (black) extract generally showed estrogenic activity at 
lower concentrations than White sorghum extract, the 3-deoxyanthocyanin pigments 
may have contributed to estrogenic activity of TX430 (black) extract. However, the red 
TX2911 sorghum extract which also contained 3-deoxyanthocyanins did not show 
estrogenic potential. Thus the roles of the sorghum 3-deoxyanthocyanins and flavanones 
in estrogenic activity deserve further investigation. 
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Sorghum Extracts Induce Apoptosis Mediated through ER in Non-Malignant Young 
Adult Mouse Colonocytes (YAMCs) 
Estradiol induces apoptosis in YAMC cells after activation of ERβ, which results 
in corresponding suppression of cell growth. This was proposed as a mechanism for 
chemoprevention of estradiol because it protects damaged colonocytes from growing 
into malignancy (11). 
In order to further determine the mechanism of growth inhibition shown in 
YAMC cells, the capacity of White (10 µg/mL) and TX430 (black) (5 µg/mL) sorghum 
extracts to induce apoptosis (by measuring activity of caspase-3) was tested in YAMC 
cells with and without co-treatment of ER antagonist ICI. At the concentrations tested, 
White and TX430 (black) sorghum extracts increased the activity of caspase-3 by 38.9%  
and 29.7%, both comparable to 1 nM estradiol (32.0%) (Figure 19). The results showed 
that sorghum extracts induced apoptosis in YAMC cells. Co-administration of 1 µM ICI 
reversed the activity of caspase-3 to the levels similar to control. The ICI did not block 
the effect of White sorghum extract completely, which may indicate that some of the 
apoptotic activity induced by White sorghum extract was not mediated through ER.  
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Figure 19. The effect of White (10 µg/mL) and TX430 (black) (5 µg/mL) sorghum 
extracts, alone or co-treated with 1 µM ICI 182, 780 (estrogen receptor antagonist), on 
the activity of caspase-3 in non-malignant young adult mouse colonocytes (YAMCs). 
Data are expressed as mean ± SEM from three separate experiments. Dunnett’s t test was 
used to compare the least square means of each treatment with control post a one-way 
ANOVA analysis. Treatments with an asterisk indicate significant difference from the 
control (DMSO) (p < 0.1). The p-value of treatment alone is 0.055, 0.11, and 0.01 for 
estradiol, TX430 (black), and White sorghum extract, respectively; all other p-values are 
greater than 0.58. 
 
 
Estrogenic Properties of 3-Deoxyanthocyanidins 
To determine the estrogenic potential of sorghum 3-deoxyanthocyanins, pure 
apigeninidin and its methoxylated derivatives were tested for their growth reduction 
effect in YAMC cells (predominantly expressing ERβ), at concentrations of 0.01-100 
µM. Growth reduction of YAMC cells was only observed at relatively high 
concentrations, i.e. 50 and 100 µM for apigeninidin and 7-O-methyl-apigeninidin, 5 µM 
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for 5,7-O-methyl-apigeninidin (Figure 20). Growth inhibition at such high 
concentrations is probably due to cytotoxic effects (78). Hence the 3-deoxyanthocyanins 
most likely were not estrogenic and did not contribute to the estrogenic activity of 
TX430 (black) sorghum extract. This also agrees with the fact that the red sorghum 
TX2911 which also contained 3-deoxyanthocyanins did not show estrogenic activity. 
Hence we may conclude that the most likely ER agonists in the sorghum varieties tested 
were the flavones. However, impact of flavanones on estrogenic activity of sorghum 
needs further investigation. 
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Figure 20. The effect of apigeninidin, 7-O-methyl-apigeninidin, and 5,7-O-methyl-
apigeninidin (0.01-100 µM) on the growth of non-malignant young adult mouse 
colonocytes (YAMCs). aThe concentration of 5,7-O-methyl-apigeninidin is 5 µM. Data 
are expressed as mean ± SEM from three separate experiments. Dunnett’s t test was used 
to compare the least square means of each treatment with control post a one-way 
ANOVA analysis. Treatments with an asterisk indicate significant difference from the 
control (DMSO) (p < 0.05). 
 93 
 
 
Sorghum Extracts High in Flavones or Flavanones Inhibit the Growth of Non-Malignant 
Young Adult Mouse Colonocytes (YAMCs) Predominantly Expressing ERβ 
The potential contribution of flavones and flavanones to estrogenic activity of 
sorghum extracts was further investigated by two additional sorghum varieties with 
contrasting flavone and flavanone compositions. The dark red 99LGWO50 sorghum 
extract contained both flavones (4.84 mg/g total), especially apigenin (4.13 mg/g, Table 
10), and flavanones (naringenin and its glycosides, 2.61 mg/g total, Table 8). On the 
other hand, the lemon-yellow sorghum extract (SC748) contained very high amount of 
flavanone glycosides and relatively low levels of flavones (Figure 5). In order to better 
evaluate the potential ERβ activation effect of flavanone aglycones, the lemon-yellow 
sorghum extract was hydrolyzed to obtain flavanone aglycones. The hydrolyzed lemon-
yellow sorghum extract (SC748-H) contained very high amount (28.1 mg/g total) of 
flavanones (naringenin and eriodictyol, Table 8) but relatively low levels (1.12 mg/g 
total) of flavones (mainly luteolin and its glycosides, Table 10). The compositional 
differences allowed investigation of the estrogenic potential of flavones in the presence 
of flavanones, which have been suggested as ER antagonists in some studies.  
The 99LGWO50 extract inhibited the growth of YAMC cells in a dose-
dependent manner (Figure 21). It significantly reduced YAMC cell growth by 20.5% at 
5 µg/mL; at 10 µg/mL, the inhibition was 25.3%. Similar trend was observed for the 
hydrolyzed lemon-yellow sorghum extract (SC748-H). However, the non-hydrolyzed 
lemon-yellow sorghum extract (SC748) did not show significant growth inhibitory effect 
in YAMC cells at 5 µg/mL and showed inhibitory effect similar to 1 nM estradiol only at 
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the highest concentration tested (50 µg/mL). These results suggest that both flavones and 
flavanones are estrogenic and that flavanone glycosides (predominant in the SC748 
extract) have a lower potency.  
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Figure 21. The effect of red sorghum 99LGWO50 extract (high in flavones), lemon-
yellow sorghum extract SC748 (high in flavanone glycosides), and SC748-H (high in 
flavanone aglycones) (1-50 µg/mL) on the growth of non-malignant young adult mouse 
colonocytes (YAMCs). Data expressed as mean ± SEM from three separate experiments. 
Dunnett’s t test was used to compare the least square means of each treatment with 
control post a one-way ANOVA analysis. Treatments with an asterisk indicate 
significant difference from the control (DMSO) (p < 0.05). 
 
  
 Considering the effect produced by 1 nM estradiol (19.1%), 5 µg/mL of red 
sorghum 99LGWO50 and hydrolyzed lemon-yellow sorghum (SC748-H) extracts were 
selected to confirm whether the growth inhibition was mediated through ER. Co-
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treatment of ICI with both 99LGWO50 and SC748-H extracts reversed the inhibitory 
effect on YAMC cell growth, which suggests that ERβ mediated this physiological 
change (Figure 22). Harris et al. (31) showed that both flavones and flavanones can bind 
to ERβ and exert transcriptional activities in MCF-7 cells co-transfected with ERα and 
ERβ. Our findings indicate that both flavones and flavanones are likely agonists of ERβ 
in YAMC cells. 
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Figure 22. The effect of co-treatment of 1 µM ICI 182, 780 (estrogen receptor 
antagonist) with 5 µg/mL of sorghum extracts, 99LGWO50 (red with flavones) and 
SC748-H (lemon-yellow with flavanone aglycones), on the growth of non-malignant 
young adult mouse colonocytes (YAMCs). Data are expressed as mean ± SEM from 
three separate experiments. Dunnett’s t test was used to compare the least square means 
of each treatment with control post a one-way ANOVA analysis. Treatments with an 
asterisk indicate significant difference from the control (DMSO) (p < 0.05). 
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It is interesting to note that the growth inhibition and estrogenic potency of 
SC748-H extract was consistently lower than that of 99LGWO50 extract (Figure 21 and 
Figure 22). As measured by Folin-Ciocalteu method, hydrolyzed lemon-yellow sorghum 
extract SC748-H contained higher total phenols than red sorghum 99LGWO50 extract 
(186.7 versus 103 mg gallic acid equivalent/g extract, Table 14). However, 99LGWO50 
extract had 4 times higher amount of flavones than the SC748-H extract (4.84 versus 
1.12 mg/g, Table 10). On the other hand, 99LGWO50 extract contained less than one 
tenth of flavanones in SC748-H extract (2.61 versus 28.1 mg/g). This compositional 
differences suggest that even though both flavones and flavanones are ERβ agonists in 
YAMC cells, the flavones (dominant in 99LGWO50 extract) possess higher estrogenic 
potency than flavanones (dominant in SC748-H extract). This also indicates that the low 
content of flavanones and absence of flavones in red TX2911 sorghum extract (Table 
14) were probably why TX2911 extract did not show estrogenic activity. Thus we 
concluded that flavones are the most potent estrogenic compounds in sorghum. 
 
Interactive Effects of Flavones and Flavanones on Estrogenic Activity 
To further determine relative potency and potential interactive effects of flavones 
and flavanones on ERβ activation, apigenin and naringenin were tested for their growth 
inhibition effect in YAMC cells. Apigenin inhibited YAMC cell growth similarly to 1 
nM estradiol at 1 µM; naringenin had a similar effect at 10 µM (Figure 23A). 
Administration of ICI reversed the growth inhibitory effect of apigenin (1 µM) and 
naringenin (10 µM) to the level of control (Figure 23B), which suggested their growth 
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inhibition effect was mediated through ERβ. The difference in relative estrogenic 
potency of apigenin and naringenin on ERβ was consistent with other reporter assays 
targeting ERβ signaling (31). The ERβ activation by naringenin was previously reported 
in cell models transfected with ERβ (31, 181). These studies may under- or over-
estimate the effects of phytoestrogens in physiological system. This is the first report 
that suggests naringenin activates ERβ in a model naturally expressing ERβ as the 
predominant ER. As observed in sorghum extracts, 99LGWO extract high in flavones 
had higher potency in estrogenic activity than SC748-H extract high in flavanones. The 
differences in relative potency of apigenin (a flavone) and naringenin (a flavanone) may 
partly explain this observation. 
Both apigenin and naringenin acted as ER agonists in YAMC cells. However, the 
concentrations at which the pure compounds were active were much higher than the 
concentrations of flavones or flavanones in sorghum extracts which showed estrogenic 
activity in YAMC cells (Table 15). One drawback of using pure compounds to 
investigate the biological effects of a complex system, such as foods, is that it ignores 
the possible synergism or interaction among different compounds present in the complex 
system. We believe the presence of both ERβ agonists, flavones and flavanones, as well 
as other phenolic compounds in sorghum extracts, may enhance the estrogenic activity 
of putative ERβ agonists in YAMC cells. To investigate this possibility, a combination 
of apigenin and naringenin were tested at different concentrations in the YAMC cell 
model. 
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Table 15. Concentrations (µM) of flavones and monomeric flavanones in sorghum 
extracts as tested in cell models (5 µg/mL, except White sorghum extract at 10 µg/mL). 
 
Flavones (μM) Flavanones (μM) 
TX2911 (red) 0 0.010 
White 0.090 0 
TX430 (black) 0.035 0 
99LGWO50 (red) 0.091 0.048 
SC748-H (hydrolyzed lemon-yellow) 0.019 0.505 
 Values are derived from means of compounds in Table 8 and Table 10.  
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Figure 23. The effect of (A) apigenin (0.1 and 1 µM) and naringenin (0.05-10 µM); (B) 
co-treatment of 1 µM ICI 182, 780 (estrogen receptor antagonist) with apigenin (1 µM) 
and naringenin (10 µM) on the growth of non-malignant young adult mouse colonocytes 
(YAMCs). Data are expressed as mean ± SEM from three separate experiments. 
Dunnett’s t test was used to compare the least square means of each treatment with 
corresponding control post a one-way ANOVA analysis. Treatments with an asterisk 
indicate significant difference from the control (DMSO) (p < 0.05). 
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When different levels of naringenin (0.1-10 μM) were added to the optimal 
concentration of apigenin (1 µM), the results showed that sub-optimal concentrations of 
naringenin (0.1 and 1 µM) did not enhance the growth inhibitory effect of 1 µM apigenin 
(Figure 24A). However the optimal concentration of naringenin (10 µM) surprisingly 
eliminated the growth inhibitory effect of 1 µM apigenin (Figure 24A). This antagonistic 
effect was unexpected. A plausible explanation may be competitive binding for ERβ. 
The ligand-binding domain of ERβ produces a more hydrophobic binding pocket when 
bound to flavonoid agonists (182). Apigenin is slightly more hydrophobic than 
naringenin, which may contribute to its stronger ERβ affinity and estrogenic potency 
than naringenin. When there are significantly more molecules of naringenin than 
apigenin, it is possible that naringenin, the less favored agonist, prevents the binding of 
apigenin to ERβ. However, this competition may also prevent naringenin from binding 
to ERβ.  As a result, neither compound can sufficiently bind to ERβ and produce 
significant changes. Another plausible explanation is that naringenin could interfere with 
the regular genomic ER activation, such as dimerization of ER and recruitment of co-
activators, after apigenin binds to ERβ. Changes in genomic ER activation after co-
administration of apigenin and naringenin need to be monitored to better understand the 
interaction. The loss of estrogenic activity after combining optimal levels of both 
apigenin and naringenin may suggest that pure compounds at high levels, such as can be 
obtained through dietary supplements, could bring undesirable effects on intended 
bioactivity.  
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Figure 24. The effect of (A) apigenin (APN 1 µM) co-treated with naringenin (NAR 0.1-
10 µM); (B) apigenin (0.1 µM) co-treated with naringenin (0.05-1 µM) on the growth of 
non-malignant young adult mouse colonocytes (YAMCs). Data are expressed as mean ± 
SEM from three separate experiments. Dunnett’s t test was used to compare the least 
square means of each treatment with corresponding control post a one-way ANOVA 
analysis. Treatments with an asterisk indicate significant difference from the control 
(DMSO) (p < 0.05). 
 
 
Interestingly, combination of sub-optimal concentrations of apigenin (0.1 µM) 
and naringenin (0.05, 0.1, and 1 µM) enhanced the growth inhibition of YAMC cells, 
which suggested enhanced ER activation (Figure 24B). For example, apigenin at 0.1 µM 
and naringenin at 0.05 µM together showed activity similar to 1 nM estradiol, which was 
1/10 and 1/200 of their corresponding optimum concentrations. This observation is 
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interesting because, firstly it indicates the activity of target compounds in complex 
systems may be much higher than what can be examined or modeled using pure 
compounds. The data also suggest that in general, the concentrations of flavones and 
flavanones in sorghum extracts are adequate to activate ER in YAMC cells (Table 15). 
The red TX2911 sorghum extract which was not estrogenic in either cell models 
predominantly expressing ERα or ERβ was the only sorghum extract tested that did not 
contain any flavones. It only contained very low levels of flavanones, primarily 
naringenin-7-O-galactoside. In general it appears that presence of flavones is a good 
predictor of estrogenic potential of sorghum. 
 
Conclusions 
We demonstrated that sorghum phenolic extracts show estrogenic activity in cells 
that primarily express ERα (MCF-7) or ERβ (YAMCs). Composition of phenolic 
compounds plays an important role in the estrogenic activity of sorghum varieties. 
Flavones are the most important phenolic compounds in predicting estrogenic potential 
of sorghum. Flavanone aglycones also showed estrogenic potential but flavanone 
glycosides, the predominant form of flavanones in sorghum, were less effective. The 
active concentrations of flavones and flavanones in sorghum extracts were much lower 
than what was predicted by pure compounds. This was likely due to additive or 
synergistic effects of the complex mixture of phenolic compounds present in sorghum. 
The observed estrogenic properties of sorghum phenolics in non-malignant epithelial 
colonocytes may imply protection against colon carcinogenesis at concentrations 
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achievable through diet. This information is important in improving the understanding of 
how sorghum phenolics influence prevention of estrogen dependent cancers. This 
information could also be used by plant breeders to selectively breed sorghum varieties 
for specific health benefits. Follow up in vivo studies in mice are necessary to confirm 
this protection of estrogenic sorghum extracts against colon carcinogenesis and 
understand their bioavailability. Findings of this study also imply that modeling 
bioactivity with pure compounds may be misleading, as it does not reflect the true 
holistic effect of such compounds in a complex system.      
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CHAPTER IV 
 SORGHUM PHENOLIC EXTRACTS PREVENT AZOXYMETHANE INDUCED 
COLON CARCINOGENESIS IN OVARIECTOMIZED MICE 
 
Introduction 
Observational studies have found lower incidence of colon cancer in females 
compared with males (8, 9), and also in premenopausal women compared with post-
menopausal women (10). Long term administration of oral contraceptives has been 
associated with reduced colon cancer incidence in women (102). Multiple observational 
studies showed approximately 30% reduction in relative risk for colon cancer in 
postmenopausal women who received hormone or estrogen replacement therapy 
compared with those who did not (103-105). These evidence suggest that estrogen plays 
a protective role in the development of colon cancer. It has been proposed that protective 
effects of estrogen are mediated via estrogen receptor-β (ERβ), the predominant estrogen 
receptor in the colon. These activities such as induction of apoptosis (11) and tumor 
suppressor genes (12) have been demonstrated in azoxymethane (AOM) induced colon 
carcinogenesis model of ovariectomized mice. 
We have shown in previous chapter that phenolic extracts of sorghum are 
estrogenic in non-malignant colonocytes and are capable of inducing apoptosis in 
damaged colon epithelial cells. Flavones, especially apigenin, were identified as the 
most potent estrogenic compounds in sorghum. The potential of these sorghum 
phenolics with inherent estrogenic activity to prevent colon cancer needs further 
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investigation. The goal of this study is to determine the colon cancer chemopreventive 
potential of sorghum phenolic extracts with estrogenic activity. The hypothesis is that 
the estrogen-like activities of sorghum phenolic extracts could prevent formation of 
premalignant lesion (aberrant crypt foci, ACF) induced  by AOM in colon of 
ovariectomized mice. The purpose of utilizing ovariectomized mice model is to 
eliminate the protective effect from edocrine estrogens (11). Two sorghum extracts, 
white and black, were selected in this study based on phenolic composition. Besides 
determination of the number of ACF as the biomarker for the onset of colon 
carcinogenesis, physiological changes (proportion of proliferative and apoptotic 
colonocytes) were also measured in fixed distal colon sections by immunohistochemistry 
to identify possible protective mechanisms induced by sorghum phenolic extracts.  
 
Materials and Methods 
 
Materials 
 
Treatments: freeze-dried phenolic extracts of white and black sorghum. Two non-tannin 
sorghum grains were selected based on the results from Chapter 3: a white variety 
(ATXArg-1/RTX436) and a black variety (A05029/TX3362). The two sorghum grains 
were of the same genetic background as White (ATX635×RTX436) and TX430 (black) 
used in Chapter 3, respectively, and had similar overall composition of phenolic 
compounds. The grains were kindly provided by Dr. W. L. Rooney in the Department of 
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Soil & Crop Sciences at Texas A&M University. The grains were decorticated to collect 
bran (15% yield) for extraction. The bran was first defatted using hexanes (1:2 w/v ratio 
for 2 hrs) then extracted with 70% aqueous acetone 3 times (1:4 ratio, 100 g portion, 2 
hrs then 1 hr and 1 hr duration of extraction); finally extracted with 0.01% formic acid in 
methanol (1:4 ratio) 2 times for 1 hr each time. The supernatant from all extractions was 
collected by filtering through a No.1 filter paper (VWR, Radnor, PA) and combined. 
Organic solvent was removed by rotary evaporation (Rotovap, Büchi, Flawil, 
Switzerland) under vacuum at 40 °C and aqueous fraction was freeze-dried to obtain 
powder extracts. 
 
Animals (11). Wild type female c57BL6/J mice of 6-7 weeks old were purchased from 
Charles River Laboratories (Wilmington, MA). All animals were housed at the 
Laboratory Animal Resources and Research facility at Texas A&M University. All the 
handling and treatment procedures were performed under an animal use protocol 
approved by the Institutional Animal Care and Use committee at Texas A&M 
University. Ovariectomy was performed on all mice after 1 week of receiving. At the 
time of surgery, mice were randomly divided into treatment groups and started treatment 
diet (n=15, Table 16). One group (treatment) received estradiol treatment by implanting 
an estradiol pellet (0.5 mg estradiol 19.5 mg cholesterol, both from Sigma-Aldrich, St. 
Louis, MO) under skin at the back of the neck. All other groups (i.e. control and 
sorghum diet treatment groups) were implanted with cholesterol pellet (20 mg 
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cholesterol) (Table 16). The pellets were replenished at week 10 to ensure steady supply 
of estradiol (Figure 25). 
 
Diet. Mice were fed with phytoestrogen free and isocaloric base powdered diet (AIN-76; 
TestDiet, Purina Mills LLC., St. Louis, MO). Mice were given 3 weeks after surgery to 
recover and adapt to powdered diet. Mice had access to food and water ad libitum during 
the study. Diet was replenished daily. White sorghum extract was added to base diet at 
1% (w/w) level, and black sorghum extract was added at 1% and 1.5%, respectively 
(Table 16). The level of sorghum extract substituted in each diet was designed to achieve 
a circulating level that is at least equivalent to the concentrations used in YAMC cell 
culture studies. The target compounds chosen were flavones and the oral absorption rate 
of flavones was estimated based on literature reports (183). Based on the fact that white 
sorghum extract had higher level of apigenin, the compound believed to be the most 
potent ERβ agonist in the sorghum extracts, a treatment with higher level of black 
sorghum extract was used (1.5% in diet) to determine if a dose-response would exist. 
 
 
Table 16. The experimental design of sorghum phenolic extracts in preventing 
azoxymethane (AOM) induced colon carcinogenesis study. 
Treatment group Diet Pellet type Functions 
1 Control diet Cholesterol pellet Control 
2 White 1.0% Cholesterol pellet Treatment 
3 Black 1.0% Cholesterol pellet Treatment 
4 Black 1.5% Cholesterol pellet Treatment 
5 Control diet Estradiol pellet Positive control 
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Methods 
 
Food intake. In order to monitor the consumption of diet across groups and different 
time points during the study, mice were single housed and fed with corresponding diets 
for 24 hr to record food intake.  The weight difference of diet before and after the 24 hr 
period was the amount of food each animal consumed. Food intake was recorded 3 times 
during the study. Feces of each mouse were collected at baseline (before start of 
treatment diet), each food intake point, and the day of sacrifice (Figure 25). Body weight 
was recorded on a weekly basis. 
 
1        2         3        4         5         6         7         8         9        10      11       12       13      14  15       16      17 week  
Surgery: ovariectomy
Assigned to groups: 
-- Pellet
-- Diet
6 weekly injections of 
AOM at 10 mg/kg 
body weight
Surgery: 
replace 
pellet Sacrifice
Baseline 
(AIN76 diet) 
collection of 
feces
1st Food intake 
and collection 
of feces
2nd Food intake 
and collection 
of feces
3rd Food intake 
and collection 
of feces
 
Figure 25. Timeline of the effect of sorghum phenolic extracts on preventing 
azoxymethane (AOM) induced colon carcinogenesis study. 
 
 
Induction of preneoplastic lesions in the colon (11). Azoxymethane (AOM, Sigma-
Aldrich, St. Louis, MO) was injected at 10 mg/ kg body weight weekly for 6 weeks, 
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starting from the 4th week after surgery (184); 7 weeks after the last AOM injection, 
mice were sacrificed (Figure 25). The AOM stock solution was dissolved in saline 
solution at 3.33 mg/mL. 
 
Serum and tissue collection. At time of sacrifice, blood was collected in EDTA (0.3 M) 
containing microcentrifuge tubes by cardiac puncture method, and plasma was separated 
from whole blood by centrifuge at 5000 X g for 15 minutes at 4 °C. Plasma was 
aliquoted in 0.1 mL portions and stored at -20 °C till use. Plasma level of estradiol was 
determined by an ELISA kit (Estradiol EIA kit, Cayman Chemical Co., Ann Arbor, MI) 
following the instructions of the manufacturer. Uteri were collected and put in phosphate 
buffer saline (PBS) to record wet weights. Colons were collected, recorded length, then 
flattened between two flat glass boards and fixed in 70% ethanol. One cm tissue from 
both proximal/distal ends of the colon was resected, cassetted and fixed in 4% 
paraformaldehyde (4 hrs). Fixed distal end colon tissue was paraffin embedded, 
sectioned into 4 µm thickness and mounted to glass slides for immunohistochemical 
analysis. 
 
Evaluation of aberrant crypt foci (ACF). Colons (except 1 cm tissue from proximal/distal 
ends) were fixed with 70% ethanol. At the time of experiment, the colons were stained 
with 0.5% methylene blue solution to count the total numbers of ACF and high 
multiplicity ACF (consisting of 3 or more individual ACFs in one cluster) in each colon 
using a bright field microscope mounted with a camera. 
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BrdU proliferation assay. Proportions of proliferative colonic crypt cells were 
determined by the ability of cells to incorporate bromo labeled nucleotide (5-bromo-2ʹ-
deoxyuridine, BrdU, a thymidine analog, Sigma-Aldrich, St. Louis, MO) into DNA 
synthesis. Two hours before sacrifice, the mice were injected with 30 mg BrdU/kg body 
weight (4 mg/mL stock solution in PBS) for further immunohistochemical determination 
in fixed distal colon sections. Tissue sections were first deparaffinized by 2 washes of 
xylene then rehydrated with sequential washes in 100%, 95%, 70% ethanol and finally in 
distilled water. Endogenous peroxidase activity was quenched by incubating tissues with 
3% hydrogen peroxide in 100% methanol for 30 min at room temperature. After three 
washes with distilled water, tissues were prepared for antigen retrieval by heating for 20 
min in a buffer solution containing 0.18 mM citric acid and 0.82 mM sodium citrate. 
Slides were washed with PBS buffer after cooling to room temperature. In order to 
eliminate non-specific binding, the tissues were blocked with 3% fetal bovine serum in 
PBS for 20 min before the application of primary antibody. Primary antibody (mouse-
anti-BrdU, Roche USA, Indianapolis, IN) was diluted 20 times with PBS and applied to 
each tissue section, then incubated in a humidified chamber overnight at 4 °C. Next, 
tissues were washed with distilled water and applied with secondary antibody (200 times 
diluted with PBS, goat-anti-mouse horseradish peroxidase conjugated antibody, Abcam, 
Cambridge, MA) then incubated in a humidified chamber for 1 hr at room temperature. 
Following three washes with PBS, tissues were incubated with 1% diaminobenzidine 
(DAB, Sigma-Aldrich, St. Louis, MO) in PBS for 10 min for secondary antibody color 
development. The tissues were then counterstained with 7g/L Harris modified 
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Hematoxylin solution (Sigma-Aldrich, St. Louis, MO) for 15 seconds, and washed with 
distilled water. Lastly, tissues were dehydrated with sequential washes in 70%, 95%, 
100% ethanol and xylene, then coverslipped with Permount (Thermo Fisher Scientific, 
Pittsburg, PA). 
 
TUNEL assay. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling 
(TUNEL) assays were used to determine the apoptotic cells in fixed distal colon 
sections. An ApopTag peroxidase in situ Apoptosis Detection Kit (Millipore, Billerica, 
MA) was used following manufacturer’s instructions with some modifications. Tissue 
sections were first deparaffinized by 3 washes of xylene then rehydrated with sequential 
washes in 100%, 95%, 70% ethanol and PBS. Tissues were treated with protein kinase K 
(10 µg/mL in PBS) for 3 min at 37 °C. Endogenous peroxidase activity was quenched by 
incubating tissues with 0.3% hydrogen peroxide in 100% methanol for 30 min at room 
temperature. After washing with distilled water and PBS, the tissues were equilibrated 
with equilibration buffer for 20 seconds at room temperature then applied with TDT 
enzyme in reaction buffer for 1 hr at 37 °C. Tissues treated with reaction buffer (no TDT 
enzyme) served as the negative stain control. The reaction was stopped by incubating the 
tissues with stop wash for 10 min at room temperature. After wash with PBS, tissues 
were applied with anti-digoxigenin and incubated for 30 min at room temperature. 
Followed by PBS wash, color was developed by incubating tissues with 0.5% DAB in 
PBS for 20 seconds, and was counter stained with 0.5% methyl green in pH 4.0 sodium 
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acetate solution for 20 seconds. Lastly, tissues were dehydrated with sequential washes 
in 70%, 95%, 100% ethanol and xylene, then coverslipped with Permount. 
 
Tissue analysis. For both proliferation and TUNEL assays, 20 well-oriented intact crypts 
were analyzed for each animal. Crypts were divided into three equal sessions along the 
sides, as top, middle, bottom, respectively. The percentage of positive cells was counted 
in each session for each crypt of each animal, by dividing number of positive cells by 
total number of cells in that session. The total percentage of positive cells was summed 
from all three sessions. The percentages of proliferative and apoptotic cells in total and 
in each session were averaged for each animal and compared across different treatments. 
 
Statistical analysis. The data obtained in this Chapter were data from counts. In order to 
compensate for unequal variance and lack of normality, Poisson regression model (with 
natural logarithm transformation) was utilized to analyze the difference among groups 
by a generalized linear model procedure of SAS (proc GENMOD). The t test was used 
to compare least square means of transformed data to determine treatment differences. 
All statistical analysis was performed with SAS 9.2 (Cary, NC). Data were still 
presented in their original untransformed form for interpretation purposes. Data obtained 
from animal #30, #22, #24, and #71 were eliminated in all analysis due to abnormal 
physiological conditions at time of sacrifice. Animal #30 had blood spots in the liver and 
abnormal serum color; animals #22, #24, and #71 had swollen kidney problems and/or 
necrosis in the intestine. The sample size of each group used for analysis was 14, 11, 14, 
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15, and 15 for control, estradiol, White sorghum 1%, Black sorghum 1%, and Black 
sorghum 1.5%, respectively. 
 
Results and Discussion 
 
Phenolic Composition and Antioxidant Capacity of the Sorghum Extracts 
The major phenolic compounds in the two sorghum extracts were identified and 
quantified according to the methods described in Chapter 3. The two sorghum varieties 
shared the same genetic background with the White (ATX635×RTX436) and TX430 
(black) sorghum respectively, hence had similar compositions. Table 17 summarizes the 
contents of major phenolic compounds in these two sorghum extracts used. Flavone 
content in white sorghum extract was 4.31 mg/g extract, most were apigenin (3.93 
mg/g). The black sorghum extract contained 2.26 mg/g flavones, with 0.57 mg/g luteolin 
and derivatives. 
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Table 17. Contentsa (mg/g extract) of major phenolic compounds in white and black 
sorghum extracts used in the animal study.  
Compound White Black 
Total phenolsb (mg gallic acid equivalent/g) 28.9 ± 1.54 268 ± 25.1 
2-O-Caffeoulglycerol-O-glucoside Trace ND 
1-O-Caffeoulglycerol-O-glucoside 0.543 ± 0.047 ND 
2-O-Caffeoulglycerol 0.066 ± 0.004 0.064 ± 0.014 
1-O-Caffeoulglycerol 0.473 ± 0.016 0.110 ± 0.027 
Caffeic acid 0.217 ± 0.009 0.084 ± 0.016 
Ferulic acid-O-galactoside 0.210 ± 0.014 ND 
Ferulic acid-O-glucoside ND ND 
Ferulic acid ND ND 
Dicaffeoylglycerol 0.216 ± 0.014 ND 
Dicaffeoylglycerol 3.23 ± 0.17 ND 
Dicaffeoylglycerol Trace ND 
p-Coumaroyl-caffeoyl-glycerol 1.39 ± 0.018 ND 
p-Coumaroyl-feruloyl-glycerol ND 1.41 ± 0.045 
Diferuloylglycerol ND 0.916 ± 0.074 
Feruloyl-caffeoyl-glycerol 1.15 ± 0.057 ND 
Total phenolic acids and estersc 7.50 ± 0.32 2.59 ± 0.17 
4'-OMe-Luteolin-7-O-rutinoside ND 0.181 ± 0.040 
Luteolin 0.197 ± 0.017 0.389 ± 0.018 
6-C-glucosyl-8-C-arabinosyl-Apigenin Trace ND 
Apigenin 3.93 ± 0.33 0.264 ± 0.033 
3'-methoxy-4', 5', 5, 7-tetrahydroxyflavone ND 0.362 ± 0.010 
Tricin 0.178 ± 0.009 0.612 ± 0.002 
3', 5'-methoxy-4', 5', 6, 7-tetrahydroxyflavone ND 0.451 ± 0.008 
Total flavonesc 4.31 ± 0.36 2.26 ± 0.010 
Luteolinidin (LUT) ND 1.47 ± 0.01 
Apigeninidin (APG) ND 1.26 ± 0.03 
7-OMe-LUT ND 0.273 ± 0.04 
7-OMe-APG ND 0.276 ± 0.02 
Total 3-deoxyanthocyaninsc ND 3.27 ± 0.11 
aAll values are expressed as mean ± SD of two separate runs, as quantified by HPLC 
with appropriate standards. bMeasured by Folin-Ciocalteu method. cSum of major peaks 
identified and quantified by HPLC. 
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The white sorghum extract also had higher concentrations of phenolic acids (7.50 
mg/g) than the black sorghum extract (2.59 mg/g). On the other hand, the black sorghum 
extract contained 3-deoxyanthocyanins (3.27 mg/g) while the white sorghum extract did 
not. Flavanones, such as naringenin or eriodictyol and their derivatives, were not 
detected in these two sorghum extracts. Overall, the black sorghum extract had much 
higher total phenols (268 mg gallic acid equivalent/g extract measured by Folin-
Ciocalteu method) than the white sorghum extract (28.9 mg gallic acid equivalent/g 
extract).  
  
Effect of Sorghum Extracts on Animal Growth and Uteri Development 
Supplementation of sorghum phenolic extracts to basal diet did not affect the 
growth of the animals, or the trend of weight gain (data not shown). The groups did not 
show significant differences in each food intake assays, final body weight, or the length 
of colon (data not shown). 
The estradiol group had 1.43 ± 0.23 nmol/L (mean ± SEM) estradiol in plasma, 
whereas the plasma estradiol level in all other animals implanted with a cholesterol 
pellet was below the detection limit (0.014 nmol/L). Estradiol group also had 
significantly higher wet weight of uteri than control group (0.5 ± 0.15 g versus 0.055 ± 
0.01 g, p < 0.05), which indicated that estradiol successfully released into circulation. 
The wet weight of uteri in all sorghum extract fed groups did not show differences 
relative to control, and were 0.041 ± 0.004, 0.047 ± 0.007, and 0.044 ± 0.004 g, for 
groups fed with white extract 1%, black extract 1% and 1.5%, respectively.  
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Estradiol is essential to support the normal development of uteri. At the 
beginning of the study, the mice were just coming to sex maturation and ovariectomy 
would stop the development of uteri. Estradiol pellet released estradiol to maintain 
regular development of uteri in the estradiol group. However, the sorghum extracts did 
not maintain development of uteri, which indicated at the level of sorghum extracts fed, 
the compounds in sorghum were not effective ERα agonists or were not absorbed to a 
critical concentration to maintain development of uteri. Au et al. (185) reported that 
female mice which were fed with up to 0.1% apigenin in the diet had no significantly 
different uterine weights compared with control non-apigenin fed animals. This 
concentration of apigenin (100 mg/100g diet) was roughly 25 times higher than what 
was present in the white sorghum (1%) diet (3.93 mg/100g diet). Apigenin was 
suggested as more selective for ERβ than ERα (31), thus the limited uteri growth 
capacity does not necessarily mean no ERβ mediated activity would be expected. 
 
Effect of Sorghum Extracts on Formation of Azoxymethane Induced Colonic 
Premalignant Lesion (Aberrant Crypt Foci) in Ovariectomized Mice 
 The effect of sorghum extracts on formation of azoxymethane (AOM) induced 
colonic premalignant lesion (aberrant crypt foci, ACF) in ovariectomized mice model is 
shown in Figure 26. Compared with control group, white sorghum extract, fed at the 
level of 1% in diet, significantly reduced the total number of ACF in the colons, by 
39.3% (p < 0.001). Black sorghum extract, fed at the same level (1%), also significantly 
reduced the total number of ACF, but to a smaller extent (by 14.7 %, p < 0.044). The 
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higher level of black sorghum extract, 1.5%, showed a mild 9.3% reduction of total 
number of ACF but was not significantly different from the control (p = 0.202). 
Surprisingly, the estradiol group had only 6.1% reduction of total ACF (p = 0.448), 
which was not different from control (Figure 26A). 
The effect of sorghum extracts on formation of high multiplicity ACF (≥ 3 single 
ACFs in one cluster) was not the same as total ACF. In general none of the treatments 
showed a significant effect relative to control (Figure 26B). Compared with control 
group, white sorghum extract at 1% level, reduced 26.4% high multiplicity ACF, but the 
effect was not statistically significant (p = 0.146); estradiol group reduced high 
multiplicity ACF by 16.0%, which was not statistically significant as well (p = 0.425). 
The capacity of a treatment to reduce numbers of ACF formed in distal colons 
suggests protection against AOM induced colon carcinogenesis. The white sorghum 
extract fed at 1% level showed protective action in reducing both total numbers of ACF 
and numbers of high multiplicity ACF. However, the black sorghum fed groups did not 
show consistent trends, and only suggested a mild protective effect. The differences of 
protective effects observed in the animal study could be attributed to the phenolic 
profiles of these two extracts. Our cell culture data suggested that apigenin was the most 
potent estrogenic compound in sorghum extracts (Chapter 3). White sorghum extract had 
a much higher concentration of apigenin (3.93 mg/g) than black sorghum extract (0.264 
mg/g), which indicates the protective effect of white sorghum, was probably related to 
its high content of apigenin. Interestingly, black sorghum extract had much higher total 
phenols than white sorghum extract (Table 17). This again indicates that phenolic 
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composition may be a better predictor of bioactivity than total phenols content. Also, the 
presence of other possibly non-estrogenic phenolic compounds in the black sorghum 
extract at such high levels could have interfered with the activity of the estrogenic 
components. 
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Figure 26. The effect of crude sorghum extracts, white (1%) and black (1% and 1.5%), 
fed in the diet on total numbers of (A) aberrant crypt foci (ACF) and (B) high 
multiplicity ACF identified in the distal colons of ovariectomized mice injected with 
azoxymethane (AOM). Data are expressed as numbers identified per animal (mean ± 
SEM). Data with the same letter do not differ (p < 0.05). 
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Effect of Sorghum Extracts on Proliferation and Apoptosis of Colonocytes  
 Induction of apoptosis is proposed as a protective mechanism against AOM 
induced colon carcinogenesis (11). In order to explore if changes in apoptosis or 
proliferation in colonocytes can be mechanisms of reduced total numbers of ACF in 
colons, percent of apoptotic and proliferative cells in 20 well-oriented crypts per animal 
were determined.  
No statistical differences were observed in average percent of apoptotic cells per 
animal, but some trends were observed (Figure 27). Estradiol group had a 38.7% 
increase in proportion of apoptotic cells overall, which may contribute to its mild effect 
on total numbers of ACF and high multiplicity ACF (Figure 26B). Black sorghum fed at 
1.5% level also had a 27.0% increase in apoptotic cells. The white sorghum and black 
sorghum extracts fed at 1% did not show any increase of apoptotic cells and actually 
showed a slight decrease (Figure 27).  
Weige et al. (11) reported that estradiol treatment (2 mg estradiol 18 mg 
cholesterol pellet) reduced the formation of total numbers of ACF by approximately 
50%, and induced 5.7-fold increase in apoptotic cells in the same mice model (AOM 
induced colon carcinogenesis model of ovariectomized c57BL6/J mice). The plasma 
level of estradiol was around 5 nM. In a different study, Weige et al. (186) observed a 
similar effect on reduction of total number of ACF in wild type C57BL6/J mice, but with 
lower estradiol treatment (1 mg estradiol 19 mg cholesterol pellet) and plasma estradiol 
concentration (1.9 nM). However, the proportion of apoptotic colon cryptic cells was 
45% higher in the estradiol group compared with that of control group.  
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Figure 27. The effect of crude sorghum extracts, white (1%) and black (1% and 1.5%), 
fed in the diet on percent of apoptotic cells in one colonic crypt of the distal colon of 
ovariectomized mice injected with azoxymethane (AOM). Data are expressed as mean ± 
SEM from 20 well-oriented crypts per animal measured by TUNEL assay. The percent 
of apoptotic cells are obtained by dividing the number of apoptotic cells in each crypt, 
identified by immunohistochemical staining of distal colon sections, by the total number 
of cells in that crypt. 
 
 
In order to better target a circulating estradiol concentration within the 
physiological range (1 nM), a pellet of 0.5 mg estradiol and 19.5 mg cholesterol was 
used in our study. This treatment produced around 1.4 nM estradiol in plasma of the 
mice. The limited inhibitory effect on formation of total ACF may be due to lower level 
of circulating estradiol in our study.  
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Figure 28. The effect of crude sorghum extracts, white (1%) and black (1% and 1.5%), 
fed in the diet on percent of proliferative cells in one colonic crypt of the distal colon of 
ovariectomized mice injected with azoxymethane (AOM). Data are expressed as mean ± 
SEM from 20 well-oriented crypts per animal measured by BrdU. The percent of 
proliferative cells are obtained by dividing the number of proliferative cells in each 
crypt, identified by BrdU immunohistochemical staining of distal colon sections, by the 
total number of cells in that crypt. 
 
 
In terms of the percent of proliferative cells, estradiol treatment was the only 
group which showed an increase in proliferative cells (59.7% increase), but not 
statistically different than that of control (p = 0.6705) (Figure 28). Other treatments had 
similar percent of proliferative cells (10.4-11.8%) as control (10.6%) (Figure 28). 
Elevated proliferation of estradiol group may indicate faster cell change-over, which 
would have contributed to the limited inhibition against formation of ACF in estradiol 
group. 
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According to our results utilizing YAMC cells as a model for potential ERβ 
activation and estrogenic activity of sorghum phenolic extracts (Chapter 3), apigenin 
was suggested as the most potent estrogenic compound in sorghum. Apigenin was 
reported to induce reversible G2/M cell cycle arrest in different human adenocarcinoma 
cells, at the concentrations of 20-80 µM (187). The cell cycle arrest was believed to be 
related to reduced levels of p34cdc2 and cyclin B1 proteins (187). The cell cycle arrest 
induced by apigenin was also reported to be p53 dependent, and apigenin was able to 
stabilize p53 proteins and induce apoptosis (188, 189). It is not clear whether these 
mechanisms were related to ER activation signaling, but induction of p53 after activation 
of ER has been suggested as the mechanism by which estradiol prevents early colon 
carcinogenesis (12).  
The protective effect of pure apigenin in reducing the AOM induced formation of 
premalignant lesions (ACF) in the colons of rodent models (approximately 50% 
reduction) was also reported by two independent studies, at the concentration of 0.1% 
apigenin added in the diet (185, 190). The proposed mechanisms were suppressing 
proliferation of colonocytes (190) and colonic ornithine decarboxylase activity (a rate 
limiting enzyme in polyamide biosynthesis) (185), but not induction of apoptosis (190). 
Interestingly, white sorghum extract fed at 1% level had a similar effect as previously 
reported for pure apigenin at 0.1% in diet (185, 190) in reducing total numbers of ACF. 
The finding was interesting and promising, considering that a crude extract was used and 
the level of apigenin in the diet (3.93 mg/100 g diet) was much lower than what was 
used in pure apigenin studies (100 mg/100 g diet).  A plausible explanation could be that 
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other phenolic compounds in the white sorghum extracts enhanced the activity of 
apigenin or stabilized the apigenin targeted protective mechanisms, as suggested by the 
enhanced effect between apigenin and naringenin in YAMC cells in Chapter 3. 
However, compared with the studies utilizing pure apigenin, the white and black 
sorghum extracts did not induce significant changes in proliferative cryptic cells. Some 
other mechanisms need to be explored.  
The black sorghum extract fed at 1% level in the diet was able to reduce the total 
number of ACF by 14.7% but not the high multiplicity ACF (Figure 26). The black 
sorghum extract contained 0.264 mg/g apigenin and a total of 2.26 mg/g flavones, 
mainly luteolin and methoxylated flavones (Table 17). Compared with the white 
sorghum extract, black sorghum extract had roughly half of the flavones present in white 
extract (2.26 versus 4.31 mg/g), which could partly explain the lower ACF reduction 
effect of black sorghum extract. Surprisingly, black sorghum extract fed at 1.5% level 
did not reduce the number of ACF significantly, compared with the effect observed for 
1% black sorghum extract. The relatively higher levels of non-estrogenic phenolic 
compounds in the black sorghum extract may have interfered with the estrogenic 
properties of flavones. In Chapter 3, using the YAMC cell model, we observed that 
higher levels of naringenin antagonized the estrogenic activity of apigenin. The impact 
of higher levels of 3-deoxyanthocyanins in black sorghum on estrogenic activity of 
flavones deserve further investigation. 
Similar to white sorghum extract, black sorghum extracts fed at 1% and 1.5% in 
the diet did not change the percentage of proliferative colon cryptic cells (Figure 28). 
 123 
 
 
However, a trend towards induction of apoptosis of black extract at 1.5% was observed 
(27% increase, Figure 27). Thus more detailed studies should be carried out to 
understand the molecular mechanisms of the chemopreventive potential of white and 
black sorghum extracts against colon carcinogenesis in an ovariectomized mice model. 
 
Future Studies 
 Our study showed that white and black sorghum extracts fed at 1% level in the 
diet were effective in reducing the total numbers of ACF formed in the colons of 
ovariectomized mice induced by AOM, by 39.3% and 14.7%, respectively. This 
suggests protection against colon carcinogenesis. Due to the fact that estradiol treatment 
did not significantly reduce total numbers of ACF and high multiplicity ACF, we can not 
conclude that these two sorghum extracts exerted protective effect through activities 
mediated via ERβ in the colon. Percent of apoptotic cells and proliferative cells did not 
suggest any clear mechanism for the protective effects observed. More detailed and 
specific mechanistic studies need to be conducted to explore the protective mechanisms 
of sorghum polyphenols. For example:  
1) The effect of composition of sorghum phenolic compounds on preventing 
colon carcinogenesis in vivo. Other estrogenic sorghum extracts with various phenolic 
composition can be tested in vivo, such as the dark red 99LGWO50 and lemon-yellow 
SC748 sorghum varieties used in Chapter 3. 
2) The effect of white and black sorghum extracts on key mutated genes and 
proteins related to colon carcinogenesis, such as APC, COX-2, and p53. 
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3) The effect of white and black sorghum extracts on enzymes and pathways 
related to metabolism and bioactivities of xenobiotics, such as cytochrome P450, 
cyclooxygenase-2, glutathione S-transferase, and Nrf-2 activation. 
4) The roles of microbiota in the gut in facilitating the metabolism and absorption 
of sorghum phenolic compounds, as well as the possible roles of the metabolites from 
sorghum phenolics in participating in the protective activities against colon 
carcinogenesis. 
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CHAPTER V 
 THERMAL STABILITY OF SORGHUM 3-DEOXYANTHOCYANINS 
 
Introduction 
Consumption of sorghum has been associated with many health benefits; 
however, the research related to phenolics in sorghum is mostly conducted on raw 
grains. Sorghum grains are typically thermally processed to make food for humans. The 
thermal processes include boiling, steaming, baking, flaking and extrusion, among the 
others. Structural changes induced by thermal processing can impact food quality and 
bioactive properties of polyphenols. Understanding the extent of degradation of 
polyphenols, mechanisms involved, and degradation products is useful to determine the 
potential impact on processed foods, such as predicting quality changes over time and 
exploring methods to stabilize the polyphenols during thermal processing. 
The common reactions of flavonoids induced by heat treatment include 
deglycosylation (157), breakage of ester bonds, generation of C6-C3-C6 structure 
fragments (e.g. protocatechuic acid) (158-160), as well as formation of neo-formation 
compounds (e.g. hydroxymethylfurfural, melanoidins) (161). These reactions contribute 
to flavor and color development during cooking (161), but the degraded and/or oxidized 
compounds may be involved in unfavorable reactions, such as oxidation (162). Heat 
treatment depolymerizes proanthocyanidins into lower molecular weight units (91), 
which are known to be more bioavailable. Some polyphenols, e.g. anthocyanins, can 
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polymerize during thermal processing, which can improve their color stability (163, 
164).  
Among the sorghum phenolics, the knowledge of thermal stability of 3-
deoxyanthocyanins is very limited. These pigments possess unique characteristics as 
potential food colorants and chemopreventive agents. Compared to anthocyanins, 3-
deoxyanthocyanins are not substituted at the C-3 position (Figure 3). Hence the 3-
deoxyanthocyanins are more stable to pH changes (27, 28) and the bleaching effects of 
common food additives, like ascorbic acid and sulfites (29). In addition, they are more 
cytotoxic than their anthocyanidin counterparts (30). Therefore, determining their 
thermal stability will add valuable information to the potential of these pigments as 
bioactive food ingredients. In addition, knowing the degradation mechanisms is valuable 
in looking for strategies to stabilize the 3-deoxyanthocyanins during processing. 
The pH of food matrix also influences color and stability of anthocyanins and 3-
deoxyanthocyanins. When in solution, anthocyanins and 3-deoxyanthocyanins establish 
a complex equilibrium between colored flavylium cation, quinoidal base, colorless 
chalcone and carbinol pseudobase. The acidity (ideally pH 1-2) of the matrix favors the 
ionization reaction for the formation and stability of flavylium cation. Increase in pH 
brings the equilibrium towards more hydration of flavylium cation into carbinol 
pseudobase, which results in loss of characteristic color (28, 191). The pH of foods and 
food products varies from ~2.0 (lime juice) to ~7.9 (Graham crackers), the majority fall 
in between 3.0-6.0 (192). Most anthocyanins are not stable in this pH range while the 3-
 127 
 
 
deoxyanthocyanins remain relatively stable (28, 86). However, how pH affects stability 
of 3-deoxyanthocyanins during thermal processing is still not clear. 
In order to evaluate thermal stability of 3-deoxyanthocyanins, the effect of heat 
treatment (121 °C, 30 min) at pHs 1-7, using different acidulants (HCl, formic acid and 
citric acid) were investigated. The severe time-temperature treatment was selected to 
ensure detectable changes (heat treatment at 95 °C for up to 2 hr did not result in 
meaningful changes, data not shown). Only acids were used in all solutions in order to 
eliminate the stabilizing effect from constituents of buffer systems. The 3 selected 
acidulants were aimed to compare the effect of mineral acid (HCl) with common organic 
acids (formic acid and citric acid). We hypothesize that type of acidulent and not pH 
alone, has an impact on stability of 3-deoxyanthocyanins.   
 
Materials and Methods 
 
Materials 
 
Crude 3-deoxyanthocyanin pigments. Crude 3-deoxyanthocyanin extract was obtained 
from dried red sorghum leaf sheaths (Health Forever Products, Lagos, Nigeria). 
Acidified aqueous methanol (formic acid : water : methanol = 1 : 49 : 50) was used to 
extract the sample, with 2 hr shaking at room temperature. Solvent was removed to 
complete dryness under vacuum at 40 °C using a Multivapor system (Büchi, Flawil, 
Switzland).   
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3-Deoxyanthocyanidin compounds. In order to evaluate the effect of 3-
deoxyanthocyanidin structure on its stability, major sorghum 3-deoxyanthocyanidins and 
methoxylated derivatives (Figure 29) were used in this study. Apigeninidin (APG), 5-O-
methyl-apigeninidin (5-OMe-APG), 7-O-methyl-apigeninidin (7-OMe-APG), 5,7-O-
methyl-apigeninidin (5,7-OMe-APG), luteolinidin (LUT), and 5,7-O-methyl-luteolinidin 
(5,7-OMe-LUT) were purchased from AlsaChim (Strasbourg, France). All pure 
compounds were synthetic and of at least 95% purity. 
 
OR3O
OR2
OH
R1
3-Deoxyanthocyanidins R1 R2 R3
Apigeninidin (APG) H H H
7-Methoxyapigeninidin (7-OMe-APG) H H CH3
5-Methoxyapigeninidin (5-OMe-APG) H CH3 H
5,7-Dimethoxyapigeninidin (5,7-OMe-APG) H CH3 CH3
Luteolinidin (LUT) OH H H
5,7-Dimethoxyluteolinidin (5,7-OMe-LUT) OH CH3 CH3
7
5
 
Figure 29. 3-Deoxyanthocyanidins used in thermal stability study. 
 
Methods 
 
Sample solution preparation. Crude 3-deoxyanthocyanin extract (10 mg/mL) and pure 3-
deoxyanthocyanidins (2 mg/mL, 5.94 - 6.84 mM) were reconstituted with HPLC grade 
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water (pH= 6.79) or acidified water of pHs 1-6 prepared with different acidulants (Table 
18) in Pyrex test tubes with plastic stoppers. Samples were sonicated at 40% output 
energy for 30 s using a tip probe (6 mm diameter) sonicator (VibraCell 40, Sonics & 
Materials Inc., Danbury, CT). Immediately after sonication, 0.5 mL of each solution was 
transferred to a 2.0 mL microcentrifuge tube for thermal treatment. 
 
Table 18. Design of 3-deoxyanthocyanin thermal stability experiment. 
Factors Variables  
Pigments Crude 3-deoxyanthocyanin extract 
Apigeninidin (APG) 
7-OMe-Apigeninidin (7-OMe-APG) 
5-O-Me-Apigeninidin (5-OMe-APG) 
5,7-OMe-Apigeninidin (5,7-OMe-APG) 
Luteolinidin (LUT) 
5,7-OMe-Luteolinidin (5,7-OMe-LUT) 
Acidulants Hydrocholoric acid (HCl) 
Formic acid 
Citric acid 
pHs 1, 2, 3, 4, 5, 6, 7 (water) 
 
 
Heat treatment. The heating experiment was carried out at 121 °C (0.13 MPa) for 30 
minutes using an autoclave (SM-300, YAMATO Scientific Co., Ltd., Tokyo, Japan). At 
the end of heat treatment, the samples were put in ice to stop any further degradation 
reaction. An aliquot of each sample after 30 minutes equilibration in ice bath was taken 
to analyze color intensity change (UV-vis spectroscopy) and degradation profiles (HPLC 
and UPLC-MS). The experiment was performed in duplicates. 
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Change in color intensity. For crude 3-deoxyanthocyanin extract, 150 µL heated sample 
was diluted 20-fold with 1% HCl in methanol (pH=1.0). For pure 3-deoxyanthocyanidin 
compounds, 50 µL of heated sample was diluted 60-fold using the same solvent for 
analysis. The absorbance at their respective λmax (A) was measured by a 
spectrophotometer (Shimadzu UV2450, Shimadzu Scientific Instruments, North 
America, Columbia, MD). A non-heat treated sample was diluted the same way and 
served as control (A0). Color retention after heat treatment was calculated by comparing 
A with its respective control A0. 
 
HPLC analysis. To profile changes in 3-deoxyanthocyanins due to thermal treatment, 
200 µL of treated crude 3-deoxyanthocyanins extract and 100 µL of treated pure 3-
deoxyanthocyanidins were diluted 5-fold and 10-fold, respectively, with 4% formic acid 
in methanol (pH=1.0), then filtered through a 0.2 μm nylon membrane syringe filter. A 
non-heat treated sample was diluted and filtered the same way and served as control. An 
Agilent 1200 series HPLC system (Agilent Technologies, Santa Clara, CA) was used for 
this analysis. It included a quadratic pump (with degasser), an autosampler, a column 
compartment, and a diode array detector (DAD). A Luna C-18 column (150 mm × 4.6 
mm, 5.0 µm, Phenomenex, Torrance, CA) was used to carry out the separation with a 
two solvent gradient: solvent A 1% formic acid in water and solvent B 1% formic acid in 
acetonitrile. The gradient based on solvent B was as follows: 0-3 min, 10%; 5 min, 18%; 
10 min, 20%; 23 min, 26%; 25 min, 28%; 28 min, 40%; 30 min, 60%; 30-32 min, 60%; 
34-40 min 10%. The column was kept at 40 °C during analysis and the flow rate was 1.0 
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mL/min. The injection volume was 20 µL for crude 3-deoxyanthocyanins extract and 5 
μL for all pure 3-deoxyanthocyanidin compounds.  
 
UPLC-ESI-MS analysis. To determine the structures of thermal degradation products, 
the 3-deoxyanthocyanidin samples used in this experiment were treated the same as for 
HPLC quantitative analysis. A Waters-ACQUITY UPLC/MS system (Waters Corp., 
Milford, MA) was used which consisted of a binary solvent manager, autosampler 
(sample manager), column heater, and photodiode array eλ detector (PDA) and 
interfaced with a tandem quadrupole (TQD) mass spectrometer equipped with an ESI 
source. The separation was performed on a Kinetex C18 column (150 mm × 2.10 mm, 
2.6 μm, Phenomenex, Torrance, CA) at 40 °C with following gradient at 0.4 mL/min: 
Solvent A (0.05% formic acid in water), solvent B (acetonitrile), and the percentage of 
solvent B was 12-41% from 0-23.5 min, 41-75% from 23.5-25.5 min, 75% isocratic 
from 25.5-28.5 min, then 75-12% from 28.5-29.5 min, and 12% isocratic for 5 minutes 
to equilibrate the column. The injection volume was 1 µL. The monitoring wavelength 
for 3-deoxyanthocyanin pigments was at 485 nm; while thermal degradation products 
were monitored at 280 nm and 340 nm. Mass spectrometric data were acquired in 
positive mode for 3-deoxyanthocyanins, and in negative mode for degradation 
compounds. Empower 2 software (Waters Corp.) was used to acquire and analyze data. 
The MS scan was recorded in the range of 100−1000 Da. Nitrogen was used both as a 
drying gas and as nebulizing gas, while argon was used as the collision gas (AOC, 
Bryan, TX). The nitrogen gas flow conditions were 800 and 50 L/h for desolvation and 
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at the cone, respectively. The source block temperature and desolvation temperature 
were set at 150 and 400 °C, respectively. Optimization of ionization conditions was 
based on the intensity of the mass signals of protonated/deprotonated molecules and 
performed for each individual peak/compound detected. Mass parameters were 
optimized as follows: capillary voltage, 3.5/3.0 kV; and cone voltage, 60/30 V for 
positive/negative ionization, respectively. The MS/MS scan was optimized as follows: 
cone voltage of 45/(30-40) V and collision energy of 35/(15-30) V. Compound 
identification was based on matching UPLC retention profile, UV-vis spectra and MS 
data with authentic standards. Where standards were not available, compounds were 
identified based on the fragment patterns compared with reports in the literature. 
 
Statistical analysis. Data were analyzed with one way analysis of variance (ANOVA) 
and treatment means were compared by Tukey’s HSD test. Differences between two 
groups of samples were compared by Student’s t-test. All statistical analysis was 
performed by SAS 9.2 (Cary, NC). 
 
Results and Discussion 
 
Thermal Stability of Crude 3-Deoxyanthocyanin Extract: Effect of pH and Acidulant 
The dried leaf sheath from red sorghum has very intense red color. It is 
commonly used in West Africa as a source of dye for various food and non-food 
applications (71). The 3-deoxyanthocyanins in the crude extract comprised mostly of 
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apigeninidin (7.5 mg/g), 7-OMe-apigeninidin (0.51 mg/g), and luteolinidin (0.27 mg/g), 
which was similar to what was reported previously (193). It also contained dimeric 3-
deoxyanthocyanidin pigments (193). Sorghum with red secondary plant color tends to 
accumulate mainly apigeninidin type pigments (24, 25). Besides 3-deoxyanthocyanins, 
the crude 3-deoxyanthocyanin extract also had a fair amount of apigenin (0.84 mg/g). 
Other phenolic compounds usually found in red sorghum, such as phenolic acids and 
flavanones, were detected in trace amounts. 
 The effect of pH and acidulants on color stability of crude 3-deoxyanthocyanin 
extract is shown in Figure 30. For HCl, color retained best in low pH conditions, i.e. pH 
1 and 2, with less than 7% loss of absorbance. As expected, the color retention decreased 
with decreased acidity between pHs 3-6 (76-39%). Color retention in distilled water was 
65%. For citric acid, the trend was similar to HCl, color retained best at pH 1. At pH 2 
and 3, a drastic decrease was observed, with 71% and 45% color retained, respectively. 
Color retention at pHs 4-6 were generally similar and ranged from 45-56%. 
Interestingly, formic acid showed a different trend in low pH conditions. Color retention 
in  pH 1 and pH 2 formic acid solutions was 61% and 48%, respectively, which were 
much lower compared with those of HCl and citric acid (p < 0.05). Color retention at 
pHs 3-6 was comparable to the other two acids (53-65%). Treatments with HCl had 
better overall color retention in high acidity solutions when compared with both citric 
and formic acids. 
The abundance of H+ in pH 1 solutions stabilizes the flavylium cation, and 
contributes to color stability. However the stability of pigments in formic acid solutions 
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was lower than the other two acids at pH 1 and pH 2. This may be because of the 
reducing properties of formic acid (194). As a reducing agent, at high concentrations, 
formic acid may get involved with redox reactions of the pigments, hence negatively 
affecting the thermal stability of 3-deoxyanthocyanins. 
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Figure 30. Color retention measured at λmax of crude 3-deoxyanthocyanin extract after 
heat treatment, at pHs 1-6 and neutral aqueous solutions. Data are expressed as mean ± 
SD of duplicate runs. Treatments with the same letter do not significantly differ 
(Tukey’s HSD, p < 0.05). Color retention was defined as absorbance of heat treated 
sample compared with corresponding non-heated control. 
  
Many studies have explored the stability of anthocyanins from different sources, 
but mostly at temperatures below 100 °C. Mishra et al. (195) reported that grape pomace 
retained 15-17% anthocyanins after heating in steel cans in a steam retort at 126.7 °C 
(steam temperature) for 25 min.  Jimenez et al. (196) found that the color of 
reconstituted blackberry juice (pH 2.8) retained about 25% after heating at 120 °C for 33 
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min. The crude 3-deoxyanthocyanin extract showed higher overall color retention after 
similar temperature-time treatment, which suggests better thermal stability. Thus the 
sorghum pigments may serve as functional food colorants. 
 
Thermal Stability of 3-Deoxyanthocyanidins: Degradation Mechanism and Structure-
Stability Relationship 
 The color retention of apigeninidin, luteolinidin and their methoxylated 
derivatives after heat treatment was determined in pHs 1-6 and neutral aqueous solutions 
to evaluate potential impact of 3-deoxyanthocyanin composition on sorghum pigment 
stability. Similar to the crude 3-deoxyanthocyanin extract, pH and acidulants affected the 
color retention of the pure compounds after heat treatment. HCl and citric acid 
treatments showed a similar trend: Highest stability at pH 1 and pH 2, with > 80% color 
retention (Figure 31). At pHs 3-6, the color retention was relatively similar among 
treatments with values of 68-78%. As observed for the crude 3-deoxyanthocyanin 
extract, formic acid treatments showed a completely different trend: Color was least 
retained at pH 1 (7.8-46%), followed by pH 2 (26-60%). Treatments at the other pH 
values had similar retention as HCl and citric acids (64-79%). The reducing properties of 
formic acid may have negatively affected color retention in pH 1 and 2 formic acid 
solutions (194). Samples treated in neutral aqueous solutions showed similar stability as 
the pHs 3-6 treatments, with 68-84% color retained. 
 The 3-deoxyanthocyanidins showed greater color retention after heat treatment 
compared with the crude 3-deoxyanthocyanin extract in general (Figure 30 and Figure 
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31). This was somewhat unexpected. The changes to other polyphenolic compounds in 
the crude 3-deoxyanthocyanin extract during heat treatment, such as oxidation, may have 
triggered degradation reactions of the pigments, hence reduced the relative color stability 
of the crude 3-deoxyanthocyanin extract. It will be important to study the thermal 
stability of additional natural 3-deoxyanthocyanin extracts with different pigment and 
copigment composition, especially those ones from various non-grain plant tissues, such 
as glumes, leaves, and leaf sheaths. This will be helpful to select suitable pigments and 
obtain them from most economical sources. 
The color retention of 3-deoxyanthocyanidins was also significantly affected by 
molecular structure. This effect was most apparent in formic acid treatments at low pH 
values (1 and 2). The methoxylated 3-deoxyanthocyanidins were less stable compared 
with non-methoxylated ones, with color retention of 7.8-39% versus 45-60%, 
respectively. The degree of methoxylation did not affect color retention: mono-
methoxylated apigeninidin (5- and 7-OMe-APG) had 7.8-39% color retained while di-
methoxylated ones (5,7-OMe-APG and 5,7-OMe-LUT) had 19-34%. However, the 
position of O-methyl substitution seems to affect stability: 5-OMe-APG was the only 
sample which has a single C-5 O-methyl substitution and yet had the lowest stability 
among all 3-deoxyanthocyanidin compounds (7.8% and 26% in pH 1 and pH 2, 
respectively). Since C-5 position is the most reactive one in anthocyanins and 3-
deoxyanthocyanins (197), the lower stability of C-5 O-methyl substituted compounds 
may be due to enhanced degradation reactions at this position because of the –OCH3 
group.
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Figure 31. Color retention measured at λmax of 3-deoxyanthocyanidins after heat treatment, in pHs 1-6 and neutral aqueous 
solutions. Treatments within the same compound with the same letter do not significantly differ (Tukey’s HSD, p < 0.05). 
Color retention was defined as absorbance of heat treated sample compared with corresponding non-heated control.
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Heat Induced Structural Changes to 3-Deoxyanthocyanidins 
In order to elucidate the structural changes contributing to loss of 3-
deoxyanthocyanidin color intensity, HPLC profiles were obtained on all treatments.  For 
all three acids, structural changes at pHs 3-6, as well as that in neutral conditions, were 
very similar. Thus chromatograms from a subset of representative samples (APG, 5-
OMe-APG, and 5,7-OMe-APG) treated with all three acids are shown as examples of 
degradation pattern (Figures 32-34). Structures of degradation products in all these 
treatments were determined by UPLC-MS using neutral solutions as the representative 
sample. For treatments at low pH conditions (pH 1 and 2), structure changes were 
minimal except for formic acid treatments. Figures 35-37 show chromatograms of the 
same subset (APG, 5-OMe-APG, and 5,7-OMe-APG) of samples treated with all three 
acids at pH 1. Structures of degradation products due to formic acid treatment (pH 2 as 
an example) were determined by UPLC-MS. Table 19 summarizes the products 
generated after heat treatment detected by UPLC-MS in neutral (water) and formic acid 
pH 2 solutions. Table 20 summarizes the MS/MS fragmentation patterns of key 
degradation products. 
In general, demethylation of 5-OCH3 substituted and condensation of 5-OH 
substituted 3-deoxyanthocyanidins were observed. Both reactions generated 3-
deoxyanthocyanidin derivatives which still had absorbance between 470-490 nm. 
Formation of chalcones was identified as a common and major degradation pattern in all 
samples, moreover, formation of reduced chalcones was identified as a minor 
degradation product in neutral conditions and the most significant product in formic acid 
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low pH treatments (1 and 2). Minor peaks of C-ring fragmentation products and 
chalcone adducts were also detected. 
 
 
 
Figure 32. HPLC chromatograms of apigeninidin (APG) in pH 6 aqueous solutions 
before and after heat treatment. Chromatograms at 280 nm, 480 nm, and 360 nm are 
sequentially stacked in one figure with 2% offset in retention time and 10% offset in 
absorbance. Peak numbers are referenced to Table 19. 
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Figure 33. HPLC chromatograms of 5-O-methyl-apigeninidin (5-OMe-APG) in pH 6 
aqueous solutions before and after heat treatment. Chromatograms at 280 nm, 480 nm, 
and 360 nm are sequentially stacked in one figure with 2% offset in retention time and 
10% offset in absorbance. Peak numbers are referenced to Table 19. 
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Figure 34. HPLC chromatograms of 5,7-O-methyl-apigeninidin (5,7-OMe-APG) in pH 6 
aqueous solutions before and after heat treatment. Chromatograms at 280 nm, 480 nm, 
and 360 nm are sequentially stacked in one figure with 2% offset in retention time and 
10% offset in absorbance. Peak numbers are referenced to Table 19. 
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Figure 35. HPLC chromatograms of apigeninidin (APG) in pH 1 aqueous solutions 
before and after heat treatment. Chromatograms at 280 nm, 480 nm, and 360 nm are 
sequentially stacked in one figure with 2% offset in retention time and 10% offset in 
absorbance. Peak numbers are referenced to Table 19. 
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Figure 36. HPLC chromatograms of 5-O-methyl-apigeninidin (5-OMe-APG) in pH 1 
aqueous solutions before and after heat treatment. Chromatograms at 280 nm, 480 nm, 
and 360 nm are sequentially stacked in one figure with 2% offset in retention time and 
10% offset in absorbance. Peak numbers are referenced to Table 19. 
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Figure 37. HPLC chromatograms of 5,7-O-methyl-apigeninidin (5,7-OMe-APG) in pH 1 
aqueous solutions before and after heat treatment. Chromatograms at 280 nm, 480 nm, 
and 360 nm are sequentially stacked in one figure with 2% offset in retention time and 
10% offset in absorbance. Peak numbers are referenced to Table 19. 
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Table 19. Identification of compounds detected after heat treatment of 3-
deoxyanthocyanidins in water (neutral) and formic acid pH 2 (acidic) aqueous solutions 
(monitored at 280 nm, 340 nm, and 485 nm) based on UPLC retention time (tR), UV-vis 
spectroscopic characteristics (λmax), and MS spectroscopic pattern. Ionization was 
performed in the positive mode for 3-deoxyanthocyanins and in the negative mode for 
the other compounds. 
Compound 
and conditions 
Peak 
No. 
tR 
(min) 
λmax 
(nm) 
[M+H]+ 
(m/z) 
[M-H]- 
(m/z) Proposed Identification
a 
Apigeninidin 
(APG) 
1 4.41 471 255 253 Standard 
neutral 2 5.589 277 
 
273 Reduced APG chalcone 
 
3 5.666 375 
 
271 APG chalcone 
 
4 15.467 224/372 
 
525 Adduct 1 
 
5 17.32 471 509 
 
APG dimer 
 
6 17.613 365 
 
525 Adduct 2 
acidic 7 3.371 282 
 
135b 1-(4-hydroxyphenyl)ethanone 
 
2 5.596 277 
 
273 Reduced APG chalcone 
 
8 15.181 264 
 
527 Adduct 3 
 
9 15.482 224/372 
 
525 Adduct 4 
 
5 17.32 471 509 
 
APG dimer 
5-OMe-APG 10 6.31 474 269 267 Standard 
neutral 1 4.41 471 255 
 
APG 
 
11 9.932 266/451 
 
287 Reduced 5-OMe-APG chalcone 
 
12 10.298 375 
 
285 5-OMe-APG chalcone 
 
13 15.252 269/477 
 
535 Adduct 5 
acidic 7 3.374 276 
 
135 1-(4-hydroxyphenyl)ethanone 
 
1 4.41 471 255 
 
APG 
 
14 7.354 294 
 
167 
Methoxylated 
phloroglucinaldehyde 
 
11 9.932 277 
 
287 Reduced 5-OMe-APG chalcone 
 
15 15.17 263 523 
 
Adduct 6 
5,7-OMe-APG 16 7.25 472 283 281 Standard 
neutral 17 5.83 469 269 
 
7-OMe-APG 
 
19 15.858 372 
 
299 5,7-OMe-APG chalcone 
 
20 16.345 276 
 
301 
Reduced 5,7-OMe-APG 
chalcone 
acidic 21 1.996 255 
 
137 p-Hydroxybenozic acid 
 
17 5.83 469 269 
 
7-OMe-APG 
 
20 16.337 276 
 
301 
Reduced 5,7-OMe-APG 
chalcone 
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Table 19-Continued      
Compound 
and conditions 
Peak 
No. 
tR 
(min) 
λmax 
(nm) 
[M+H]+ 
(m/z) 
[M-H]- 
(m/z) Proposed Identification 
Luteolinidin 
(LUT)  
3.363 487 271 269 Standard 
neutral 
 
3.704 278/306 
 
289 Reduced LUT chalcone 
  
3.953 379 
 
287 LUT chalcone 
acidic 
 
3.704 278/306 
 
289 Reduced LUT chalcone 
  
3.953 379 
 
287 LUT chalcone 
  
10.976 277/308 
 
559 Adduct 7 
7-OMe-APG 
 
5.83 469 269 267 Standard 
neutral 
 
3.363 278 
 
135 1-(4-hydroxyphenyl)ethanone 
  
10.196 275 
 
287 Reduced 7-OMe-APG chalcone 
  
17.81 486 537 
 
7-OMe-APG dimer 
  
22.06 486 805 
 
7-OMe-APG trimer 
acidic 
 
3.374 276 
 
135 1-(4-hydroxyphenyl)ethanone 
  
9.514 373 
 
285 7-OMe-APG chalcone 
  
10.204 277 
 
287 Reduced 7-OMe-APG chalcone 
  
17.81 486 537 
 
7-OMe-APG dimer 
  
22.06 486 805 
 
7-OMe-APG trimer 
  
22.803 273 
 
555 Adduct 8 
5,7-OMe-LUT 
 
6.26 487 299 297 Standard 
neutral 
 
1.333 
218/258/
293  
153 Phloroglucinaldehyde 
  
4.66 487 285 
 
7-OMe-LUTc 
  
13.28 377 
 
315 5,7-OMe-LUT chalcone 
acidic 
 
4.66 487 285 
 
7-OMe-LUTc 
  
13.173 
276/309/
377  
317 
Reduced 5,7-OMe-LUT 
chalcone 
  
13.281 377 
 
315d 5,7-OMe-LUT chalcone 
aRefers to UPLC-MS-MS/MS spectroscopic patterns summarized in Table 
20. bDominant MS fragment. cAssignment of O-methyl substitution pattern was based on 
degradation pattern of 5,7-OMe-APG. dCo-eluting, very small peak. 
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Table 20. Identification of compounds detected after heat treatment of 3-
deoxyanthocyanidins (monitored at 280 nm, 340 nm, and 485 nm) based on UPLC 
retention time (tR), UV-vis spectroscopic characteristics (λmax), and MS-MS/MS 
spectroscopic pattern. Ionization was performed in the negative or positive mode. 
Peak 
No. 
tR 
(min) 
λmax 
(nm) 
[M+H]+ 
(m/z) 
[M-H]-
 (m/z) 
MS/MS fragments 
(m/z) Proposed Identification 
7 3.37 276 
 
135 120, 93, 92 
1-(4-
hydroxyphenyl)ethanone 
14 7.35 294 
 
167 152 , 124, 96 
Methoxylated 
phloroglucinaldehyde 
 
9.51 373 
 
285 191, 165, 93 7-OMe-APG chalcone 
11 9.93 277 
 
287 193, 151, 147, 139, 93 
Reduced 5-OMe-APG 
chalcone 
 
10.20 277 
 
287 193, 191, 151, 147, 139 
Reduced 7-OMe-APG 
chalcone 
15 15.17 263 523 
 
507, 491, 415, 370, 255 Adduct 6 
 
22.06 486 805 
 
537, 385, 269 7-OMe-APG Trimer  
 
22.80 273   555 267 Adduct 8 
 
 
Compounds generated by demethylation. All the 5-O-methyl substituted 3-
deoxyanthocyanidins (5-OMe-APG, 5,7-OMe-APG, and 5,7-OMe-LUT) generated new 
pigment peaks with λmax between 470-490 nm that eluted earlier than the parent 
compound (Figures 33 and 34). By comparing the masses and retention times with those 
of the standards, it was confirmed that all the 5-O-methyl substituted compounds were 
partially demethylated at position C-5 into their corresponding 5-OH substituted 
compounds (Table 19, Figure 38). The fact that C-7 O-methyl substituted compound (7-
OMe-APG) was not demethylated,  may be due to the higher reactivity of the C-5 than 
C-7 as reported for anthocyanins (197). This indicates 3-deoxyanthocyanin structure 
may affect thermal stability. 
 
 148 
 
 
OR3O
OR2
OH
R1
OH
R2O
OR3
O
OH
R1
O
OH
OH
O
OH
H3CO
OH
OH
H3CO
O
O
OH
OH
HO
OCH3
O
HO
OH
R2O
OR3
O
OH
R1
1-(4-hydroxyphenyl)ethanone
[M-H]- = 135
OHR2O
OR3
O
B
A
or
Ring opening
Chalcone
C3-C4 Cleavage
Reduced chalcone
3-Deoxyanthocyanidin
Adducts
Condensation
OH
R2O
OR3
O
R1
OH
Hydration
Carbinol
pseudobase
OH
R2O
OR3
O
OH
R1
OH
OH
O
OH
B
Adducts
A
B
C
Examples:
Phloroglucinaldehyde
[M-H]- = 153
Methoxy-
phloroglucinaldehyde
[M-H]- = 167
p-Hydroxybenzoic acid
[M-H]- = 137
Apigeninidin dimer
R2 = H
[M+H]+ = 509
7-O-methyl-apigeninidin dimer
R2 = CH3
[M+H]+ = 537
Condensation
Condensation
5-OH substitutionDemethylation
5-OCH3 substitution
OH
O
CH3
OR3O
OH
OH
R1
O
O
OH
OH
OH
OH
R2O
R2O
 
Figure 38. A schematic illustration of thermal degradation mechanism of 3-
deoxyanthocyanidins. Intermediates [in brackets] were not detected. 
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Compounds generated by condensation reaction. Two C-5 –OH substituted 3-
deoxyanthocyanidins, APG and 7-OMe-APG formed condensed pigments which had 
similar λmax as 3-deoxyanthocyanins and eluted much later than the parent compounds 
(Figure 32). The product generated from APG (tR = 17.322 min, λmax = 471 nm) had 
[M+H]+ of m/z 509, and the one from 7-OMe-APG (tR = 17.806 min, λmax = 486 nm) 
had [M+H]+ of m/z 537. These two peaks had elution profiles and masses that matched 
dimers of APG and 7-OMe-APG, respectively (193) (Figure 38). 7-OMe-APG also 
generated a pigment product (tR = 22.064 min, λmax = 486 nm) which had [M+H]
+ of m/z 
805 and had major MS/MS fragments at m/z 537 (49% intensity, M-268 amu = loss of a 
7-OMe-APG group), m/z 269 (13% intensity, M-536 amu = loss of a 7-OMe-APG dimer 
group), and m/z 385 (45% intensity) (Table 20), which matched the fragmentation 
pattern for 7-OMe-APG trimer. Interestingly, the condensed dimers and trimers were 
only detected in APG and 7-OMe-APG samples after heat treatment, but not in the 5-O-
methyl substituted samples. This indicates that the 5-OH structure allows easier 
formation of the C4-C8 linkage of the dimers and trimers. This 5-OH reaction pattern 
was also observed in cyclic condensation reactions between 3-deoxyanthocyanidins and 
pyruvic acid (198). 
Anthocyanins from various sources, such as grape pomace (164), blackberry 
juice (199), wine (200), black olives (201), condense during processing and storage. Due 
to the presence of other phenolic compounds, flavanol-anthocyanin and pyrano-
anthocyanin type dimeric or oligomeric products are commonly detected. These 
condensed products are considered to contribute to stability of color during long term 
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storage. The formation of condensed dimers and trimers from 5-OH substituted 3-
deoxyanthocyanins would possibly contribute to color retention and stability after heat 
treatment.  
 
Chalcone formation after heat treatment. Products with λmax at 370-379 nm and a pattern 
of [M-H]- of m/z [M+18 amu] were detected in all samples after heat treatment at neutral 
and pHs 3-6 (Figures 32-34, Table 19). For example, the [M+18 amu] product from 7-
OMe-APG (tR = 9.51 min, λmax = 373 nm, [M-H]
- = 285) had MS/MS fragments of m/z 
165 (dominant ion), m/z 191 (37% intensity), and m/z 93 (43% intensity) (Table 20). The 
fragmentation pattern matched that of 7-OMe-APG chalcone (Figure 39). Chalcone is an 
opened C-ring product of 3-deoxyanthocyanidin as a result of hydroxyl addition at C-2 
and corresponding formation of carbinol pseudobase in mildly acidic aqueous solutions 
(202). Based on the spectrophotometric characteristics and MS pattern, chalcones of 
LUT, APG, 7-OMe-APG, 5-OMe-APG, 5,7-OMe-APG, and 5,7-OMe-LUT were all 
identified (Table 19). 
Chalcones were detected as the major degradation product in samples heated in 
neutral and pHs 3-6 solutions. The type of acidulant did not have a significant effect on 
the extent of chalcone formation (Figures 32-34).  
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(A) 7-O-methyl-apigeninidin (7-OMe-APG) chalcone
tR = 9.514 min [M-H]- = 285
(B) Reduced 7-O-methyl-apigeninidin (7-OMe-APG) chalcone
tR = 10.204 min [M-H]- = 287
m/z 135
 
Figure 39. Chemical structures and schematic fragmentation pattern (referenced to Table 
20) of 7-O-methyl-apigeninidin chalcone (A) and reduced chalcone (B). 
 
 
Structure of 3-deoxyanthocyanidins had an effect on the formation of chalcone. 
Non-methoxylated 3-deoxyanthocyanidins, APG and LUT, formed very small quantities 
of chalcones, while degree of methoxylation increased chalcone formation due to heat 
treatment (Figures 31-33). At pHs 4-6 and neutral conditions, chalcones were detected 
before heat treatment as a result of spontaneous hydration reaction at C-2 position.  
3-Deoxyanthocyanidins have greater deprotonation rate constant (ka) than 
hydration rate constant (kh) (202), hence convert less to the colorless carbinol 
pseudobases in aqueous solutions, which would lead to less formation of chalcones at 
low acidity and after heat treatment. Formation of carbinol pseudobase due to 
hydrophilic attack at the C-2 position, and corresponding formation of chalcones is the 
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first step of anthocyanins degradation due to thermal treatment (203-205). In this regard, 
less formation of chalcones of 3-deoxyanthocyanins may have contributed to better 
stability after heat treatment compared to anthocyanins. 
The methoxylated 3-deoxyanthocyanidins showed less color retention after heat 
treatment (Figures 31, 33, 34), which may be because of their higher tendency to form 
chalcones and hence are more prone to thermal degradation. Moreover, degree of 
methoxylation seemed to further increase the level of chalcone formation (Figures 32-
34), which was probably the reason for lower color retention of 5,7-OMe-APG and 5,7-
OMe-LUT in pHs 4-7. C-5 and C-7 O-methyl substitution eliminates the electron-
donating capacity of –OH at these positions compared to APG and LUT, thus strongly 
favors the cation hydration reaction towards more carbinol pseudobase and chalcone 
formation (206). Methoxylated anthocyanidins (such as malvidin, peonidin, petunidin) 
have been reported to form more chalcones than non-methoxylated ones (such as 
delphinidin and cyanidin) in pHs of 4-7 aqueous solutions (207). Furtado et al. (203) 
also found that malvidin had a slightly greater rate constant for chalcone formation and 
fission compared with cyanidin during thermal degradation. Thus, it is reasonable to 
believe that methoxylation of 3-deoxyanthocyanidins negatively affected their thermal 
stability. 
 
Reduced chalcone formation after heat treatment. Products with absorbance (λmax) at 
265-276 nm and a pattern of [M-H]- of m/z [M+20 amu] were detected in all samples as 
major products after heat treatment in low pH formic acid solutions (pH 1 and 2), as well 
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as a minor product after heat treatment in higher pH solutions (Table 19, Figures 32-37). 
 Peak 11 (tR = 9.932 min, λmax = 277 nm, [M-H]- = 287) was found as a product 
of 5-OMe-APG after heat treatment, which had MS/MS fragments of m/z 139 (dominant 
ion), m/z 135, m/z 151, and m/z 93 (Table 3); a similar compound (tR = 10.196 min, λmax 
= 275 nm, [M-H]- = 287) with almost identical fragmentation pattern was found as a 
product of 7-OMe-APG. The fragmentation pattern (Figure 39) of these two compounds 
was similar as that of 3-deoxyanthocyanin chalcones, but according to mass and UV-vis 
spectroscopic characteristics, the structures must have a saturated C3-C4 bond; thus 
were denoted as reduced chalcones. Based on the spectrophotometric characteristics and 
MS pattern, reduced chalcones from LUT, APG, 7-OMe-APG, 5-OMe-APG, 5,7-OMe-
APG, and 5,7-OMe-LUT were identified (Table 19). Adams (208) first identified α-
diketone as a thermal degradation product of cyanidin, which was formed as a result of 
formation of chalcones. The detection of reduced chalcones in 3-deoxyanthocyanidins 
after heat treatment in pHs 4-6 solutions followed a similar chalcone  ketone reaction 
pattern. 
 In samples treated in low pH formic acid solutions (pH 1 and 2), reduced 
chalcones were the major product formed after heat treatment. This effect was unique to 
formic acid, and only at pH 1 and 2. Formic acid has been used as a reducing agent for 
its capacity to give out both hydrogens and decompose into carbon dioxide (194). Hence 
the favored formation of reduced chalcones in pH  1 and 2 formic acid solutions should 
be a result of the reducing capacity of formic acid. The relative quantities of reduced 
chalcones followed the same trend as for formation of chalcones: Methoxylation 
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increased the level of reduced chalcones formed. This was probably due to the higher 
tendency of methoxylated 3-deoxyanthocyanidins to form chalcones (203, 207). Based 
on this reaction pattern, we thus conclude that the reduced color intensity of 3-
deoxyanthocyanidins in pH 1 and 2 formic acid solutions is probably due to the shift of 
equilibration to formation of reduced chalcones, which would favor higher chalcone 
formation from flavylium cation. 
    
C-Ring fragments and adducts formation after heat treatment. Several peaks with various 
masses were detected in samples after heat treatment. MS pattern, elution pattern, and 
the spectrophotometric characteristics indicated some were fragments from C-ring 
fission due to thermal degradation. 
Peak 7 (tR = 3.374 min, λmax = 276 nm, [M-H]- = 135) was identified as 1-(4-
hydroxyphenyl)ethanone (Table 19 and Table 20, Figure 38), a B-ring fragment, based 
on degradation pattern of anthocyanidins (158, 159). Peak 7 was detected in 7-OMe-
APG neutral and formic acid pH 2 solutions, as well as 5-OMe-APG formic acid pH 2 
solution after heat treatment (Table 19). Similarly, p-hydroxybenzoic acid (tR = 1.996 
min, λmax = 255 nm, [M-H]
- = m/z 137) was identified as another B-ring fragment 
(Figure 38), in 5,7-OMe-APG formic acid pH 2 solution after heat treatment. 
Peak 14 (tR = 7.354 min, λmax = 294 nm, [M-H]- = 167) was identified as 2-
methoxy-phloroglucinaldehyde (Table 20, Figure 38), an A-ring fragment, according to 
patterns of anthocyanidins (158, 159). Peak 14 was only detected in 5-OMe-APG formic 
acid pH 2 solution after heat treatment. Similarly, phloroglucinaldehyde (tR = 1.333 min, 
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λmax = 218/258/293 nm, [M-H]
- =  m/z  153) was also detected in 5,7-OMe-LUT formic 
acid pH 2 solution after heat treatment (Table 19, Figure 38). 
Formation of C-ring cleavage products is a common degradation scheme of 
anthocyanidins. Products such as phloroglucinaldehyde, p-hydroxybenzoic acid and its 
hydroxylated or methoxylated derivatives have been reported in different studies (158, 
159, 203). Formation of chalcone is considered as the initial step for anthocyanidins to 
yield C-ring cleavage products. All C-ring cleavage products were detected as minor 
peaks in pH 1 and 2 formic acid solutions, especially in the methoxylated 3-
deoxyanthocyanidins. Thus without the reducing effect of formic acid in these reactions, 
the evidence actually suggests that 3-deoxyanthocyanidins resisted fragmentation during 
thermal treatment. 
Minor dimeric adducts were detected in most samples after heat treatment except 
the two dimethoxylated 3-deoxyanthocyanidins (adduct 1-adduct 8, Table 19). These 
were likely chalcone adducts based on UV-vis characteristics, MS pattern and MS/MS 
fragmentation pattern. Examples of fragmentation pattern and proposed structures are 
shown in Figures 40 and 41 for adduct 6 (peak 15) and adduct 8 (chromatograms not 
shown), respectively.  
Sadinova et al. (158, 159) observed several adducts after heat treatment of 
purified anthocyanin fractions from different fruits/vegetables. They deduced the 
adducts were from two fragments from either the A-ring or the B-ring. Interestingly, the 
adducts detected in our study were mostly condensed with intact C-rings. This may 
indicate higher resistance to C-ring cleavage of 3-deoxyanthocyanidins than 
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anthocyanidins during heat treatment, which may additionally contribute to their thermal 
stability. 
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Figure 40. Proposed structure of adduct 6 (peak 15), as well as UV-vis characteristics 
and MS/MS fragmentation pattern.  
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Figure 41. Proposed structure of adduct 8 (peak not shown), as well as UV-vis 
characteristics and MS/MS fragmentation pattern. 
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Overview of Thermal Degradation Mechanisms of 3-Deoxyanthocyanidins 
 In summary, the degradation mechanisms of 3-deoxyanthocyanidins were 
depended on pH and acidulants, as well as the structure. Only the C-5 -OH substituted 3-
deoxyanthocyanidins (APG and 7-OMe-APG) condensed into dimers and trimer. The C-
5 O-methyl substituted 3-deoxyanthocyanidins (5-OMe-APG, 5,7-OMe-APG, and 5,7-
OMe-LUT) demethylated into their corresponding 5-OH substituted 3-
deoxyanthocyanidins. This was due to the more reactive nature of C-5 relative to C-7 
(197). Chalcone formation was the major color degradation product after heat treatment 
in pHs 3-6 and neutral aqueous solutions. High formic acid environment (pH 1 and 2) 
favored the formation of reduced chalcones, which shifted equilibration towards 3-
deoxyanthocyanidin hydration and chalcone formation thus resulted in greater color loss, 
due to the reducing capacity of formic acid (194). The C-ring cleavage products 
following chalcones or reduced chalcones formation were detected as minor peaks 
mostly in the methoxylated 3-deoxyanthocyanidins in the low pH formic acid solutions. 
Minor adducts of chalcones were also detected, especially in the low pH formic acid 
solutions. The thermal degradation pattern of 3-deoxyanthocyanidins followed the same 
reaction identified for the anthocyanidins. Compared with anthocyanidins, 3-
deoxyanthocyanidins were more resistant to C-ring fission, and chalcone formation was 
the major degradation product, which indicated relatively good thermal stability. 
 
 
 
 158 
 
 
Conclusions 
 The fact that no meaningful changes in color retention of sorghum 3-
deoxyanthocyanidins could be detected after heating in 95 °C water bath for up to 2 hr 
(data not shown) indicated good thermal stability of these pigments. In the subsequent 
treatments under severe heat (121 °C 30 min under pressure), it was clear that pH as well 
as acidulants affected thermal stability of 3-deoxyanthocyanidins. All 3-
deoxyanthocyanidins retained good color stability (< 20% loss) at pH 1 and 2 in the 
presence of HCl and citric acid, and retained 64-84% color in pHs 3-6 for all acidulants, 
as well as water after heat treatment. The effect of pH on color stability was expected 
because low pH conditions favor stability of colored 3-deoxyanthocyanidin flavylium 
cations. 
The type of acidulants did not affect color retention significantly at pHs 3-6, 
however, contrary to the effect of HCl and citric acid, formic acid treatments at pH 1 and 
pH 2 negatively affected the color retention of 3-deoxyanthocyanidins, due to its 
reducing capacity and generation of reduced 3-deoxyanthocyanidin chalcones. This 
suggests that the characteristics of acidulants should be considered during thermal 
processing of products containing natural anthocyanin pigments.  
Structure of 3-deoxyanthocyanidins also had an impact on their thermal stability. 
Methoxylation of 3-deoxyanthocyanidins decreased the thermal stability, especially in 
pH 1 and 2 formic acid solutions. Hydroxylation on the B-ring did not seem to affect 
thermal stability of 3-deoxyanthocyanins. Chalcone formation was recognized as the 
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first step of thermal degradation. Methoxylation of 3-deoxyanthocyanidins increased the 
formation of chalcones, hence negatively affected thermal stability. 
The presence of other phenolic compounds in the matrix of crude 3-
deoxyanthocyanin extract may have affected the thermal stability of 3-deoxyanthocyanin 
pigments. More studies are needed to establish the effect of 3-deoxyanthocyanin and 
copigment composition on thermal stability of natural sorghum 3-deoxyanthocyanin 
pigment extracts. 
Thermal stability of 3-deoxyanthocyanins is an important property when 
evaluating the potential of these pigments as bioactive food colorants. Results obtained 
from this study indicate good thermal stability of 3-deoxyanthocyanins, especially when 
tested as individual pure compounds. Strategies targeting less chalcone formations in 
low acid conditions, as well as the avoidance of reducing agents would help improve the 
stability of 3-deoxyanthocyanidins during thermal processing.  
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CHAPTER VI 
 SUMMARY 
 
 This study demonstrates that specific sorghum varieties possess estrogenic 
acitivity in cell models predominantly expressing ERα or ERβ. The estrogenic potential 
is related to phenolic compositions, especially the differences in flavonoid profiles 
among sorghum varieties. Flavones were found to be the most potent estrogenic 
compounds present in sorghum; while flavanones also suggested estrogenic activity at 
higher concentrations. On the other hand, studies with pure 3-deoxyanthocyanidins 
revealed that these pigments are probably not estrogenic. Experiments with pure 
apigenin (a flavone) and naringenin (a flavanone) supported the concept of higher 
estrogenic potency of flavones. In addition, we also found that naringenin enhanced the 
estrogenic potency of apigenin when the two compounds were combined at suboptimal 
levels. However, when combined at optimal levels, naringenin antagonized the 
estrogenic activity of apigenin. This evidence indicates that compounds in a crude 
mixture could synergistically exert bioactivity at lower concentrations than what is 
modeled with pure compounds. This study utilized crude sorghum phenolic extracts to 
determine the estrogenic activity, thus provided a more realistic evidence in the context 
of diet when compared to pure isolated compounds. Models using pure compounds may 
underestimate bioactivity by ignoring possible synergism among different polyphenols 
that occurs in a crude phenolic extract. 
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 White and black sorghum extracts fed at 1% level in the diet inhibited the 
formation of premalignant lesions induced by carcinogen azoxymethane in the colons of 
ovariectomized mice. This suggested that estrogenic sorghum extracts may contribute to 
colon cancer prevention in vivo at concentrations achievable through diet. However, no 
changes were observed in the proportions of colonic apoptotic or proliferative cells of 
the mice fed with sorghum extracts compared with the control. This suggested that other 
mechanisms were likely responsible for the observed inhibition of premalignant lesion 
formation. 
Thermal stability is an important property which could affect the 
chemopreventive capacity of sorghum phenolics. 3-Deoxyanthocyanins, as the most 
unique flavonoids in sorghum, have good potential to be used as functional food 
colorants. Sorghum 3-deoxyanthocyanins retained good color stability after heat 
treatment at 121 °C for 30 minutes (under pressure). The pH of media and type of 
acidulants affected color stability: More than 80% of color retained in pH 1 and 2 HCl 
and citric acid solutions, and 39-84% retained in solutions of pHs 3-7. Formic acid 
negatively affected the color stability at pH 1 and pH 2 due to its reducing capacity, 
while color retention in pHs 3-6 formic acid solutions was similar as HCl and citric acid. 
Methoxylation of 3-deoxyanthocyanidins decreased their color stability. Major 
degradation products of 3-deoxyanthocyanidins due to heat treatment were also 
identified, which would enable development of strategies to stabilize 3-
deoxyanthocyanins during processing. This information would open up opportunities to 
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evaluate 3-deoxyanthocyanins as food colorants in the context of food products and to 
maximize their color stability during food processing.  
Overall, the study showed that estrogenic activity of specific sorghum phenolic 
compounds is a likely mechanism for colon cancer prevention. This information is 
important in understanding the chemopreventive mechanisms of sorghum phenolic 
compounds, as well as identifying possible active components. The chemopreventive 
benefits of sorghum would promote the utilization of sorghum grains and brans as 
functional ingredients in food products. The 3-deoxyanthocyanins can be used as natural 
colorants in food products, especially low acid foods. The information on phenolic 
compositions of sorghum and estrogenic activity is also useful to selectively breed 
sorghum varieties accumulating compounds targeting prevention of specific diseases.  
Further studies on estrogenic activity of sorghum phenolic compounds and colon 
cancer prevention could focus on:  
1) Identifying molecular mechanisms for chemopreventive potential of sorghum 
polyphenols in vivo. 
2) Understanding the interactions among different phenolic compounds in crude 
sorghum extracts on estrogenic activity, and the potential impact of these interactions on 
colon cancer prevention. 
3) Determining active metabolites of sorghum phenolic compounds in vivo and 
their role on colon cancer chemoprevention. 
4) Evaluating the effect of food processing on the bioactivity and bioavailability 
of sorghum phenolic compounds. 
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5) Assessing physiologically relevant dose of sorghum phenolic compounds for 
colon cancer prevention. 
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